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I. Synthesis of pyroglutamic acid derivatives via double Michael reactions 
of alkynones 
Pyroglutamic acids and their derivatives are common structural units of widespread 
chemical significance and they have been heavily utilised as building blocks for 
asymmetric synthesis.  
A new method for the synthesis of highly functionalised pyroglutamic acid 
derivatives, which consists in a Double Michael addition route that utilises amide-
tethered carbon diacids and aromatic alkynones as substrates, is here described. The 
reaction proceeds with good levels of trans-diastereoselectivity, provided that 





II. Michael additions combined with Friedel-Crafts cyclisations  
A domino Michael/Friedel-Crafts alkyation of aryl ethers with propargyl ketones was 
developed as a continuation of our double Michael additions. The reaction, here 
described, proceeds in good yield over two steps, when the aryl ethers and alkynones 
are treated with substoichiometric quantities of Yb(OTf)3 and heated to 100 oC in a 
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1.1 Pyroglutamic acids 
1.1.1 Background  
Glutamic acid (1) is one of the 20 α-amino acids commonly found in animal and 
vegetal proteins as the L-form. It is very abundant in nature and can be found as the 
terminal group in biologically active peptides.1 Almost half of the antibodies 
reported in the literature contain a glutamic acid residue at the N-terminus.2 L-
Glutamate also serves as a major excitatory neurotransmitter in the mammalian 
central nervous system. It contributes not only to fast synaptic neurotransmission but 
also to complex physiological processes like plasticity, learning, and memory.3 
Glutamic acid is the most widely used α-amino acid in asymmetric synthesis because 
of its versatility and low cost. 
 
Pyroglutamic acid or 2-oxotetrahydropyrrole-5-carboxylic acid (2), a naturally 
occurring α-amino acid, can be regarded as a glutamic acid derivative with the 
carboxylate γ to the nitrogen internally protected. It can be easily obtained from 
glutamic acid by intramolecular dehydration,4 or by enzymatic5 or nonenzymatic2 
degradation in proteins (Scheme 1). It is, therefore, very abundant in nature. 
 
Scheme 1 
Pyroglutamic acid and its derivatives have a wide range of chemical significance 
since they can be employed in numerous chemical processes, including: 
1.1.1.1 as building blocks for the synthesis of natural products,  
1.1.1.2 as precursors of azabicyclic compounds,  
1.1.1.3 as scaffolds for the de novo design of peptides, 
1.1.1.4 as chiral auxiliaries. 
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1.1.1.1 Pyroglutamic acids as building blocks for the synthesis of natural 
products 
Enantiomerically pure derivatives of pyroglutamic acid can be used as scaffolds in 
the synthesis of numerous biologically active compounds and natural products 
including domoic acid (3),6 kainic acid (4),6 the neurotoxin anatoxin A (5),7 (-)-
stemoamide (6),8 and the alkaloid (+)-gephyrotoxin (7)9 (Scheme 2). 
 
Scheme 2 
The synthetic routes for the synthesis of the aforementioned natural products are 
reported here, beginning with the synthesis of (-)-domoic acid (3), isolated from the 
red algae Chondria armata (Rhodomelaceae) by Okamura (Scheme 3).6 
 
Scheme 3 
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The synthesis, performed by Ohfune and co-workers,6 starts with N-tert-
butoxycarbonyl-L-pyrroglutamic acid (8), which is converted into the alcohol 9a. 
Adduct 9a, upon treatment with tert-butyldimethylsilyl chloride and imidazole in 
dimethylformamide, afforded silyl ether 9b, which was converted into the 
unsaturated amide 10 by the selenenylation oxidative-deselenenylation10 procedure. 
Cycloaddition of 2-(trimethylsi1yl)oxy-1,3-pentadiene (prepared from trans-3-
pentene-2-one/LDA/trimethylsily chloride, -78 oC) with the pyrrolone 10 in toluene 
(135 oC, sealed tube, 3 days) proceeded stereoselectively to afford a single adduct 12. 
After several further steps adduct 12 was transformed into the desired product 3. 
 
The total synthesis of anatoxin A (5), a potent nerve-depolarising agent, was 
performed by Martin and Brenneman,11 and commenced with the N-protection of the 
commercially available D-methyl pyroglutamate (13) (Scheme 4).  
 
Scheme 4 
The resulting Cbz-lactam 14 was reacted with 3-butenylmagnesium bromide (15) in 
the presence of TMEDA to afford the ring-opened product 16. Ketone 16 was 
subsequently transformed into the cis-2,5-disubstituted pyrrolidine 17 (dr) 11:1 by a 
highly diastereoselective cyclisation-reduction strategy. At this stage, 17 was 
converted into the acetylene 18. Subsequently the intramolecular enyne metathesis 
converted (2R,5R)-18, into (1R,6R)-19. Conversion of (1R,6R)-19 into (+)-anatoxin-
A (5) was achieved through osmylation of the alkene, followed by cleavage of the 
resulting diol (71% yield over three steps).7  
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(-)-Stemoamide (6) is an alkaloid isolated from Stemona tuberose, extracts of which 
have been employed in Chinese traditional medicine for many years.8 Similarly to 
the previous examples, its synthesis began with a pyroglutamate derivative, the 
known hydroxymethyl lactam 21 (Scheme 5). 
 
Scheme 5 
The hydroxymethyl lactam S-21, was obtained from L-pyroglutamic acid (2a) 
through a three-step route involving esterification by treatment with thionyl chloride 
in methanol (90%), followed by ester reduction by treatment with NaBH4 (92%), and 
protection of the resulting primary alcohol S-20 with ethyl vinyl ether and 
trichloroacetic acid (93%).8 The oxazole S-23 was then obtained by alkylation of S-
21 with 2-(3-chloropropyl) oxazole (22) and NaH in dimethylformamide (67%), 
followed by deprotection upon treatment with TsOH in MeOH that produced adduct 
S-24 (83%). After further steps oxazole S-24 was then transformed into (-)-
stemoamide (6). 
 
The Kishi-Fujimoto synthesis of (+)-gephyrotoxin (7),9 isolated from dendrobatid 
frogs, also began with the commercially available L-pyroglutamic acid (2a), which 
was converted into the nitrile 25 following the Silverman procedure12 (Scheme 6).  




Treatment of the nitrile 25 with P2S5 gave a thiolactam which was subjected to the 
Eschenmoser sulfide contraction and deacylation reactions13 to give the vinylogous 
urethane 26. Hydrogenation of 26 afforded a 2.3:1 mixture of cis- and trans-
pyrrolidines 27a/27b. The cis-pyrrolidine 27a was then converted into the urethane 
28 in a three-step procedure involving treatment of 27a with phenylchloroformate, 
followed by ester reduction with LiBH4 and ring closure by treatment with potassium 
hydride. DIBAL reduction of 28, followed by acid hydrolysis, gave an aldehyde 
which was reduced and protected as a methoxymethyl ether. Base hydrolysis of this 
product gave the pyrrolidine 29, which had the indicated absolute configuration. The 
pyrrolidine 29 was converted to the vinylogous amide 30. Finally, following a known 
procedure,14 the vinylogous amide 30 was converted to gephyrotoxin (7). 
 
The total syntheses reported above showed the importance of pyroglutamic acid and 
its derivatives as precursors in the construction of pharmacologically important 
compounds. Pyroglutamic acid could also be regarded as γ-lactam and since the γ-
lactam subunit is widespread in nature, it serves as an important pharmacophore in 
the drug-discovery process. For example, compounds containing γ-lactams have 
direct applications in the treatment of epilepsy, HIV, neurodegenerative diseases, and 
depression.15 The neurotrophic agent lactacystin (31)16, and its derivative omuralide 
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(32),17 the potent anticancer agent salinosporamide A (33),18 the HIV protease 
inhibitor (35) and (-)-pramanicin (34),19 are just a few examples of 




1.1.1.2  Pyroglutamic acids as precursors of azabicyclic compounds 
As well as being important precursors for the synthesis of natural products 
pyroglutamic acid derivatives can be efficiently transformed into numerous 
pharmacologically active azabicyclic20,21 compounds as N-bridged species 36,20,22 
pyrrolizidines 37 and indolizidines 3820,23 (Scheme 7).  
 
Scheme 7 
In general, azabicyclic ring skeletons are important structural subunits present in 
numerous alkaloids and are common scaffolds in biologically active and 
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pharmaceutically significant compounds. The N-bridged compound anatoxin A, of 
which the synthesis has been reported above (Scheme 4, pp. 4), is a nerve 
depolarising agent, and several pyrrolizidine derivatives, isolated mostly from 
plants,24 are responsible for chronic liver poisoning in animals.25 Moreover, 
indolizidine alkaloids have been isolated from a myriad of sources, including ants, 
frogs, fungi, and trees, and can exhibit phytotoxic, fungicidal, antibacterial, and 
neurological properties.26  
 
The pyrrolizidine (-)-heliotridane (44)27, provided a framework for testing new 
synthetic methodologies applicable to alkaloid total synthesis (Scheme 8).  
 
Scheme 8 
The synthesis began with the pyroglutamate derivative 39 which, after condensation 
with n-butanal and ester reduction with NaBH4, gave the enamide 40 in 66% yield. 
Enamide 40 underwent Moffat oxidation affording aldehyde 41 (83% yield), which 
subsequently underwent Wittig olefination and hydrolysis of the butenyl group 
affording lactam 42. Adduct 42 was alkylated with ethylbromoacetate, reduced, and 
transformed into the iodide 43 (36%). Finally the iodide 43 was cyclised 
stereoselectively and reduced to the desired (-)-heliotridane 44.  
 
Two examples of indolizidines derived from pyroglutamic acids are swainsonine 
(45), known for its ability to inhibit glycosidases, and (+)-monomorine (46), a trial 
pheromone of the pharaoh ant Monomorium pharaonis L. The synthesis of the latter 
is shown below (Scheme 9).28 
 





After protection of 47a, which is derived from commercially available L-
pyroglutamic acid as the Cbz derivative 47b, cross metathesis reactions were carried 
out with a stoichiometric quantity of methyl vinyl ketone in a 0.05 M 
dichloromethane solution, using the Grubbs-Hoveyda catalyst. The reaction 
proceeded in CH2Cl2 at room temperature affording 48 in 81% yield. Adduct 48 was 
then subjected to removal of the Cbz group by treatment with catalytic Pd/C (10%) 
under hydrogen atmosphere, resulting in concomitant intramolecular reductive 
amination and cyclisation to compound 49. Reduction of 49 with DIBALH afforded 
the intermediate corresponding aldehyde, which was immediately added to the 
propyl Wittig ylide to give the Z-alkene 50 in satisfactory yield. Finally, Pd catalysed 
reduction of 50 afforded (+)-46. 
 
1.1.1.3 Pyroglutamic acids as scaffolds for the de novo design of peptides 
The examples reported above showed in general the importance of pyroglutamic acid 
derivatives in the synthesis of azabicyclic compounds. Among the pyroglutamic 
acids, the β-substituted derivatives 52 are also very important as they can give access 
to a family of sterically constrained β-substituted amino acids 53-56. These serve as 
indispensable χ-(chi)-constrained scaffolds for the de novo design of peptides and 
peptidomimetics with a predetermined tridimensional structure (Scheme 10).20 





In a peptide, the χ-(chi)-angles, in conjunction with the backbone angles, define the 
position of side-chain functional groups in space (chi space) (Figure 2). The 
conformation of a peptide (including the chi space) is crucial for biological activity 
and is regarded as the critical issue in the design of more selective and/or more 
potent peptides as enzyme inhibitors, and agonists or antagonists at receptors. Thus 
the χ-(chi)-angles are of key importance in understanding the mode of action of 
peptides.29  
 
Figure 2 Definition of the dihedral angles φ, ψ, ω and χ of a peptide. 
 
The β-substituted derivatives of pyroglutamic acid can be regarded as 
conformationally restricted α-amino acids with well-defined complementary χ-
characteristics. Therefore they are of considerable importance among the many tools 
that are required to aid investigations of χ-space.29  
 
β-Substituted derivatives of pyroglutamic acids can also be used as precursors in the 
synthesis of pharmacologically important compounds. Transformation of 51 
(Scheme 11) into the β-substituted γ-amino acid derivatives 56 led to the synthesis of 
the very well known commercial drug Baclofen (57)30,31.  





Baclofen 57 is a GABAB (γ-aminobutyric acid transmembrane) receptor agonist that 
is used to treat spasms caused by spinal cord injuries and also shows some potential 
as a treatment for cocaine addiction. The synthesis, performed by Herdeis and 
Hubmann, is reported below (Scheme 12).  
 
Scheme 12 
Once the pyroglutamic acid derivative 58 was obtained the synthesis proceeded in a 
reasonably straightforward way.31 Barton-decarboxylation32 of 59 followed by ring 
opening with acid treatment (HCl, 6M) gave the desired product R-Baclofen·HCl 57.  
 
1.1.1.4 Pyroglutamic acids as chiral auxiliaries 
As well as versatile building blocks for the asymmetric synthesis of natural products 
and numerous pharmacologically interesting compounds, pyroglutamic acid 
derivatives have also been widely employed as chiral auxiliaries.1 The well known 
chiral auxiliary (R)-1-amino-2-methoxymethylpyrrolidine (RAMP) 60b, to give an 
example, is easily prepared in five steps from (R)-pyroglutamic acid 2b 33,34 and it 
has been employed, together with its enantiomer (S)-1-amino-2-
methoxymethylpyrrolidine SAMP 60a, in a wide range of reactions involving C-C or 
C-heteroatom bond formation (Scheme 13).35,36 





The so-called “hydrazone method”, involving the RAMP/SAMP chiral auxiliaries, 
has mostly been used to carry out an asymmetric version of the classical alkylation α 
to the CO group of aldehydes and ketones.34 According to the general mechanism, 
which is summarised in four steps below, the chiral hydrazone 65 was easily 
obtained by mixing RAMP 60b or its analogue 60a and the carbonyl compound 
under water separation conditions (Scheme 14).35 With the aldehydes 64a, the 
reaction runs at 0 oC without any solvent, while the ketones 64b have to be heated to 
reflux with catalytic amount of acid in benzene or cyclohexane using a Dean and 
Stark separator. Metallation with lithium diisopropylamide in ether at 0 oC formed 
the chiral azaenolates 66 followed by alkylation with various iodides and bromides at 
-110 oC, furnished the product hydrazones 67.  
 
Scheme 14 
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Finally hydrazone cleavage, either by acidic hydrolysis of the methyl iodide in a two 
phase system of 3N HCl/n-pentane, or by ozonolysis in n-pentane at -78 oC, leads to 
the α-susbstituted acyclic carbonyl compound 68. The “chiral information” contained 
in the hydrazine enables the enantioselective control of the C-C bond-forming 
reaction. The broad application and versatility of the RAMP/SAMP hydrazone 
methodology makes it a very useful tool for the synthesis of natural products. 
RAMP-Derivatives have been employed in the past for the synthesis of the 
polypropionate metabolites denticulatin (69)33,37, isolated from Simphonaria 
denticulate; the fruiting body-inducing pheromone of the myxobacterium S. 
aurantica (S)-stigmolone (70);33,38 stenusine (71),33,39  a propulsion fluid produced by 
the beetle Stenus comma and the polyketide marine natural product callystatin 
(72)33,39 isolated from the sponge Callyspongia truncate, to name just a few (Scheme 
15).  
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Other examples of pyroglutamic acid derivatives used as chiral auxiliaries include 
ethyl (S)-4,4-dimethylpyroglutamate (75) reported by Ezquerra and co-workers, 
which has been used in aldol reactions40 and Michael addition reactions41 (Scheme 
16). Ethyl (S)-4,4-dimethylpyroglutamate (75) was prepared from N-Boc protected 
pyroglutamate 73 by dimethylation of the corresponding lithium lactame enolate 
with CH3I. After the urethane protecting group removal with TFA, 75 was obtained 
with a 70% overall yield from 74.42 
 
Scheme 16 
The chiral auxiliary thus obtained was employed in the aldol reaction reported below 
(Scheme 17). It was treated with butyllithium and propionyl chloride affording the 
N-propionyl derivative 76 in 80% yield. The (Z)-boron enolate of 77 was then 
allowed to react with benzaldehyde giving the syn product 78 in 70% isolated yield 
and > 98% de40 After hydrolysis of 78, the ester 79 was obtained in good yield (94%) 
and the chiral auxiliary 75 was effectively recovered (70%). Remarkably, the 
potentially labile pyroglutamate C-2 stereogenic centre, which is responsible for the 
asymmetric induction, was preserved during the aldol reaction. 
 
Scheme 17  
The chiral auxiliary 75 was employed again by Ezquerra and co-workers to perform 
conjugate addition reaction of Grignard-derived organocopper reagents to α,β-
unsaturated N-acyl fragments, as an effective means of preparing enantiopure β-
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substituted carboxylic acids.41 Ezquerra et al. reported in their work that 
deprotonation of 75  with n-BuLi followed by treatment with crotonyl chloride 
furnished the Michael acceptor ethyl (S)-N-trans-2-butenoyl-4,4-
dimethylpyroglutamate (80) in 65% yield (Scheme 18). It was found that the best 
general reaction conditions for conjugate additions required the addition of TMSC1 
to generate the PhCu-TMEDA-TMSCl as an organocopper-Lewis acid reagent. This 
methodology afforded product 81 in good yield (81%) and excellent stereoselectivity 
(> 95% de). 
 
Scheme 18 
Adduct 81 was then hydrolysed with LiOH in THF yielding a chromatographically 
separable mixture of (S)-4,4-dimethylpyroglutamic acid 83 (71% yield) and the 
corresponding β-branched carboxylic acid, (S)-3-phenylbutanoic acid (82) (75% 
yield). 
Ethyl N-dienylpyroglutamates 94  have been used as chiral dienes in Diels-Alder 
reactions (Scheme 19).43 The dienes 96 are easily prepared in one step from ethyl 
pyroglutamate 94 and the α,β-unsaturated aldehydes 95 in toluene with p-TsOH.44 
Reported here is an example of a Diels–Alder reaction, presented by Smith and co-
workers, where 87a-c reacts with acrylates (88a-c) (50% aq. EtOH reflux) giving the 
cycloadducts 31a-c and 32a-c in very good yield (77%-91%).43  




entry R R1 R2 Y (%)      dr (%)      
1 CO2Et H CO2Et 91 93:7 
2 CO2Et Me CO2Et 77 92:8 
3 CO2Et H COMe 79 82:18 
 
Scheme 19 
The diastereoselectivity was also excellent and the cis-adducts 89a-c were isolated in 
91-97% de  
The hetero Diels-Alder reaction of dienes 91 with nitrosodienophiles generated in 
situ, reported by J. B. Behr et al,44 took place in a regioselective manner leading to 
cycloadducts 92a-e and 93a-e in a range of 62% - 80% yield (Scheme 20). The best 
asymmetric induction was found when R = NMe2 (de = 84 %), whereas induction 
was small when R = NH2 (de = 28 %), as shown below. 
 
entry R Yield (%) de (%)  
1 NMe2 70 84 
2 OMe 63 52 
3 Ph 70 44 
4 Me 62 34 
5 NH2 80 28 
 
Scheme 20 
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Ohsawa and co-workers,45 in their asymmetric synthesis of 1-substituted 1,2,3,4-
tetrahydro-β-carbolines 110, carried out a screening of chiral auxiliaries made from 
pyroglutamic acid derivatives. (S)-Pyroglutamic acid 2a was chosen as the starting 
material for the design of new chiral auxiliaries owing to its similarity with other 
standard amino acids employed in the past as chiral auxiliaries, including alanine, 
valine, or phenylalanine (Scheme 21). However, in contrast to these, (S)-
pyroglutamic acid 2a possesses a more rigid structure. Thus, tert-butyl (S)-
pyroglutamic 94 was treated with 9-anthracenylmethyl halide in the presence of 
sodium hydride, to give derivative 95, which was then transformed into the 
corresponding carboxylic acid 96. 
 
Scheme 21 
The chiral auxiliary 96 thus prepared readily reacted with β-carboline 97, a common 
nucleus of various indole alkaloids, through the use of 1-(3-dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride (EDCI), to give 9-acyl-β-carbolines 98 (Scheme 
22). Adduct 98 then underwent asymmetric addition with allyltributyltin and reacted 
with 2,2,2-trichloroethyl chloroformate to give a 1,2-dihydro adduct 99 in 98% yield, 
which was subsequently hydrolysed to 100 in a quantitative yield and 91% ee. 
Finally the chiral auxiliary 96 was completely recovered under mild hydrolytic 
conditions.  
 





Owing to the reasons outlined above, the development of asymmetric methods for 
the preparation of enantiomerically pure pyroglutamic acid derivatives would give 
access to a whole family of these extraordinarily valuable compounds. 
 
1.1.2 Previous Methodologies for the Synthesis of Pyroglutamic Acid 
Derivatives 
As previously mentioned, L-pyroglutamic acid is very abundant in nature and can be 
easily derived from L-glutamic acid by dehydration; both L and D-pyroglutamic acid 
are commercially available. Nevertheless, highly substituted and enantiomerically 
pure derivatives of pyroglutamic acid, which are key components for a wide range of 
synthetic applications, are not easily accessible. There is no straightforward general 
synthesis available for this simple framework and many research groups have been 
focusing on the development of new synthetic routes toward pyroglutamic acid 
derivatives. Some selected methods that have been employed in the past are 
summarised below (Scheme 23): 
1.1.2.1 Ugi condensation  
1.1.2.2 Michael addition  
1.1.2.3 [3+2] Annulations 
1.1.2.4 1,3-Dipolar cycloaddition  
1.1.2.5 Radical cyclisation 






1.1.2.1 Ugi condensation  
The Ugi reaction is a four component condensation which involves the reaction of an 
aldehyde or a ketone, an imine, an isocyanide and a carboxylic acid forming a bis-
amide in one single step (Scheme 24). Therefore it is a very useful method for the 
syntheis of complex molecules.  
 
Scheme 24 
When two of the components, for example a ketone and a carboxylic acid, are 
incorporated into a single molecule, cyclic products are formed. The Ugi 4-centre-3-
component reaction of γ-ketoacids, for example, provides ready access to the carbon 
framework of many pyroglutamic acid analogues. Harriman et al. reported an 
intramolecular Ugi reaction leading to the γ-lactam 103 in good yield (79%) 
(Scheme 25).46  





In the proposed mechanism the reaction proceeds first through the formation of 
imine 104. Additon of the isocyanide 102 then provides the nitrilium intermediate 
105. Intramolecular attack of the carboxylate on the nitrilium carbon provides the 
cyclic intermediate 106 which, upon treatment with methanol, resultes in ring-
opening and formation of intermediate 107. Subsequently, intramolecular 
nucleophilic attack of the amine to the carbonyl group affordes the desired γ-lactam 
102.46 
Kobayashi and co-workers also employed the Ugi condensation to prepare a range of 
unprotected 2-substituted pyroglutamic acids, starting from levulinic acid (108) 
(Scheme 26).47 Ammonium acetate and levulinic acid (108) were premixed in 
trifluoroethanol at 60 oC to promote imine formation. Addition of the isonitrile 109 
to the mixture then afforded product 110 from average to good yield (49%-67%). 
The Ugi product (110), when treated with camphorsulphonic acid (0.2 equiv.), 
afforded the N-acyl-indole (111), which was subsequently cleaved to form the free 
pyroglutamic acid (112).47 





In addition to being a key step in the formal synthesis of omuralide (Introduction, 
pp.6), this methodology was also applied by Kobayashi and co-workers for the total 
synthesis of (-)-dysibetaine,48 a natural product isolated from the Micronesian sponge 
Dysidea herbacea.49 
 
1.1.2.2 Michael addition   
Michael addition between a nucleophilic glycine equivalent and a substituted acrylic 
acid derivatives represents a very straightforward and general route to β-substituted 
prolines, glutamic and pyroglutamic acids (Scheme 27).  
 
Scheme 27 
Soloshonok et al. developed a stereoselective Michael addition employing chiral 
derivatives of α,β-unsaturated carboxylic acids with achiral glycine equivalents.21 
Their idea was to provide geometric homogeneity of the glycine enolate (E- or Z-
enolate only) and conformational homogeneity of the Michael acceptor (s-cis or s-
trans only), in order to impart high diastereoselectivity to the reaction. Therefore, 
Soloshonok and co-workers designed and produced o-aminoacetophenone-derived 
Ni(II) complexes of glycine 113, which were then employed in a Michael addition 
with the α,β-unsaturated ester 114, generating the product 115 in quantitative yield 
and high diastereoselectivity (98%) (Scheme 28).  





Adduct 115 was subsequently decomposed with HCl to give the glutamic acid 
intermediate 116, which was generally converted into the target pyroglutamic acid 
117 by treatment with ammonia.  
 
1.1.2.3 [3+2] Annulations 
Another easy access to the pyroglutamic skeleton is through the [3+2] annulation 
reaction between a dianion and an activated alkene (Scheme 29).  
 
Scheme 29 
An example is the reaction between the α-sulfonylacetamide 118 and the α,β-
unsaturated ester 119 employed by Chang and co-workers13,20 for the synthesis of the 
commercial drug Baclofen mentioned above (Scheme 12, pp. 11). The one-pot 
synthesis begins with the 1,4 addition of dianion 118 to α-bromoester 119 and 
proceedes through ring closure after bromide substitution resulting in the formation 
of adduct 120 as a single isomer in 61% yield. Treatment of 120 with sodium 
amalgam and sodium phosphate, followed by addition of water to the resulting 
mixture and acidification, afforded product 121 (Scheme 30). 




Despite the excellent stereo- and regioselective outcome the reaction requires at least 
three steps, plus formation of the α-sulfonylacetamide. 
 
1.1.2.4 1,3-dipolar reactions. 
Similar to [3+2]-annulations are the 1,3-dipolar reactions, which represent another 
easy route toward heterocyclic five-membered rings and pyroglutamic acids. The 
latter involves a reaction between a 1,3-dipol (a species with a nucleophilic and an 
electrophilic end) and a dipolarophile species such as an activated alkene (electron-
deficient or electron rich) (Scheme 31). 
 
Scheme 31 
In order to prepare pyroglutamate derivatives Alverez-Ibarra et al. selected a 
Sm(III)-azomethine ylide 124 as the dipole (Scheme 32).50 In the past 
metalloazomethine ylides have been used for the synthesis of highly substituted 
prolines.51 In his reaction Alverez-Ibarra replaced the azomethine counterpart with an 
imidothiocarbonate. The Sm(III)-azomethine ylide 124 was prepared in three steps 
from 122. The radical fragmentation of compound 122 was triggered by addition of 
SmI2, producing the Sm(III)-azomethine ylid 124 through intermediate 123. 124 Was 
then employed in the cycloaddition with α,β-unsaturated ester 125 affording adduct 
126, which upon acid treatment afforded the γ-carboxypyroglutamate 127 in good 
yield (70-85%) and high diastereoselectivity (80-85%).50 





Although elegant this process requires several steps, including the synthesis of the 
Sm(III) ylide 124 and acid hydrolysis to give the final product 127 and gives access 
only to the racemic adduct.  
 
1.1.2.5 Radical cyclisations 
Pyroglutamates can also be prepared via a radical mechanism. Radical cyclisations of 
carbamoylmethyl radicals onto N-allyl52 or N-vinyl53 groups producing  
pyrrolidinones have long been known (Scheme 33).  
 
Scheme 33 
Parsons and co-workers, inspired by previous work, developed a radical cyclisation 
to generate pyroglutamate derivatives using dehydroalanine 128 with Bu3SnH 
(Scheme 34).54 In the proposed mechanism the dehydroalanine 128 undergoes 
radical cyclisation through the formation of the intermediate 129, which is relatively 
stable and easy to form. 





The reaction then proceedes in a 5-endo-trig mode that produce the 4-substituted 
pyroglutamate 130 in 77% yield, which upon treatment with ceric ammonium nitrite 
(CAN) in acetonitrile affordes the unprotected product 131. Unfortunately, there is 























1.2 Double Michael additions 
1.2.1 Proposed methodology 
The aforementioned methodologies are all well designed, giving the desired product 
in high yield, and in some cases with a stereoselective outcome. However, they often 
require many steps, stoichiometric amounts of promoters, or the use of strong bases, 
all of which diminish their attractiveness.  
An ideal pathway in a synthetic sequence should have the following features: brevity, 
convergence and modularity. A route which satisfies these ideal requirements in the 
synthesis of pyroglutamic acid derivatives is a domino Michael-Michael reaction 
between a tethered diacid and a propargyl ketone (Scheme 35). A domino, tandem, 
or cascade reaction consists of two or more intramolecular reactions which often 
proceed via highly reactive intermediates. The reaction is often fast, and displays 
high atom economy, since it is intramolecular and does not involve workup or 
isolation of the intermediates. 
 
Scheme 35 
The suggested strategy would be concise and convergent since an amide-tethered 
diacid 132 would react with an alkynone 133 to give the mono-Michael product 134 
and/or 135, which would then cyclise to give the highly functionalised product 136 
in a maximum of one or two steps. This strategy would provide significant 
modularity because small modification on the alkynone, or on the tethered diacid 
moiety, would provide a small library of Michael acceptors and nucleophiles, 
allowing the production of a wide array of pyroglutamate building blocks. Moreover, 
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the possible use of substoichiometric amounts of a base or Lewis acid could offer 
good prospects for asymmetric catalysis. The proposed strategy belongs to a broader 
group of reactions known as double Michael additions, of which a brief overview is 
reported in the following section. 
 
1.2.2  Double Michael additions  
Domino Michael-Michael reactions, better known as double Michael additions, had 
been known for a very long time since they can quickly lead to the construction of 
polycyclic compounds and therefore they hold a great potential in the synthesis of 
complex natural products.55 Although there are many different examples of 1,4 
double conjugate additions they can be divided into four main classes: 
1.2.2.1 addition of two ambiphilic species,  
1.2.2.2 addition between a 1,1-dinucleophile and a 1,n-dielectrophile,  
1.2.2.3 addition between a 1,n-dinucleophile and a 1,n-dielectrophile,  
1.2.2.4 addition between a 1,n-dienucleophile and a 1,1-dielectrophile. 
 
1.2.2.1 Additions of two ambiphilic species 
Ambiphilic species possess one or more groups which can act as both a nucleophile 
and an electrophile, such as α,β-unsaturated ketones (Scheme 36). This feature 
allows them to undergo domino conjugate additions with other α,β-unsaturated 
carbonylic compounds.  
 
Scheme 36 
An intramolecular version of these domino additions is the reaction employed as the 
key step in the synthesis of (±)-culmorin and (±)-longiborneol, performed by Ihara 
and co-workers,56 where the two ester groups within the methylcyclopentenone 
derivative 137 react with each other, with the aid of a base (LiHMDS), giving the 
functionalised polycyclic product 138 (Scheme 37). 





A more recent and slightly different example is the organocatalytic asymmetric thio-
Michael-Michael intermolecular reaction performed by Wang and co-workers in 
which a heteroatom (sulphur) linked to an α,β-unsaturated ester acts as the 
nucleophile which initiates the domino process (Scheme 38).57  
 
Scheme 38 
According to Wang’s report,57 trans-ethyl 4-mercapto-2-butenoate 140 undergoes 
double Michael reaction with α,β-unsaturated aldehyde 139 when treated with chiral 
diphenylprolinol TMS ether (141) (10 mol %) in toluene at room temperature, 
affording tetrahydrothiophenes 142 in high yield (up to 96%) and excellent 
enantioselectivity (>99% ee, 18:1 dr). 
With regards to organocatalytic asymmetric reactions it is also worth mentioning the 
domino organocatalytic Michael-Michael reaction performed by Wang et al. for the 
diastereoselective and enantioselective synthesis of cyclopentanes 144 (Scheme 
39).58 Similarly to the previous example, the α,β-unsaturated aldehyde 139 undergoes 
a cascade process when treated with the catalyst 141 (10 mol %) and the ester 143 in 
EtOH, at room temperature, affording the cyclopentene 144 in good yield (up to 
95%) and high enantioselectivity (99% ee).58  





In the proposed mechanism the α,β-unsaturated aldehyde 139 forms a reactive 
intermediate 145 with catalyst 141. The intermediate 145 then undergoes a first 
Michael addition with the α,β-unsaturated ester 143 forming intermediate 146, which 
subsequently reacts in a second Michael addition affording the desired cyclopentane 
144. 
 
1.2.2.2 Additions between a 1,1-dinucleophile and a 1,n-dielectrophile  
In this process a 1,1-dinucleophile, e.g. a primary amine, reacts with a 1,n-
dielectrophile, e.g. a bis(enone) (Scheme 40).59 
 
Scheme 40 
In the process, shown below, aniline 147 (the nucleophile) is treated with vinyl 
sulfone 148 (the electrophile) and AlCl3 in toluene giving phenylthiomorpholine 
dioxide 149 (Scheme 41). 





In their efforts towards the synthesis of xestocyclamine, Danishefsky and co-
workers60 also developed a type of cascade reaction where the primary amine 152  
reacts with the (bis)enone 151 affording the two complex structured products 153 




1.2.2.3 Addition between a 1,n-dinucleophile and a 1,n-dielectrophile  
This type of conjugate addition is similar to the previous one, except that the 
nucleophile has two separate reactive centres, such as in a ketoester or nitroester. An 
example of an addition of a (bis)enone and a 1,n dienucleophile is the reaction 
reported by Aube and co-workers.61 They carried out a regioselective double 
conjugate addition between ethyl acetoacetate (155), and the cyclohexadienone 154 
producing intermediate 157, which then cyclises in the oxo-bridge bicyclic 
compound 156, in good yield (84%) (Scheme 43). 
 





Two years later, Aube published another report on double conjugate additions using 
a very similar mechanism.62 In this more recent work an addition between the lithium 
dianion 162 of ethyl 3-nitropropionate (158) and p-benzoquinone dimethyl ketal 159 
was carried out and this afforded intermediate 163 which then cyclised to give a 
mixture of diastereomeric [3.2.1]bicyclooctanones 160. These products were then 
converted into an advanced intermediate, which was previously used in the formation 




1.2.2.4 Additions between a 1,n-dinucleophile and a 1,1-dielectrophile 
In this process, a 1,1-dielectrophile, which in most cases is a propargyl ketone, 
undergoes a double nucleophilic attack with a generic tethered dienucleophile, such 
as a diamine, a dithiocompound, an amino alcohol or a diacid. A recent example of 
this methodology, first developed by Grossman and co-workers, is the synthesis of β-
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keto dithiane derivatives performed by Ley et al.64 In their efforts to produce a robust 
and efficient route to orthogonally protected 1,3-dicarbonyl precursors to use in 
polyketide assembly programs, they developed a double conjugate addition for the 
synthesis of β-keto dithiane derivatives.64 In the reaction shown below, ethane or 
propane dithiol 165, was added to the ynones 164 in the presence of methoxide in 
dichloromethane and methanol, to give β-keto dithiolanes 166a and β-keto dithianes 
166b in high yields (90% and 94%) (Scheme 45).64 
 
Scheme 45 
In the proposed mechanism the dithiol 165, would initially undergo mono-
deprotonation followed by addition to the ynones 164 to give intermediate 167, 
which then rearranges to 168. The α,β-unsaturated carbonyl compound 168 leads to 
the desired product 166a-b after a second and intramolecular conjugate addition.64 
Another recent example of a hetero domino Michael-Michael reaction between a 1,n-
dinucleophile and a 1,1-dielectrophile is the asymmetric synthesis of azolidines 
reported by Kwon and co-workers.65 Amino-acid-derived pronucleophiles 169 were 
employed as Michael donors, and electron deficient acetylenes 170 as Michael 
acceptors, providing efficient access to azolidines 171a-c, containing both diversity 
and asymmetry, with the aid of a phosphine ligand (dppp) (Scheme 46).65 





The proposed mechanism, reported below, begins with the conjugate addition of the 
phosphine ligand to the acetylene 170 and proton transfer, followed by the mono-
deprotonated amino alcohol attack on the intermediate I, that produces the 
intermediates III and IV. An intramolecular nucleophilic attack from the amine 
would then occur affording the desired product 171a-c (Scheme 47).  
 
Scheme 47 
The last example presented here is of most interest to us not only within this 
particular category of Michael additions, but also within the whole range of double 
conjugate additions. In fact, the reaction occurs between a 1,1-dielectrophile (the 
usual alkynone that has been so commonly employed in this type of double Michael 
additions) and a 1,n-dinucleophile that possesses two carbon acidic centres connected 
by a tether to give the resulting cyclised product. In the previous examples the 
nucleophilic centres were heteroatoms, thio, aza or oxygen based (Scheme 48).  





Grossman, in his effort to find a suitable pathway for the synthesis of the natural 
product Azadirachtin, was the pioneer in this field, being the first to employ 
electrophilic alkynes as the 1,1 dielectrophiles.66  
An overview of Grossmann double Michael additions is provided in the next section.  
 
1.2.3 Grossman’s double Michael additions 
Over the past few years, Grossman and co-workers have described a range of 
reactions where compounds containing two acidic carbon atoms (tethered diacids) 
undergo double Michael reactions with electron deficient alkynes (mostly 3-butyn-2-
one) to provide highly functionalised cyclic products, generating two new carbon-
carbon bonds and up to three new stereogenic centres, often with high levels of 
diastereoselectivity.66 This reaction has been effectively utilised in the preparation of 
a range of five- and six-membered carbocycles. In comparison, application of this 
methodology to heterocycle construction has been limited, with just one report of a 
[5 +1] annulation route to piperidines having been described.67  
Grossmann’s first attempt of intramolecular double Michael addition between the 
tetraester 172 and the ketone 173 actually failed. He did not obtain the desired 
product 175 but only the mono-Michael adduct 174 and in very poor yield. It was 
suggested that the reason for this failure was an incipient 1,3-diaxial interaction 
between the two ester groups of the hypothetical transition state I (Scheme 44). 
 
Scheme 49 
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The problem was overcome by substituting one or more esters with a cyano group. 
The cyano group was in fact a powerful electron-withdrawing group (Ka of ethyl 
cyanoacetate was about five orders of magnitude smaller than the Ka of diethyl 
malonate) and had a smaller 1,3-diaxial interaction in cyclohexanes than almost any 
other group. As expected the reaction with the dicyano diester 176 was successful 
giving the three products 177a, 177b, and 177c in 83% combined yield and 4:4:1 dr, 
after treatment of the cyanoester 176 and alkynone 173 with a substoichiometric 
quantity of potassium carbonate in acetone (Scheme 50). 
 
Scheme 50 
They also discovered that 177b and 177c could be converted into the lower energy 
177a by treatment with potassium tert-butoxide in dichloromethane. Indeed when 
176 and 173 were combined under these conditions the dr of the crude mixture was 
30:1:1 in favour of 177a.  
The double Michael reaction also proceeds well when the two carbon acidic atoms in 
the substrate were connected by a shorter tether as in diethyl 2,5-dicyanoadipate 178 
giving the five-membered rings 179a and 179b in good yield (72%) (Scheme 51).68 
 
Scheme 51 
It was observed when using sodium hydride as a base in tetrahydrofuran that the dr 
after 1 h was 1:1 but if the reaction mixture was stirred at room temperature for four 
days the ratio improved to 8:1. A further example is the cyclisation of the nitroester 
180 into the cyclopentanes 181a and 181b (Scheme 52).66 





In this case the mixture of tethered diacids and the propargyl ketone was first treated 
with sodium hydride in tetrahydrofuran giving the products 181a and 181b in a 2:1 
dr. After treatment with potassium tert-butoxide in dichloromethane at room 
temperature, 181a was completely converted into 181b. It was concluded that 
thermodynamic ratios of products are obtained with potassium tert-butoxide in 
dichloromethane, whereas kinetic ratios of products are obtained under other 
conditions such as sodium hydride in tetrahydrofuran, potassium carbonate in 
acetone at room temperature, and triphenyl phoshpine in acetonitrile. It was also 
found that the kinetic products can be converted into the thermodynamically more 
stable products by treatment with potassium tert-butoxide in dichloromethane. It was 
speculated that the mechanism behind the equilibration was probably a retro-
Michael-Michael process, during which a first retro-Michael reaction occurs, 
followed by rotation about the σ bond and then ring reclosure via a second Michael 
addition (Scheme 53).  
 
Scheme 53 
Grossman and co-workers also extended the double Michael reactions to carbon 
diacids that have a ketone group or a heteroatom in the tether, for the synthesis of 
cyclic ketones69 and piperidines67 respectively. Treatment of tethered diacid 182 and 
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3-butyn-2-one (173) with triphenylphosphine in acetonitrile led to the two 
diasteromeric mono-Michael products 183a and 183b which both cyclised and 
afforded ketone 184 as a single stereisomer, in 59% and 69% yield respectively after 
treatment with sodium hydride in tetrahydrofuran (Scheme 54).69  
 
Scheme 54 
Tethered diacid 185 and 3-butyn-2-one (173) were treated with potassium tert-
butoxide in dichloromethane affording the desired piperidine 186 as a single 
stereisomer in very good yield (99%) (Scheme 55).67 
 
Scheme 55 
The six- and five-membered cyclic compounds thus obtained were considered useful 
for the synthesis of densely functionalised and architecturally complex compounds 
such as trans-fused bicyclic products, usually trans-decalins, but also trans-
hydrindane. For example the six- and five-memebered rings 177b, 188, and 181a, 
underwent Dieckman reaction when treated with sodium ethoxide in ethanol and the 
resulting products were immediately treated with TsOH and ethanol in benzene 
affording the corresponding enol ethers 187, 189 and 190 (Scheme 56). 68 
 





Double Michael adducts with two cyano groups, of which one is equatorial, may 
undergo hydrogenation over Pd/C in AcOH, affording trans-perhydroisoquinoline as 
in the example shown below, where 191 was obtained as a single stereoisomer in 
69% yield upon reduction of 192 (Scheme 57). 
 
Scheme 57 
Grossman finally applied the strategy he discovered for the synthesis of the naturally 
occurring product (±)-sacacarin (199)70, a minor component in the bark of a Brazilian 
tree used as a natural drug for the treatment of digestive upset (Scheme 58). 
Scheme 58 
The key part of the synthesis is a double annulation, which consists of a combined 
double Michael addition, Pinner and Dieckman reactions. The Michael addition of 
the tethered carbon diacid 193 to a 3-butyn-2-one (194) gave the six-membered ring 
product 195 in 66% yield and 60:1 dr after recrystallisation. Then the Pinner 
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reaction, followed by the Dieckman reaction provided the trans-octalone 198 in 90% 
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2. RESULTS AND DISCUSSION 
 
2.1 Design and synthesis of starting materials  
In view of the convergent and modular nature of double Michael reactions of 
alkynones, we were drawn to the prospect of utilising these transformations in a 
concise synthesis of highly functionalised pyroglutamic derivatives, according to the 
strategy outlined below (Scheme 59). 
 
Scheme 59 
It was hoped that under suitable conditions, an amide-tethered diacid 132 would react 
with an alkynone 133 with the aid of a base and with or without a Lewis acid to first 
give mono-Michael adduct 134 and/or 135, which would then cyclise to the 
pyroglutamic acid derivative 136.  
As far as the choice of alkynones was concerned, we selected the aromatic alkynones 
133a-f, since they were easy to prepare with a two-step synthesis, which consisted of 
a nucleophilic addition of the Grignard reagent to the corresponding aromatic 
aldehyde 200 (Table 1). The resulting alcohols 201, without further purification, 











entry alkynone R yield (%) 










































The p-fluoro alkynone 133g was already available because it had been previously 
prepared by a former postdoc in the Lam group Dr Hu (Figure 2). 
 
Figure 2 
In all previous examples of double Michael reactions reported by Grossman and co-
workers,4,5 a mandatory requirement for success was the presence of at least one 
cyano substituent in the tethered diacid, which ends up in a pseudoaxial position in 
the product (see, Scheme 49, pp 40). It was proposed that the small size of the nitrile 
group reduces the magnitude of unfavourable 1,3-diaxial interactions between 
acidifying groups in the transition state for cyclisation, which would otherwise 
inhibit ring closure. Therefore at the outset of this work, we chose to make a 
preliminary screening of the amides containing a nitrile group. Tethered diacids 202, 
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The amide-tethered diacid 202 was then treated with potassium tert-butoxide and 
with a solution of the aromatic alkynone 133a in dry dichloromethane at room 
temperature (Scheme 61). The reaction provided a complex mixture of products. 
 
Scheme 60 
The reaction was then repeated using the tethered diacid 203 with a methyl group in 
the β-position to the amide producing the unexpected five-membered heterocycle 
204 (Scheme 61).  
 
Scheme 61 
The likely explanation of this result is an intramolecular nucleophilic attack of the 
malonyl group onto the nitrile group, followed by formation of intermediate 205. 
Intermediate 205, thus obtained, would then tautomerise to give the five-membered 
ring 204 (Scheme 62). 
 
Scheme 62 
Other starting materials were selected including substrates both with or without 
protecting groups. Tethered diacids with only esters as electron withdrawing groups 
were also targeted, although it was uncertain whether diacids without a cyano 
substituent would undergo successful double Michael addition. Tethered diacids 207, 
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The amide-tethered diacids not bearing a protecting group (206 and 209) were easily 
prepared by treatment of the corresponding aminomalonate 213 and 
aminocyanoacetate 217 with ethyl chloromalonate (214) in dichloromethane 
(Scheme 64). Aminocyanoacetate 217, unlike the aminomalonate 213, was not 
commercially available and was prepared from 215. The cyanoester 215 underwent 
oxidation upon treatment with sodium nitrite and acetic acid at room temperature. 
The resulting oxime 216 was then treated with sodium dithionite and sodium 
bicarbonate in water affording adduct 217, which was used for the next step without 
further purification. Upon treatment of adduct 217 with ethylchloromalonate (214), 














In order to generate the starting material 208 with a benzyl group as the protecting 
group, we started from the aminomalonate 218 (Scheme 65). Upon treatment with 
benzaldehyde and sodium cyanoborohydride in methanol, the aminomalonate 218 
underwent reductive amination. The resulting residue 219, without further 
purification, was treated with chloromalonate 220 and a saturated aqueous solution 
of sodium carbonate in dichloromethane affording the desired product 208 in 40% 
yield. 
Scheme 65 
Diacids 211 and 210 were prepared in generally good yield upon treatment of amines 
223 and 224 with methyl or ethyl malonyl chloride (214, 220) in dichloromethane 
(Scheme 66). In some cases the malonyl chloride was generated in situ from the 
corresponding acid with oxalyl chloride and DMF. Amine 225 was already available 
because it was prepared by Isabel Villanueva Mrgalef (a former PhD student in the 
Lam group), while 223 was prepared by treatment of methyl bromomalonate 222 
with an excess of aniline 222. The mixture was heated to reflux in tetrahydrofuran 
and after purification afforded the amine 211.  































 Chapter 2-Results and discussion  
 
 47
2.2 Double Michael additions  
It is known that N,N-disubstituted amides generally prefer to exist as the Z-amide 
rotamer, presumably for steric reasons, and also that N-alkyl-N-arylamides exist 
predominantly as the E-amide rotamer, with the aryl group twisted such that the 
plane of the aromatic ring is approximately perpendicular to that of the amide group 
(Scheme 67).71  
 
Scheme 67 
At the outset of these investigations it was not clear whether this rotamer distribution 
would have any impact on the ability of these substrates to undergo cyclisation. 
However, using the aforementioned conditions (potassium tert-butoxide in 
dichloromethane), several reactions were performed employing tethered diacids with 
a benzyl group as a protecting group or without protecting group (Scheme 68). 





When amides 206 and 207 were treated with potassium tert-butoxide the reaction 
produced a complex mixture of products, while when amides 209 and 206 were 
treated under the same conditions, no product was observed. The results of these 
experiments clearly indicated the importance of the protecting group in the reactivity 
of the double Michael reaction. Most likely these results depend on a different 
acidity of the protons in the tethered diacids and/or on the steric hindrance of the 
protecting group. The total absence of reactivity in the unprotected diacids is perhaps 
due to the deprotonation of the N-H group. 
Substrate 212 was treated with potassium tert-butoxide and a solution of the aromatic 
alkynone 133a in dichloromethane at room temperature (Scheme 69). The reaction 
produced the mono-Michael product 226 as single diastereoisomer (E). Although 226 
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Several methods to cyclise the mono-Michael product 226 were attempted but in 
most cases only starting material was recovered. These results suggested that the 
acidic centre β to the amide was possibly too hindered to undergo a second Michael 
addition. Therefore the tethered diacid 210 was selected. We were particularly 
pleased to observe the formation of the double Michael product 227a upon treatment 
of 210 with potassium tert-butoxide and a solution of the aromatic alkynone 133a in 
dichloromethane at room temperature. The reaction produced the Michael product 
227a in good yield, albeit as a 1:1 mixture of the two diastereomers (Scheme 70).  
 
Scheme 70 
We next investigated the effect on the reaction of different bases, along with Lewis 
acidic additives.72 Among the conditions explored, treatment of 210 with 
triphenylphosphine, which was employed by Grossman in his double Michael 
reactions (Scheme 54, pp. 40) the cyclisation did not occur, while triethylamine gave 
the cyclised product in poor yield. Treatment of 210 with potassium tert-butoxide 
and substoichiometric quantities of Lewis acid additives were found either to inhibit 
or improve the yield and the diastereomeric ratio of the conjugate addition (Table 2). 
Many metal salts were used as additives and the most representative examples are 
shown below. 
 
entry reagent (20 mol %) dr yield(%) 
1 KOtBu 1:1  68 
2 KOtBu, Fe(acac)3 1:1 31 
3 KOtBu, Zn(OTf)2 > 19:1 27 
4 KOtBu, Mg(OTf)2 11:1  68 
5 KOtBu, Ni(acac)2 18:1 76 
 
Table 2 
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Addition of Fe(acac)373 and Zn(OTf)274 was found to inhibit the reaction (entries 2 
and 3), even if Zn(OTf)2 had a beneficial effect on diastereoselectivity (entry 3). 
Mg(OTf)275,76 (entry 4) and Ni(acac)277 (entry 5) gave better results allowing double 
Michael product 227a to be isolated in 68-76% yield and with up to an 18:1 
diastereomeric ratio. Interestingly the use of sodium tert-butoxide as a base gave a 
1:1 mixture of diastereomers even in the presence of Lewis acid additives.  
It was expected that the major diastereomer would possess trans configuration as it 
was thermodynamically more favourable. This hypothesis was endorsed by the 
coupling constant values of the protons in C(3) and C(4), analysed by 1H NMR 
spectroscopy, which was about 11Hz. Following the rules of the Karplus equation, 
this value usually suggests a trans interaction between two vicinal protons in six-
membered rings (Figure 4).  
 
Figure 4 
Nevertheless 227a is a five-membered ring and because it has a different 
conformation from a six-membered ring, its coupling constant values do not 
necessarily obey the Karplus equation. Therefore the stereochemistry was analysed 
by crystallographic methods. The major diastereomer was consequently isolated by 
recrystallisation of 227a from a mixture of diethyl ether and hexane affording 
colourless crystals. The crystals were suitable for X-ray crystallography, which 
allowed us to confirm that the major diastereomer obtained in these reactions 
possesses trans configuration (Figure 5).  





With optimised conditions in hand, the scope of the reaction was explored (Table 3). 
Using 210 as the tethered diacid, a range of different aromatic alkynones 133a-e 
possessing substituents of varying electronic character underwent double Michael 
reactions, when treated with potassium tert-butoxide and Ni(acac)2, to provide 


























































































7 133h Me 227h traces n/a* 
* The peaks of the cyclised product were just visible in the 1H NMR spectrum. 
Table 3 
The double Michael addition of aryl alkynones generally produced the corresponding 
cyclised products in high yield with the exception, as expected, of the more electron 
rich alkynone 133b (entry 2). The aliphatic alkynone 133h (entry 7) surprisingly 
gave only traces of product. 
The tethered diacid 210 and the range of alkynones 133a-e underwent double 
Michael reactions, also when treated with potassium tert-butoxide and Mg(OTf)2, to 
provide pyroglutamic acid derivatives 227a-g in 50-75% yield and 8:1->19:1 dr 
(Table 4). Comparing Table 3 and Table 4 it is not possible to observe major 
differences other than that in the latter the most activated ketone 133e gave the 
lowest yield and the dr values were generally lower then in the previous range of 
reactions. 
 



















































































8 133h Me 227h traces n/a* 
* The peaks of the cyclised product were just visible in the 1H NMR spectrum 
Table 4 
The tethered diacid 211, containing methyl esters in place of the ethyl esters, 
likewise underwent double conjugate addition affording double Michael products 
228a-f with lower yields (39%-68%) but comparable dr (10:1->19:1) to the previous 






































































































 Chapter 2-Results and discussion  
 
 55
2.3 Mechanistic investigations  
There are two reasonable pathways for a double Michael addition, as was briefly 
outlined at the beginning of this chapter (Scheme 59). When the tethered diacid 132  
reacts with the alkynone 133 an initial Michael reaction takes place either at Site 1 of 
132 (due to this carbon being less sterically hindered (Path A)), or at Site 2 (due to 
this carbon possessing a lower pKa value (Path B)) (Scheme 71). Hypothetically Path 
B seems to be the one more likely to happen on the basis of the aforementioned 
acidity argument and also on the assumption that intermediates I/II  formed in Path 
A, being a very acidic vinylogous ketoester amide will undergo rapid deprotonation 
(at site 3), thus inhibiting ring closure to the product 136. 
Scheme 71 
However, to shed more light on whether one or both pathways are operative and to 
understand the role played by the metal salts, additional experiments were carried 
out. A number of methods might be employed: (i) monitoring the reaction by NMR 
spectroscopy, and/or (ii) quenching the reaction at low conversions and analysing the 
composition of the resulting mixture. 
Normally crude 1H NMR spectra of double Michael products are not very clear and 
the addition of peaks of intermediates could have caused further uncertainity in the 
spectra. For this reason it was decided not to use method (i). Method (ii) was also 
discounted as TLC analysis showed only spots resulting from the starting material 
and the product, suggesting that the transformation of the intermediate into the 
product was too fast. 
Nevertheless a simple way to gauge the relative reactivity of Site 1 and 2 was to 
perform a Michael addition with a tethered diacid 132 and a simple enone 229 in the 
place of an alkynone. This would result in products 230 or/and 231 (Scheme 72).  




 Scheme 72  
A reaction of methyl vinyl ketone (232) with diacid 210, using Mg(OTf)2 as an 
additive, was performed producing 233 as the only observable Michael product in 
52% yield, with the remainder of the starting material being unreacted (Scheme 73).  
 
Scheme 73 
The experiment showed that under these conditions, the carbon on Site 2 of 210 is 
more reactive than that on Site 1, as was expected. However, the analogous 
experiment carried out using Ni(acac)2 provided a mixture of 233 and the alternative 
Michael product 234, respectively 11% and 30% among other side-products. The 
experiment highlights the differences in the effect of Mg(OTf)2 and Ni(acac)2 on the 
reaction and how different metal salts have different affinity toward the two groups 
in the tethered diacid, thus enhancing C-H acidity either on Site 1 or Site 2. 
In his work Grossman explained how different conditions generate both 
thermodynamic or kinetic products and how this influences the diastereoselectivity 
of the double Michael reaction (see Scheme 53, pp. 42). In particular, treating 
tethered diacids and alkynones with potassium tert-butoxide in dichloromethane 
preferably generated the thermodynamically more stable products. Even treatment of 
a 1:1 mixture of the kinetic double Michael products with the above mentioned 
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conditions would cause the conversion in to the more thermodynamically stable 
product.  
We have also found that an additional Lewis acid (in addition to the potassium ions 
from potassium tert-butoxide) is important for the efficiency and steroselectivity of 
the double Michael reaction. The beneficial effect on the conversion is most likely 
due to deprotonation of the reactive sites being facilitated through metal chelation of 
the 1,3-dicarbonyl functions (Scheme 74). Lewis acid activation of the alkynone is 
another possibility. The beneficial effect on diastereoselectivity could be due to: (i) 
inherently greater trans-selectivity when additional metal ions are bound to the 
substrate in the ring-closing step, or (ii) metal promoted equilibration of the cis-
isomer to the more thermodynamically stable trans-isomer.  
 
Scheme 74 
We could test whether this latter scenario is operative by subjecting a 1:1 mixture of 
the product 227a, obtained using potassium tert-butoxide alone, to the reaction 
conditions in the presence of the metal salt and observing whether the diastereomeric 
composition is altered (Scheme 75). This treatment led to the recovery of 227a in 
high yield with no discernible change in diastereomeric composition.   





This result suggests that under these conditions, post-cyclisation epimerisation 
(which could occur via a deprotonation-reprotonation sequence or a retro-Michael-
Michael sequence, as in Grossmann case) does not occur, and therefore 
diastereoselection observed in the presence of additional metal salt is the result of a 
kinetically controlled process. However, the manner in which the metal salt imparts 
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2.4 Synthetic elaboration of the products 
The double Michael reaction that we have presented allows for the formation of two 
new C-C bonds and up to three new stereogenic centres, resulting in highly 
functionalised heterocycles. Although the density of functionality that exists in the 
double Michael product could be considered a virtue, it could also present a 
challenge for subsequent selective synthetic manipulation, restricting the utility of 
the process. Therefore, as a completion of our work several experiments were carried 
out on one of the most representative products to establish what type of 
transformations were possible. Several of these are sumarised below (Scheme 76): 
2.4.1 removal of the protecting group, 
2.4.2 decarboxylation, 
2.4.3 protection of the ketone and eventually ester reduction, 




2.4.1 Removal of the protecting group 
Our first step toward the derivatisation of compound 227a was trying to remove the 
p-methoxyphenyl group on the nitrogen. That was attempted through an oxidising 
process involving the oxidizing agent ceric ammonium nitrate (CAN). Following a 
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known procedure78 compound 227a was treated with CAN in acetonitrile at 0 oC 
(Scheme 77). The reaction produced either only starting material (with three 
equivalents of CAN) or a complex mixture of products (with five equivalents of 
CAN). 
 
Scheme 77  
After these results we proceeded towards other derivatisation methods. 
 
2.4.2 Protection of the ketone and ester reduction 
Our attention then focused on the protection of the ketone, which was believed to be 
easily achieved by treatment of 227a with ethylene glycole or 1,3-propane dithiol 
(Table 6). Although several conditions were applied, including treatment of 227a 
with either ethylene glycol or 1,3-propane and triethyl orthoformate and TsOH, or 
iodine in tetrahydrofuran, or BF3·OEt2 in dichloromethane, but without success. In 














entry reagents  solvent T (oC) results 
1 ethyleneglycol, 
orthoformate, TsOH 




CH2Cl2 rt s. m. 
2 ethyleneyglycol, 
TsOH 
toluene rt s. m. 




toluene  reflux s. m. 
4 1,3-propandithiol, I2 THF  rt s. m. 
5 1,3-propandithiol, 
BF3·OEt2 
CH2Cl2 0-rt s. m. 




Another approach to the product elaboration was to try to selectively remove one of 
the ester groups present in the molecule 227a. The ester group, in order to be 
removed, must contain an electron-withdrawing group in the β-position (in a 
Krapcho-type decarboxylation).79 The reaction is then usually heated to reflux and 
catalysed by metal salts (Scheme 78).  
 
Scheme 78 
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Compound 227a contains two ester groups which could be both decarboxylated 
having each a withdrawing group in the β-position (amide and an ester). Therefore 
treatment of compound 227a with the Krapcho conditions could give the three 
different decarboxylated products: 235, 236 and 237 or even a mixture of them 
(Scheme 79).  
 
Scheme 79 
A short screening of conditions was carried out, in which a solution of compound 
227a in dimethylformamide or dimethylsulfoxide was heated at different 
temperatures, with or without the aid of a metal salt (Table 7). In most cases, for 
example, the use of metal salts (LiBr or NaCl) with DMF or DMSO or the use of 
DMSO by itself generates a mixture of 235 and a complex mixture of products (entry 
1, 3, 4, 5, 6, 7). In some cases when the temperature was raised the formation of a 
mixture of products could be observed without any trace of products 235 (entry 2, 
entry 5). Finally, by heating a DMF solution of 227a to 110 °C for three days 












entry solvent  T oC metal salt time yield % 
1 DMF 100 LiBr 16h mixture 
2 DMF 130 LiBr 16h mixture 
3 DMF 115 NaCl 16h mixture 
4 DMF reflux NaCl 16h mixture  
5 DMSO/H2O 
(1:1) 
reflux NaCl 1h mixture 
6 DMSO/H2O 
(5:1) 
130 - 16h 27 
7 DMSO/H2O 
(5:1) 
130 - 2d 29 




2.4.4  Insertion of a functional group in the C(4) position 
Finally, insertion of a substituent, in particular a benzyl group, in the C(4) position of 
double Michael product 227a  was also achieved by treatment of 227a with sodium 




To summarise our results, the double Michael product 227a was successfully 
derivatised in two different products of which one was the product of 
monodecarboxylaction 235 and the other was the benzylated product 238 (Scheme 
81). 
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2.5 Conclusions  
In summary, we have developed a double Michael addition route to highly 
functionalised pyroglutamic acid derivatives that utilises amide-tethered carbon 
diacids and aromatic alkynones as substrates. The reaction proceeds with good levels 
of trans-diastereoselectivity, provided that substoichiometric quantities of Mg(OTf)2 
or Ni(acac)2 are employed as Lewis acids (Table 3, 4, pp.56, 57). In particular the 
best yield and best diastereoselectivity was achieved when tethered diacid 210 and 
the nitro substituted alkynone 133e were treated with substoichiometric amount of 
Ni(acac)2 and potassium tert-butoxide, producing the desired double Michael product 
227e in 77% yield and >19:1 dr (Scheme 82). 
 
Scheme 82 
The double Michael product 227a (Scheme 81) was also successfully derivatised to 
synthetically useful products 235 and 236, by decarboxylation and benzyl insertion 
as previously described. Furthermore, we were able to analyse the crystals of product 
227a with x-ray crystallography and therefore to prove that the major diastereomer 
possesses trans configuration.  
Although we achieved some of the targets that we set up at the outset of this work, 
there are limitations to this methodology. For example, only two of all the selected 
starting materials (210 and 211, Scheme 63, pp. 48) undergo double Michael 
reaction when treated with an alkynone in the presence of a base. When the 
protecting group was changed from PMP to PMB or a benzyl group the reaction did 
not occur (Scheme 68, pp. 52) and if a cyano group is placed in the substrate in the 
place of an ester group the result is either a complex mixture of products or a 
byproduct generated by an intramolecular reaction of the diacid (Scheme 60 and 61, 
pp. 47). Moreover the selected starting materials that undergo double Michael 
reaction seem to be mainly active toward aryl alkynones. The aliphatic methyl 
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alkynone 133h that was targeted only gave traces of product (Table 3 and 4 pp. 56, 
57).  
Finally in the derivatisation of the product we failed to remove the protecting group 
(PMP) (Scheme 77, pp. 60). We were also not able to separate the enantiomeric 
peaks of the double Michael product with HPLC chiral columns, ruling out the 
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2.6 Further work 
One of the future targets is the development of enantioselective variants of the 
double Michael reactions. Asymmetric induction could arise in an enantioselective 
intermolecular or intramolecular Michael addition of chiral metal-bound enolate. 
Previous literature for this mode of induction comes in the form of magnesium 
triflate-bis(oxazoline) 241 catalysed enantioselective Michael addition of 1,3-
dicarbonyl compounds such as 239 to nitroalkenes such as 240 described by Barnes 
and co-workers (Scheme 83).76 Enantioinduction is proposed to arise through the 
approach of a chiral metal bound enolate to nitroalkene 240 according to the 
stereochemical model 243. Other chiral ligands for possible evaluation are 244, 245, 




An alternative approach to achieve asymmetric induction might be through activation 
of the alkynone using iminium catalysis. In recent years, numerous examples of 
asymmetric reactions using imidazolidinone catalysts and α,β-unsaturated aldehydes 
as electrophiles have been reported.80 One report that may have relevance to our 
work is in the selective activation of α,β-unsaturated ketones using iminium catalyst, 
developed by MacMillan and co-workers.81 For example ethyl vinyl ketone 247 
undergoes a highly enantioselective Diels-Alder reaction with the diene 248 under 
the influence of imidazolidinone 249 (Scheme 84).81 Hopefully, in our case, the 
iminium catalysis would be applicable to the selective activation of aliphatic 
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alkynones and this activation will be sufficient to promote reaction with a diacid with 
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3. DOMINO MICHAEL ADDITIONS/FRIEDEL-
CRAFTS-TYPE ALKYLATIONS 
 
3.1 Proposed mechanism 
In the previous chapter we have extensively reported about double Michael reactions, 
their importance in organic synthesis and their versatility, and we have shown a 
series of double conjugate additions that we carried out using amide-tethered diacids 
and a range of aromatic alkynones (CHAPTER II, pp 41). Subsequently, we decided 
to carry out further experiments in a similar field and a new idea arose by comparing 
amide-tethered diacids 132 (Figure 6) that we targeted for our double Michael 
additions with arenes 251.  
 
Figure 6 
Both compounds possess two nucleophilic centres connected by a tether and since 
diacids 132 undergo a domino Michael-Michael reaction when treated with 
alkynones with a suitable base and a Lewis acid, we thought that arenes 251 could 
undergo a domino Michael-Friedel-Crafts-type reaction when treated similarly. It 
was expected that upon treatment with alkynones 133 and a base the tethered 
dinucleophile 251 would first undergo a Michael addition giving the intermediate 
252 as a mixture of E/Z isomers and that ideally intermediate 252 would be reactive 
enough to subsequently undergo a nucleophilic attack from the tethered arene moiety 
with a Friedel-Crafts (F-C) alkylation (path a), affording a range of cyclised products 
253. The order of events could of course be different, with the F-C alkylation 
happening first and the Michael addition afterwards (path b) (Scheme 85). 





Due to their importance in our strategy and in general as a class of powerful reactions 
for the synthesis of complex cyclic compounds, an overview on Friedel-Crafts 
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3.2 Ring closing Friedel-Crafts-type alkylation of arenes 
The intramolecular alkylation of aromatics has become a matter of increasing 
importance since it gives access to synthetically challenging polycyclic fused 
aromatic compounds, which are important for agrochemical and pharmaceutical 
purposes.82 Of particular interest are catalytic alkylation processes that involve the 
use of milder experimental conditions and unactivated Caryl-H bonds rather than C-X 
(X = halide) analogues because they would increase the atom economy of the 
reactions. In general, intramolecular aromatic C-H alkylations are triggered by a 
catalyst (a Lewis acid or an organocatalyst) that activates the electrophilic species 
linked to the arene 255, thus promoting cyclisation to form polycyclic compounds 
256 (Scheme 86). 
 
Scheme 86 
This group of reactions can be further divided into different categories depending on 
the electrophilic framework of the substrates. Here we report several reaction classes 
that more closely concern our project: 
3.2.1 Michael-type Friedel-Crafts alkylations, 
3.2.2 Pictet-Spengler condensation, 
3.2.3 Cyclisation of aryl alkynes, 
3.2.4 Allylic reactions. 
 
3.2.1 Michael-type Friedel-Crafts alkylations  
Among all the Friedel-Crafts type alkylations, the conjugate addition of electron-rich 
aromatic systems to α,β-unsaturated carbonyl compounds is particularly interesting 
for our work. These types of Michael additions have received much attention over 
the last decade as a straightforward synthetic shortcut to the chemo- and 
regioselective synthesis of functionalised aromatic systems, and what makes these 
reactions so attractive is the mildness of the reaction conditions and the large number 
of known strategies to achieve these cyclisations.82 
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An example of the aforementioned strategy is the catalytic Friedel-Crafts alkylation 
of indoles with electrophilic carbon synthons in the presence of low loadings of 
anhydrous indium(III) bromide developed by Umani-Ronchi and co-workers for the 
synthesis of 4-substituted tetrahydro-β-carbolines 259 (THBC) and 
tetrahydropyrano[3,4-b]indoles 261 (Scheme 87).83 
 
Scheme 87 
The synthesis of the requisite indolyl enone 258 was accomplished from readily 
available indole-2 carbaldehyde (257). With the starting material in hand several 
reactions conditions were screened, and it was found that in the presence of 10% 
indium(III) bromide, the enone 258 underwent cyclisation affording the protected 
carboline 259 in high yield (85%). Similarly, the indolyl enone 261 was obtained 
from the corresponding N-Me-indolyl alcohol 260 and initial attempts for the 
intramolecular cyclisation were performed with 10 mol % indium(III) bromide 
affording the product 262 in 75% yield. However it was found that with a lower 
catalytic loading (5 mol %) the reaction afforded the product 262 in 97% yield and in 
similar time.83 The results were partially rationalised with the occurrence of a 
concomitant intermolecular Michael addition and undesired degradation processes of 
the α,β-unsaturated indolyl ketone 261 observed with higher catalyst loading. 
Generally, intramolecular F-C cycloalkylations often suffer from moderate yields 
and a lack of regioselectivity and thus significant quantities of Lewis acid are 
normally required. On the contrary, indium(III) bromide was able to promote the 
aforementioned reactions under mild experimental conditions (rt) and in catalytic 
amount (5-10 mol %).  
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Very unusual is the double F-C alkylation of divinyl ketones reported by Carbery and 
co-workers,84 in which a divinyl ketone (a double electrophile usually exploited in 
double conjugate additions or Nazarov reactions), undergoes a tandem nucleophilic 
attack by indole species. Thus, when indole 263 was treated with the non-
symmetrical divinyl ketone 264 and 2,4-dinitrobenzenesulfonic acid (DNsOH) in 
acetonitrile at 0 oC it underwent a first F-C alkylation producing monoadduct 265 
(Scheme 88). This was followed by a solvent swap, which led to cyclisation of the 
monoadduct 265, affording the fused tricyclic indole 266 in good yield (88%) and 
good diasteroselectivity (20:1). 
 
Scheme 88 
It was speculated that monoadduct 265, formed after the first F-C alkylation, would 
both react with a second divinyl ketone to form the bis-product 267 in small quantity 
and undergo a second intramolecular F-C alkylation giving the spiroindoleninium 
intermediate II (Scheme 89). The syn relationship between the methyl and phenyl 
groups is established in the cyclisation process that occurs via a chair transition state 
(I). The final tricyclic indole product 266 is then obtained after the suprafacial 
migration of benzylic group (transition state III) followed by rearomatisation. The 
syn arrangement of the methyl and phenyl group in the product was preserved due to 
the suprafacial migration occurring with retention of configuration. The consecutive 
addition of two molecules of indoles to the divinyl ketone was minimised by keeping 
the reaction temperature below 40 oC because higher temperatures would favour the 
formation of the bis-products. 
 





A recent example of Michael-type Friedel-Crafts cyclisation was reported by Xiao 
and co-workers in which the alkylation of indolyl α,β-unsaturated adehyde 268 is 
involved (Scheme 90).85 This organocatalytic methodology gives access to the 
synthesis of tetrahydropyrano[3,4-b]indoles (THPIs) and THBCs with the aid of a 
MacMillan catalyst.86 This example is important since organocatalytic intramolecular 
alkylations of indoles are not so common in the literature.  
 
Scheme 90 
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The starting material 268 was obtained in few steps from the corresponding and 
commercially available indole-2 carbaldehyde (257). After the screening of several 
reaction conditions it was found that MacMillan’s second-generation catalyst 269 
along with 3,5-dinitrobenzoic acid as additive, gave the desired product 270 in good 
yield (85%) and high enantioselectivity (90%).  
In order to prove its generality, this methodology was also applied to a similar 
substrate, the phenoxyl-substituted α,β-unsaturated adehyde 271 (Scheme 91). After 
25h the corresponding chroman-4-yl acetaldehyde (272) was obtained as expected in 
excellent enantiomeric excess (90%) and good yield (88%).85 
 
Scheme 91 
It was later found that treatment of aryl aldehyde 271 with catalyst 273 instead of the 
MacMillan catalyst 269 could improve the enantioselectivity (96%) (Scheme 92).87 
Moreover it was possible to expand the hydroarylation not only to phenol-derived 
enals (for the synthesis of chromans) but also to aniline-derived enals (for the 
synthesis of tetrahydroquinolines). The aniline aldehyde 274, upon treatment with 
catalyst 273 and hydrochloridric acid (in dioxane 4.0 M) in dichloromethane, 
afforded the isomeric mixture of tetrahydroquinolines 275 (71%yield, 92% ee) and 
276 (29%).87  





In the proposed mechanism the α,β-unsaturated aldehyde reacts with the pyrrolidine-
based catalyst to form the iminium ion 277. Subsequently, the electron-rich benzene 
framework attacks from the re face of the activated alkene (since the si face is 
shielded by the bulky group of the catalyst) thus generating the bicyclic system 278 
(Scheme 93). Hydrolysis of the enamine 278 affords the desired product and 
regenerates the catalyst. 
 
Scheme 93 
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Chiral Lewis acids have also been exploited in enantioselective intramolecular F-C 
alkylations. Sc(OTf)3-Pybox complex 280, for example, employed by Evans and co-
workers88 mostly for intermolecular F-C alkylation, was also effective in the 
cyclisation of the arene ketone 279 affording the tetrahydrocarbazole 281 in excellent 
yield (99%) and high enantioselectivity (97%) (Scheme 94).  
 
Scheme 94 
Similar to Michael-type F-C-cyclisations are the F-C-triflations,89 where enones are 
activated by triflic anhydride toward reactions with an electron-rich arene with the 
concomitant formation of an enol triflate. In the reaction reported below (Scheme 
95), the nucleophilic arene 282 underwent F-C alkylation upon treatment with triflic 
anhydride and 2,6-di-tert-butyl pyridine in MeNO2, affording the cyclised product 
283 in good yield (72%). 
 
Scheme 95 
Polar solvents, such as MeNO2, were thought to stabilise the allylic cation I, 
allowing it to undergo ring closure, leading toward intermediate II, rather then loss 
of a proton. The reaction seemed to work best with a sterically demanding, non-
nucleophilic base such as 2,6–di-tert-butyl pyridine. 
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A further example of F-C-cyclisation employing triflic acid (TfOH) was reported by 
Li and Wang in their effort toward the synthesis of cephalotaxine and its 
derivatives.90 In the reaction reported below (Scheme 96) spiro-cyclopentenone 
precursor 284 underwent Friedel-Crafts-type enone cyclisation upon treatment with 
triflic acid (2.5 equiv.), as a slurry mixture in dichloromethane at room temperature, 
giving the desired product 284 in good yield (93%).  
Scheme 96 
Product 285 could then be transformed into the cephalotaxine analogue 286 by a 
known procedure.91 
Another noteworthy reaction similar to Michael- F-C alkylations is the annulation of 
aryl-substituted α-alkoxy acylimines performed with mild Lewis acid.92 The one-pot 
reaction reported below (Scheme 97) included hydrozirconation and acylation93 of 
cyanohydrine ether 287 that led to the in situ formation of acylamine 288, which then 
underwent F-C cyclisation upon treatment with ZnCl2. The desired product β-alcoxy-
amide 289 was obtained in 78% yield and excellent diastereoselectivity. 
 
Scheme 97 
The stereochemical outcome is consistent with cyclisation through conformer II 
rather than chelated conformer I (Scheme 98). 






3.2.2 Pictet-Spengler condensation 
Another interesting class of F-C-type alkylation are the acid-promoted annulation of 
amino arenes in the presence of carbonyl compounds, better known as the Pictet-
Spengler condensation.94 This process, known for a very long time, was first 
discovered by Amè Pictet and Theodor Spengler in 191195 and involves the 
condensation of β-arylethylamine 290 with an aldehyde or its synthetic equivalent 
(Scheme 99). Therefore, this condensation is a convenient method for the synthesis 
of tetrahydroisoquinoline 291 derivatives or related heterocyclic systems as 
substitutedtetrahydro-β-carbolines 293 through the replacement of benzene rings 
with indole derivatives.  
 
Scheme 99 
The mechanism starts with the reaction of amine 292 with benzaldehyde and 
formation of the imine I, which by protonation forms the iminium ion II (Scheme 
100). Subsequently, electrophilic substitution at the 2-position gives the cyclised 
intermediate III. After deprotonation, the desired product 293 is formed. The 
electrophilicity of the imine is thought to be the driving force of the cyclisation. 





The reaction commonly involves the use of Brønsted acid for the activation step. 
However, there are examples in the literature where Lewis acids and even 
organocatalysts are used in their place. Kobayashi and co-workers,96 for example, 
carried out a screening of Lewis acids for the Pictet-Spengler condensation of m-
tyramine (294) and benzaldehyde and they found that Yb(OTf)3 (with a 10 mol % 
loading) was a good catalyst giving the cyclised product 295 in 98% yield with good 
regioselectivity (the regioisomer 296 was obtained in only 3% yield) (Scheme 101).  
 
Scheme 101 
Previous to this work, a parallel screening approach for the discovery of effective 
Lewis acid catalysts for the Pictet-Spengler condensation was reported.97 This 
method was focused on the synthesis of substituted tetrahydro-β-carbolines 298 and 
the alkylation occurred on the preformed starting compounds 297 by activation of the 
imine moiety (Scheme 102).  
 
Scheme 102 
Many Lewis acids were found to be effective catalysts, however, Yb(OTf)3 gave the 
best results. In fact with 5 mol % of Yb(OTf)3 and 30 min of microwave irradiation, 
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high conversions were obtained with both aliphatic and aromatic imines. The above 
conditions were equally applicable to a one-pot version in which the imine was 
formed in situ and these consistently gave even higher yields and cleaner products 
mixtures.98 
Asymmetric versions of the Pictet-Spengler reaction are well known in the literature. 
Particularly well known is the reaction developed by Jacobsen and co-workers,99 
catalysed by thiourea derivatives such as 301. The reaction provides a range of 




entry R R1 T(oC) yield(%) 301 ee(%) 
1 H CH2CH(CH3)2 -60 75 93 
2 5-MeO CH(CH2CH3)2 -40 81 93 
3 6-MeO CH(CH2CH3)2 -50 76 86 
 
Scheme 103 
The two-step procedure consisted of condensation of tryptamine 299a-c with an 
aldehyde, generating the imine adducts 300a-c which are employed in the next step 
without further purification. The imines 300a-c were then cyclised to give the β-
carbolines products 302a-c in good yield (75-81)% over two steps and high 
enantiomeric excess (86-93)%. Although variation of the indole moiety was tolerated 
(entries 2 and 3), substrates derived from aromatic aldehydes or 
trimethylacetaldehyde displayed lower reactivity, which is a limitation to this elegant 
methodology. 
An improvement of this methodology was reported in a recent work,100 where a one-
pot Pictet-Spengler reaction co-catalysed by the thiourea catalyst 304 and benzoic 
acid is described (Scheme 104). The reaction proceeds smoothly giving the 
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unprotected tetrahydro-β-carbolines 303a-c in high yield (78-90)% and high 
enantiomeric excess (94-99)% either with aliphatic or aromatic aldehydes (entries 1-
3). 
 
entry R BzOH(mol %) t(h) yield(%) 302 ee(%) 
1 p-ClC6H4 20 66 78 94 
2 iPr 0 88 90 94 
3 o-BrC6H4 40 50 82 99 
 
Scheme 104 
The suggested mechanism for the catalytic cycle reported below includes: a) 
protonation of the imine, b) cyclisation of the highly reactive iminium and c) re-
aromatisation of the cyclised product (Scheme 105).100 
 
Scheme 105 
The protonation of the imine I is induced by the thiourea catalyst associated via H-
bonding to the conjugate base of a weak Brønsted acid additive (such as BzOH), thus 
generating the reactive iminium ion II, which then undergoes cyclisation. Finally, the 
 Chapter 3-Domino Michael additions/Friedel-Crafts-type alkylations  
 
 83
cyclised product III undergoes rearomatisation, which affords the product 303 and 
regenerates the acid co-catalyst HX. 
Asymmetric Pictet-Spengler reactions can also occur with the aid of chiral Brønsted 
acid catalysts such as that reported by List and co-workers,101 where geminally 
disubstituted tryptamine 305 and aldehydes are treated with chiral binaphtol-derived 
phosphoric acid 306 (Scheme 106). 
 
Scheme 106 
This one-pot procedure, which led to the synthesis of enantioenriched tetrahydro-β-
carbolines, tolerates a variety of different aldehydes both aliphatic and aromatic and 
proceedes from average to good yield (40-96)% and from average to high 
enatiomeric excess (62-96)%. 
 
3.2.3 Cyclisation of aryl alkynes 
This process, also called F-C alkenylation of arenes, or hydroarylation of alkynes 
involves the reaction between the alkyne and the aromatic group of a ω-aryl-1-alkyne 
308 (Scheme 107). It was first described by Murai et al82,102 and is considered an 
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The F-C alkenylation of arenes is believed to be triggered by the interaction between 
a Lewis acid catalyst and the C-C triple bond of the substrate 309a/310b. This 
interaction leads to the Wheland-type intermediates 310a/311b, which can produce 
either the 6-endo-dig product 311a or the 6-exo-dig product 311b. In accordance with 
the mechanism shown below, electron-donating substituents should facilitate the 
hydroarylation process (Scheme 108). The metal salts involved in the process are 
usually late transition metals such as PtII and RuII, GaII, InII and AuI which have high 
electron affinity toward π-systems.82 
 
Scheme 108 
Echavarren and co-workers103 found that the cyclisation of aryl alkynes can be 
catalysed by gold and platinum complexes and they reported that resorcinol 312, 
upon treatment with a catalytic amount of PtCl2 (5 mol %), underwent a 6-endo-dig 
cyclisation giving a (1:2) mixture of the two regioisomers 313a and 313b in 76% 
combined yield (Scheme 109).  
 
Scheme 109 
Arene 314 upon treatment with a gold complex in dichloromethane afforded product 
315 in good yield (82%) (Scheme 110).103  
 





Murai and co-workers104,105 carried out a screening of metal salts for the 
cycloisomerisation of ω-aryl-1-alkynes and they found that reactions catalysed by 
RuII salts and GaCl3 produced the desired dihydronaphthalenes through a 6-exo-dig 
process. They observed that generally RuII salts work better with highly activated 
arenes (with electrondonating groups in the aromatic ring) while GaCl3 is compatible 
with only mildly activated arenes. For instance, the reaction of the mildly activated 
ω-aryl-1-alkyne 316, with RuII salts produced the two isomeric dihydronaphthalenes 
317a and 317b in 66% yield and (85:15) diastereoselectivity, while with GaCl3 the 
yield and diastereoselectivity are higher (85% and 94:6) (Scheme 111).  
 
Scheme 111 
In the proposed mechanism for the GaCl3 cycloisomerisation, the key step is 
represented by the formation of the bridged-type cation complex 318 or the open-
type vinyl cation complex 319 that would occur when the metal salt coordinates to 
the alkyne. The complexes 318 and 319 would both be expected to serve as a good 
electrophile for nucleophilic attack of the benzene moiety (Scheme 112).105  
 
Scheme 112 
TMSOTf and BF3·OEt2 are catalysts not commonly used for the cyclisation of arene 
alkynes. A rare example is the intramolecular TMSOTf-promoted Friedel-Crafts 
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reaction of propargylic silyl ethers 320106 that led to the formation of the allenyl 
isochromane derivative 321 through an 6-exo-dig process in high yield (98%) 
(Scheme 113).106  
 
Scheme 113 
In a more recent work, it was reported that tethered propargyl arenes 322, when 
treated with BF3·OEt2, underwent intramolecular Friedel-Crafts reactions producing 
allenyl species 323a and 323b in high yield (60-99)% and good regioselectivity (3:1-
10:1)107. It was speculated that in the mechanism reported below (Scheme 114) the 
intermediate species I/II were formed and that the regioisomeric products 323a and 
323b were dependent upon the canonical form II.107 
 
Scheme 114 
The allenyl products 323a and 323b thus obtained were subsequently employed for 
the synthesis of quinolines.107 For this purpose substrate 323a was treated with TsOH 
in ethanol, producing species 324 that after desulfonylation by exposure to KOH in 
MeOH gave adduct 325. Subsequently oxidative cleavage of the diphenylvnyl 
moiety of 325 followed by esterification afforded quinoline (326) (Scheme 115).  






3.2.4 Allylic reactions 
A very straightforward and mild Friedel-Crafts-type cyclisation is the intramolecular 
arene addition to allylic halides catalysed by Lewis acids reported by Cook and 
Hayashi.108 According to this a catalytic amount of InCl3 can trigger a mild and 
efficient atom transfer cyclisation in aliphatic compounds. The suggested mechanism 
includes an electrophilic allylation of the alkyne 327 via the polarised species I or the 
ionic species II, which then affords the cyclised product 328 (Scheme 116).  
 
Scheme 116 
The same methodology was employed to carry out F-C cyclisations of compounds 
with an allylic bromide moiety attached to an electron-rich arene, such as 329 or 330 
(Scheme 117).108 The arene compound 329 or 331, upon treatment with sub-
stoichiometric amount of indium(III) chloride (10 mol %) in dichloromethane at 
room temperature and in the presence of molecular sieves, afforded carbocycles 330 
and 332 in excellent yields (88% and 97% respectively).  





All the previous examples showed the importance of Friedel-Crafts-type cyclisations 
in the synthesis of complex fused cyclic compounds. Among different reaction 
classes Michael-type-Friedel-Crafts cyclisations are the most interesting for us since 
our target is to carry out a domino-Michael-addition/ Friedel-Crafts-type alkylations 
as outlined previously (Introduction pp. 69). Other examples of Friedel-Crafts 
reactions, such as the Pictet-Spengler, the cyclisation of aryl alkynes and the allylic 
cyclisations are also important as they suggest possible methodologies that could be 
applied to our reactions. 
Although many asymmetric Michael-type-Friedel-Crafts cyclisations have been 
carried out in the past, several of them asymmetrically, a domino-Michael-addition/ 









 Chapter 4-Results and discussion: Friedel-Crafts-type alkylations  
 
 89
4. RESULTS AND DISCUSSION: FRIEDEL-
CRAFTS-TYPE ALKYLATIONS 
 
4.1 First steps toward domino Michael addition/Friedel-Crafts alkylation 
At the outset of our work, substrate 333 was initially targeted as a suitable starting 
material for our Michael addition/Friedel-Crafts-type cyclisations (Figure 7). It 
possesses an acidic centre in the malonyl moiety and an electron-donating group (the 
dimethylamine) in the arene moiety, which could promote the F-C alkylation; 
moreover it is easy to prepare. 
 
Figure 7 
Treatment of the commercially available phenol 334 with the acid chloride of the 




Substrate 333, thus obtained, was subsequently treated with alkynones 133a and 
133h and a metal salt ((Mg(OTf)2, Mg(ClO4)2 or Ni(acac)2)) plus base (KOtBu, or 
NEt3) in dichloromethane. However, in all cases, only the starting material was 









entry alynones R metal salt (20 mol %) base (1 equiv.) Yield (%) 
1 133a Ph Mg(OTf)2 NEt3 _ 
2 
 
133a Ph Mg(OCl4)2 NEt3 _ 
3 
 
133a Ph Ni(acac)2 NEt3 _ 
4 
 








A few pyrrolidine-based and MacMillan-type organocatalysts (335, 336, 141, 337) 
were also selected to catalyse the reaction (Figure 8).  
 
Figure 8 
Together with propargyl ketone 133h, propargyl aldehyde 339 was targeted for our 
reaction (Scheme 119). It is known that aldehydes in general are more reactive 
toward pyrrolidine based organocatalysts then ketones.109 Aldehyde 339 was also 
chosen because it is easily obtained by oxidation of the corresponding and 
commercially available alcohol and it is more stable then an unsubstituted propargyl 




Nevertheless, after treatment of substrate 333 and propargyl aldehyde 339 with a few 
of the organocatalysts only the starting material 333 was recovered in most cases 
(Table 9). The same results were obtained with propargyl ketone 133h. 































































After the first results, we started to consider new methodologies and our attention 
focused on the elegant work reported by Kwon and co-workers (see Scheme 46, 
pp.33),65 concerning double conjugate additions of amino alcohols to alkynones, 
(mostly 3-butyn-2-one) employing phosphine ligands as catalysts. This suggested the 
idea of exploiting phosphine-based catalysts in our cyclisation.  
Therefore several reactions were screened employing dppe as the phosphine catalyst, 
in acetonitrile (as described in the Kwon procedure), at either 80 oC or room 
temperature, with slow addition of alkynone 133a to substrate 333 (Scheme 120).  





In both cases the desired product was not observed, but instead the starting material 
333 decomposed to generate phenol 334. The reaction was then repeated at room 
temperature and over a longer period of time (3 days), but again phenol 334 was 
obtained. Interestingly, the use of the methyl alkynone 133h gave byproduct 340 
along with phenol 334 (Scheme 121).  
 
Scheme 121 
After these results we thought about the design of a different tethered dinucleophile 
that would be unable to undergo similar fragmentation, such as the phenol ether 341 
(Scheme 122).  
 
Scheme 122 
At the first attempt of carrying out the synthesis of the phenol ether 341, phenol 334 
was treated with bromomalonate 343 and potassium carbonate in refluxing acetone. 
Following this procedure, the desired product 341 was generated in poor yield (20%) 
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along with some starting material and a large quantity of a byproduct 342, which by 
1H NMR analysis seemed to be a dimer of arene ether 341 (Scheme 123).  
 
Scheme 123 
It was speculated that the formation of byproduct 342 occured through a radical 
mechanism, maybe due to the presence of oxygen in the solvent. Therefore the 
solvent (acetone) was degassed and the reaction repeated in the same conditions, but 
no significant improvement in the reaction was observed. 
In an effort to improve the yield of the reaction, other methodologies were employed, 
including: the slow addition of bromomalonate 343 to a stirred mixture of the phenol 
334 and Et3N in acetonitrile at 0 oC; treatment of a stirred mixture of phenol 334 and 
NaOEt in ethanol with bromomalonate 343 at room temperature; and a slow addition 
of bromomalonate 343 to a stirred mixture of phenol 334 and potassium tert-
butoxide in tetrahydrofuran (Table 10). In most cases the reaction produced a very 
small amount of product 341 along with a large quantity of byproduct 342, or a 
complex mixture of products. 
 
entry base solvent t(h) T yield(%) 




NaOEt EtOH 16 rt-reflux traces of x 
3 
 




K3CO3 acetone 16  rt 12 
5 
 
K3CO3 acetone 4  reflux 20 
 
Table 10 
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Further attempts were made to improve the yield, such as the treatment of phenol 334 
with diazomalonate 344 and Rh2(OAc)4, but the result was a complex mixture of 
products (Scheme 124). 
 
Scheme 124 
Finally, an improvement in the reaction (49% yield) was obtained by employing 
chloromalonate 345 instead of bromomalonate 343 (Scheme 125).  
Scheme 125 
The reaction was stopped before completion, in order to minimise the formation of 
byproduct 342, which complicates the purification of the phenol ether 341.  
Once substrate 341 was obtained, it was subjected to treatment with propargyl ketone 
133h (slow addition) and dppe in acetonitrile at room temperature. The reaction 
mixture thus obtained was stirred for 16h (Scheme 126). 
 
Scheme 126 
As expected phenol ether 341 did not undergo fragmentation and although the F-C 
cyclisation did not occur, the Michael addition was successful, giving products 346a 
and 347a as a mixture of E/Z isomers (1:3) in 48% yield. An improvement in the 
yield was achieved by treatment of phenol ether 341 with potassium tert-butoxide in 
dichloromethane. After 15 minutes this procedure afforded a 2:1 mixture of E/Z 
isomers 346a and 347a in 87% yield (Scheme 127). The addition of a metal salt 
(Mg(OTf)2 or Ni(acac)2) in the reaction mixture did not have any significant effect. 





After these encouraging results, the arene ether 341 was treated with a range of 
propargyl ketones 133a,b,d-f,h,i, propargyl ester 133h and with potassium tert-
butoxide in dichloromethane at room temperature thus generating a small library of 
Michael products 346a-g and 347a-g from average to good yield (59%-92%) (Table 
11). 
 
entry alkynone  R product yield % (E/Z) 
1 133h Me  346a/347a 87 2:1 
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Several organocatalysts and metal salts were screened with the Michael product 346a 
in dichloromethane, in order to carry out the Friedel-Crafts cyclisation, including the 
pyrrolidine-based organocatalyst 141, the imidazolidine-based catalyst 337 and the 
Lewis acids indium(III) bromide and indium(III) acetate. However no product was 
observed (Scheme 128). 
 
Scheme 128 
Finally, upon treatment with an excess of TMSOTf in dichloromethane the Michael 
adduct 346a underwent intramolecular F-C alkylation affording the cyclised product 
348a in good yield (72%) along with a small quantity of the regioisomer 349 in very 
small quantity (16% yield) (Scheme 129). Also when treated with BF3·OEt2 in 
dichloromethane 346a underwent intramolecular F-C alkylation affording 348a 
(64%). However in the latter reaction the regioisomer 349 was not observed. 
 
entry Lewis acid equiv. yield(%) 348a yield(%) 349 
1 
 
TMSOTf 4 72 16 
2 
 
BF3·OEt2 3 64  n/a 
 
Scheme 129 
The regioselectivity was proven by comparison of the 1H NMR spectra of two 
regioisomers, in particular by observing the coupling constant values of the aromatic 
hydrogens. Reported below are the sections of the 1H NMR spectra of compound 
348a and 349 that concern the aromatic region (Figure 9 and Figure 10). The 
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spectrum in Figure 9 shows two doublets (Hc and HA) and a doublet of doublets 
(HB). The coupling constant values indicated an ortho coupling (Hc, d, JCB = 8.4 Hz), 
a meta coupling (HA, d, JAB = 1.8 Hz) and an ortho/meta coupling (HB, dd, JBA, JBC = 






The spectrum in Figure 10 shows a pseudotriplet (HB) and two doublets (HA and 
HC). The coupling constant values of the two doublets indicated two ortho couplings 






Consequently we applied the two-step method developed (Michael addition followed 
by F-C cyclisation) to the arene compound 341 and a range of propargyl ketone 
133a,b,d-g and propargyl ester 133h. In order to improve the efficiency of the 
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subjected to aqueous work-up (washed with a saturated solution of NaHCO3 and 
extracted with dichloromethane). The crude product thus obtained was then dissolved 
with dichloromethane and then treated with BF3·OEt2. The two-step procedure 
afforded a small library of cyclised products 348a-g from average to good yield 
(37%-65% over two steps) (Table 12).  
 
















6 133h Me 348h 59 
7 133i OEt 348i - 
 
Table 12 
The isomeric mixture of Michael products generated by treatment of substrate 341 
with propargyl ester 133i failed to undergo F-C cyclisation when treated with 
BF3·OEt2 (entry 7). The same result was obtained even when the cyclisation was 
attempted on the isolated Michael adduct 346b (E isomer), either with TMSOTf or 
BF3·OEt2 (Scheme 130) 





The isomeric mixture of Michael products generated by treatment of substrate 341 
with propargyl ketone 133e, afforded only traces of product when treated with 
BF3·OEt2 (entry 4). The mixture obtained (which mostly contained arene ether 341 
and the isomeric Michael products 346d/347d) was then dissolved in 
dichloromethane and heated to reflux with Yb(OTf)3·XH2O (20 mol %). However 
after 16h the reaction was not complete. The Michael addition was then repeated and 
a solution of substrate 341 in dichoromethane was treated with propargyl ketone 
133e and potassium tert-butoxide. The crude product obtained was dissolved in 
dichloromethane treated with Yb(OTf)3·XH2O (20 mol %) and microwaved to 100oC 
for 15 min. The reaction reached completion and the desired product was obtained in 
38% yield over two steps (Scheme 131). 
Scheme 131 
Microwave techniques have been employed before in F-C cyclisation, for example 
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4.2 Domino Michael addition/Friedel-Crafts alkylation 
Several attempts to carry out a tandem reaction (Michael addition plus Friedel-
Crafts-type alkylation) were tried: for example by treating the phenol ether 340 and 
the alkynone 133h directly with BF3·OEt2 or TMSOTf in dichloromethane. However 
those procedures did not produce any product and only starting material was 
recovered (Scheme 132). A one-pot cyclisation was also attempted, in which, after 
the consumption of the starting material in the Michael addition step, an excess of 
BF3·OEt2 (7 equiv.) was directly added to the reaction flask by syringe. Some product 
was obtained this time, although with very low conversion. 
 
Scheme 132 
An organocatalytic approach was also attempted by treating the phenol ether 341 and 
aldehyde 339 with pyrrolidine- imidazolidine-based catalysts 335, 336, 141 or 337 
(Figure 8, pp. 90) in dichloromethane or dimethylsulphoxide (Scheme 133). 
 
Scheme 133 
Lewis acids were also employed in the attempted tandem F-C alkylation. Phenol 
ether 341 and alkynone 133h were treated with Yb(OTf)3 or La(OTf)3 and 
triethylamine in dichloromethane at room temperature. Only Michael products could 
be observed without any trace of the cyclised product (Scheme 134). 





A domino Michael/F-C-cyclisation was attempted employing a microwave 
technique. Thus a solution of phenol ether 341 and propargyl ketone 133e in 
dichloromethane was treated with a sub-stoichiometric quantity of Yb(OTf)3·XH2O 
and heated to100 oC (Scheme 137).  
 
Scheme 135 
Although the reaction did not reach completion and it was not possible to isolate the 
product at this stage, the conversion was very good (78%). This encouraged us to try 
different alkynones, many of which proved to be compatible with this methodology. 
A small library of cyclised products was therefore obtained by heating to 100 oC a 
mixture of phenol ether 341 and Michael acceptors 133a-h with Yb(OTf)3·XH2O in 
dichloromethane (Table 13). 

























133h Me 348h 54 
8 
 
133i OEt 348i n/a* 
* entry 2,4,6: it was not possible to separate the desired product from the starting materials and/or by-
products. 
Table 13 
The result in Entry 8 is particularly interesting, although the product has not yet 
been separated, because the cyclisation failed when either the isomeric mixture of 
Michael products 346a/347a (E/Z), or the isolated Michael adduct 346a (E) were 
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4.3 Conclusions  
In summary, we have developed a domino-Michael-addition/F-C-type-cyclisation for 
the synthesis of fused bicyclic compounds by heating a mixture of an arene ether and 
an alkynone with Yb(OTf)3 in dichloromethane to 100 oC in a microwave oven. The 
reaction afforded the desired product from average to good yield (44-80)% when the 
arene ether 341 is treated with a range of different alkynones (mostly aromatic) or 
propargyl ester (Scheme 136). 
 
Scheme 136 
Only one of the two starting materials selected at the outset of this work, the arene 
ether 341, seems to be able to undergo F-C cyclisation. After a screening of several 
reaction conditions, arene 333 failed to undergo both Michael addition and F-C 
alkylation. Nevertheless there are still other alternatives that need to be considered to 
differentiate the starting material and other Michael acceptors that could be selected 
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4.4 Further work 
Although only arene ether 341 seems to be able to undergo F-C cyclisation, a wide 
range of different starting materials could be prepared by modifying both the arene 
moiety and the molonyl-ether moiety (Scheme 137).  
 
Scheme 137 
The possibility of carrying out an asymmetric domino-Michael-addition/F-C-
cyclisation could be considered if the reaction is promoted by Brønsted acid 
catalysis. In this circumstance a chiral acid such as binaphtyl phosphoric acid 
derivative, or a thiourea based organocatalyst could be employed. In fact, 
asymmetric F-C cyclisations which employ these conditions have already been 











5.1 General Information 
All non-aqueous reactions were carried out under a nitrogen atmosphere in oven-
dried apparatus. CH2Cl2 and THF were dried and purified by passage through 
activated alumina columns using a solvent purification system from 
www.glasscontour.com ‘Petrol’ refers to that fraction of light petroleum ether boiling 
in the range 40-60°C. Thin layer chromatography (TLC) was performed on Merck 
DF-Alufoilien 60F254 0.2 mm precoated plates. Product spots were visualized by UV 
light at 254 nm, and subsequently developed using potassium permanganate or ceric 
ammonium molybdate solution as appropriate. Flash column chromatography was 
carried out using silica gel (Fisher Scientific 60Å particle size 35-70 micron) 
employing the method of Still and co-workers.110 Melting points were recorded on a 
Gallenkamp melting point apparatus and are uncorrected. Infra-red spectra were 
recorded on a Jasco FT/IR-460 Plus instrument as a thin film on sodium chloride 
plates or as a dilute solution in CHCl3. 1H NMR spectra were recorded on a Bruker 
DPX360 (360 MHz) spectrometer or a Bruker ARX250 (250 MHz) or a Bruker 
ARX500 (500 MHz)spectrometer. Chemical shifts (δ) are quoted in parts per million 
(ppm) downfield of tetramethylsilane, using residual protonated solvent as internal 
standard (CDCl3 at 7.27 ppm). Abbreviations used in the description of resonances 
are: s (singlet), d (doublet), t (triplet), q, (quartet), app (apparent), br (broad). 
Coupling constants (J) are quoted to the nearest 0.1 Hz. Proton-decoupled 13C NMR 
spectra were recorded on a Bruker DPX360 (90.6 MHz) spectrometer or a Bruker 
ARX250 (62.9 MHz) spectrometer. Chemical shifts (δ) are quoted in parts per 
million (ppm) downfield of tetramethylsilane, using deuterated solvent as internal 
standard (CDCl3 at 77.0 ppm). Assignments were made using the DEPT sequence 
with secondary pulses at 90° and 135°. 19F NMR spectra were recorded on a Bruker 
ARX250 (235 MHz) spectrometer. Chemical shifts (δ) are quoted in parts per million 
(ppm) downfield of CFCl3. High resolution mass spectra were recorded on a 
Finnigan MAT 900 XLT spectrometer using the electrospray (ES) positive ion mode 
at the EPSRC National Mass Spectrometry Service Centre, University of Wales 
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Swansea, or on a Kratos MS50TC spectrometer using the fast atom bombardment 
(FAB) technique in the mass spectrometry laboratory at the School of Chemistry, 
University of Edinburgh. Stated calculated mass values refer to that of the ion (i.e. 
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5.2 Double Michael additions 
5.2.1 General procedure for the preparation of alkynones 
 
Ethynyl magnesium bromide (1.2 equiv., 0.5 M in THF) was added to a solution of 
the aldehyde 200a-g (1 equiv.) in dry Et2O (1.0 M) at 0 oC. The reaction mixture was 
then allowed to warm up to room temperature and left under stirring. After 2h 
saturated aqueous NH4Cl (10 mL) solution was added to the mixture. The organic 
phase was separated and the aqueous layer was extracted with Et2O (3 x 50 mL). The 
collected organic layers were washed with brine, dried over MgSO4 and concentrated 
in vacuo. The resulting yellow residue, without any further purification, was 
dissolved in dry CH2Cl2 (0.05 M) and treated with activated manganese dioxide (10 
equiv.) at room temperature. After 3h, the reaction mixture was filtered through 
ceelite and washed with CH2Cl2. The resulting solution was concentrated in vacuo 
and the residue was purified by column chromatography (petrol/diethyl ether, 4:1) 
affording the alkynones 133a-133g as yellow solids. 
 
1-Phenylpropynone (133a).111 The title compound was prepared 
according to the General procedure from aldehyde 200a (5.7 mL, 57 
mmol), and ethynyl magnesium bromide (136 mL, 67 mmol) and 
purified by column chromatography (petrol ether/ Et2O, 4:1) to give a yellow solid 
(4.50 g, 61 %); m.p. 46-48°C (50-51°C, lit.111); 1H NMR (500 MHz, CDCl3) δ 8.18 
(2H, d, J = 8.1 Hz, ArH), 7.65 (1H, t, J = 7.3 Hz, ArH), 7.52 (2H, t, J = 7.8 Hz, 
ArH), 3.44 (s, 3H, C≡CH); 13C NMR (62.9 MHz, CDCl3) δ 177.3(C), 135.9 (C), 
134.4 (CH), 129.5 (2 x CH), 128.5 (2 x CH), 80.9 (CH), 80.1 (C). 
 
1-(4-Methoxyphenyl)propynone (133b).112 The title compound 
was prepared according to the General procedure from aldehyde 
200b (0.8 mL, 6.6 mmol), and ethynyl magnesium bromide (15.8 
mL, 7.9 mmol). The yellow residue (533 mg) resulting from the first step, without 
any further purification, was dissolved in dry CH2Cl2 (30 mL) and treated with 
activated manganese dioxide (4.0 g, 40 mmol) at room temperature. After 3h, the 
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reaction mixture was filtered through ceelite and washed with CH2Cl2. The resulting 
solution was concentrated in vacuo and the residue was purified by column 
chromatography (petrol ether/ Et2O, 4:1) to give a yellow solid (339 mg, 54 %); m.p. 
78-80 °C (82-83 °C, lit.112); IR (CHCl3) 3253, 2914, 2094, 1639 (C=O), 1599, 1574, 
1259, 1171, 11024, 841 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.12 (2H, d, J = 8.8 Hz, 
ArH), 6.96 (2H, d, J = 8.8 Hz, ArH), 3.89 (3H, s, OCH3), 3.39 (1H, s, CH); 13C 
NMR (125.8 MHz, CDCl3) δ 175.9 (C), 164.7 (C), 132.1 (2 x CH), 129.5 (C), 113.9 
(2 x CH), 80.3 (C), 80.0 (CH). 
 
1-(4-Bromophenyl)propynone (133c).113 The title compound was 
prepared according to the General procedure from aldehyde 200c 
(1.0 g, 5.4 mmol), and ethynyl magnesium bromide (12.9 mL, 6.5 
mmol) and purified by column chromatography (petrol ether/ Et2O, 4:1) to give a 
yellow solid (651 mg, 60 %); m.p. 98-100 °C; IR (CHCl3) 3219, 3093, 2098, 1635 
(C=O), 1583, 1261, 1174, 1068, 1007, 839 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.01 
(2H, d, J = 8.3 Hz, ArH), 7.65 (2H, d, J = 8.3 Hz, ArH), 3.48 (1H, s, C≡CH); 13C 
NMR (125.8 MHz, CDCl3) δ 176.2 (C), 134.9 (2 x CH), 132.0 (C), 131.5 (2 x CH), 
130.1 (C), 81.3 (CH), 79.9 (C). 
 
1-Naphthalenylpropynone (133d).112 The title compound was 
prepared according to the General procedure from aldehyde 200d 
(1.5 mL, 11 mmol), and ethynyl magnesium bromide (26.4 mL, 13.2 
mmol) and purified by column chromatography (petrol ether/ Et2O, 4:1) to give a 
yellow solid (1.12 g, 58 %); m.p. 64-66 °C (70-71 °C, lit.112); IR (CHCl3) 3226, 
3041, 3006, 2090, 1635 (C=O), 1589, 1574, 1238, 1190, 771 cm-1;1H NMR (500 
MHz, CDCl3) δ 9.22 (1H, d, J = 8.7 Hz, ArH), 8.63 (1H, dd, J  = 7.3, 1.1 Hz, ArH), 
8.11 (1H, d, J = 8.2 Hz, ArH), 7.92 (1H, d, J = 7.7 Hz, ArH), 7.71-7.68 (1H, m, 
ArH), 7.61-7.58 (2H, m, ArH), 3.46 (1H, s, C≡CH); 13C NMR (62.9 MHz, CDCl3) δ 
178.8 (C), 135.6 (CH), 135.5 (CH), 133.7 (C), 131.8 (C), 130.6 (C), 129.2 (CH), 
128.6 (CH), 126.8 (CH), 125.8 (CH), 124.4 (CH),  81.6 (C), 79.4 (CH). 
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1-(4-Nitrophenyl)propynone (133e).114 The title compound was 
prepared according to the General procedure from aldehyde 200e 
(1.0 g, 6.6 mmol), and ethynyl magnesium bromide (15.8 mL, 7.9 
mmol). The yellow residue (545 mg) resulting from the first step, without any further 
purification, was dissolved in dry CH2Cl2 (30 mL) and treated with activated 
manganese dioxide (4.0 g, 40 mmol) at room temperature. After 3h, the reaction 
mixture was filtered through ceelite and washed with CH2Cl2. The resulting solution 
was concentrated in vacuo and the residue was purified by column chromatography 
(petrol ether/ Et2O, 4:1) to give a yellow solid (386 mg, 54 %); m.p. 78-80 °C (74-75 
°C, lit.114); IR (CHCl3) 3280, 3114, 2098, 1657 (C=O), 1603, 1522, 1321, 1236, 
1007, 854 cm-1; 1H NMR (360 MHz, CDCl3) δ  8.38-8.32 (4H, m,  ArH), 3.61 (1H, 
s, C≡CH); 13C NMR (62.9 MHz, CDCl3) δ 175.4 (C), 151.1 (C), 140.1 (C), 130.6 (2 
x CH), 123.9 (2 x CH), 82.8 (CH), 79.6 (C). 
 
1-(4-Chloro)phenylpropynone (133f).115 The title compound was 
prepared according to the General procedure from aldehyde 200f 
(1.0 g, 6.6 mmol), and ethynyl magnesium bromide (15.8 mL, 7.9 
mmol). The yellow residue (513 mg) resulting from the first step, without any further 
purification, was dissolved in dry CH2Cl2 (30 mL) and treated with activated 
manganese dioxide (4.0 g, 40 mmol) at room temperature. After 3h, the reaction 
mixture was filtered through ceelite and washed with CH2Cl2. The resulting solution 
was concentrated in vacuo and the residue was purified by column chromatography 
(petrol ether/ Et2O, 4:1) to give a yellow solid ( 287 mg, 48 %); m.p. 94-96 °C (96-
97 °C, lit.115); IR (thin film) 3217, 2092, 1633 (C=O), 1587, 1568, 1485, 1400, 1259, 
1092, 843 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.09 (2H, d, J = 8.0 Hz, ArH), 
7.47(2H, d, J = 8.0 Hz, ArH), 3.48 (1H, s, C≡CH); 13C NMR (125.8 MHz, CDCl3) δ 











A solution of alcohol 337 (1.8 mL, 15.1 mmol) was dissolved in dry CH2Cl2 (250 
mL) and treated with activated manganese dioxide (13g, 150 mmol) at room 
temperature. After 3h, the reaction mixture was filtered through ceelite and washed 
with CH2Cl2. The resulting solution was concentrated in vacuo and the residue was 
purified by column chromatography (hexane/AcOEt, 10:1) affording aldehyde the 
338 as a yellow oil; (1.53 g, 76%); 1H NMR (360 MHz, CDCl3) δ 9.43 (1H, d, J = 
0.7 Hz CHO), 7.62-7.59 (2H, m, ArH), 7.52-7.47 (1H, m, ArH), 7.43-7.38 (2H, m, 
ArH); 13C NMR (90.5 MHz, CDCl3) δ 176.8 (C), 133.2 (2 x CH), 131.2 (CH), 128.7 
(2 x CH), 119.3 (C), 95.1 (C), 88.4 (C). 
 
5.2.2 Preparation of Tethered Diacids 
 
Dimethyl 2-(4-methoxyphenyl)aminomalonate (224).117 
 
A mixture of methyl bromomalonate (2.91 mL, 20.0 mmol) and p-anisidine (4.93 g. 
40.0 mmol) in THF (90 mL) was heated to reflux, then allowed to cool to room 
temperature and left under stirring. The reaction mixture was concentrated in vacuo 
and the residue was triturated with Et2O (100 mL). The filtrate was concentrated in 
vacuo and purification of the residue by column chromatography (petrol 
ether/EtOAc, 5:1-3:1) afforded the product 224 as a pale brown solid (4.81 g, Y = 
96% ); m.p. 70-72 °C (78-79 °C lit.117); 1H NMR (250 MHz, CDCl3) δ 6.78 (2H, dm, 
J = 9.1 Hz, ArH), 6.63 (2H, dm, J = 9.1 Hz, ArH), 4.74 (1H, s, CHNH), 3.80 (6H, s, 
2 x OCH3), 3.74 (3H, s, OCH3); 13C NMR (62.9 MHz, CDCl3) δ 168.2 (2 x C), 153.2 
(C), 139.2 (C), 115.1 (2 x CH2), 114.9 (2 x CH2), 61.4 (CH), 55.5 (OCH3), 53.1 (2 x 
OCH3). 
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Diethyl N-(2-carbethoxyacetyl)aminomalonate (209) 
 
To a vigorously stirred mixture of the diethyl aminomalonate hydrochloride 213 
(1.00 g, 4.72 mmol) in CH2Cl2 (4 mL) and saturated aqueous Na2CO3 solution (4 
mL) at room temperature was added ethyl malonyl chloride 214 (0.73 mL, 5.67 
mmol) in one portion. The mixture was stirred for 1 h and then partitioned between 
saturated aqueous NaHCO3 solution (30 mL) and CH2Cl2 (30 mL). The aqueous 
layer was separated and extracted with CH2Cl2 (3 x 50 mL) and the combined 
organic layers were dried (MgSO4) and concentrated in vacuo to leave the amide 209 
(1.32 g, 97%) as white solid (1.32 g, Y= 97%); m.p. 69-71 °C; IR (film) 3342 (NH), 
2985, 1743 (C=O), 1684 (C=O), 1525, 1373, 1344, 1182, 1030, 860 cm-1; 1H NMR 
(500 MHz, (CD3)2SO) δ 9.07 (1H, d, J = 7.2 Hz, CHNH), 5.1 (1H, d, J = 7.2 Hz, 
CHNH), 4.28-4.10 (4H, m, 2 x CH2CH3), 4.12 (2H, q, J = 7.1 Hz, CH2CH3), 3.44 
(2H, s, CH2C=O), 1.26-1.21 (9H, m, 3 x CH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 
168.4 (C), 165.8 (2 x C), 164.9 (C), 62.4 (2 x CH2), 61.6 (CH2), 56.4 (CH), 40.8 
(CH2), 13.9 (CH3), 13.8 (2 x CH3); LRMS (ES) Exact mass calcd for C12H20NO7 




To a stirred mixture of ethylcyanoacetate 215118 (18.8 mL, 177 mmol) and glacial 
acetic acid (80 mL) at room temperature, NaNO2 (36.5 g, 530 mmol) was added 
portionwise over 1.5h. The mixture was stirred for 3 h and then partitioned between 
H2O (100 mL) and Et2O (150 mL). The aqueous layer was separated and extracted 
with Et2O (3 x 100 mL) and the combined organic layers were dried (MgSO4) and 
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concentrated in vacuo to leave the adduct 216 as a white solid (24.0 g). Without any 
further purification adduct 216118 (10.0 g) was added to a saturated aqueous solution 
of NaHCO3 (6.4 mL), then Na2S2O4 (86%, 34.0 g, 196 mmol) was added portionwise 
to the mixture until completion of the reaction. The aqueous solution was extracted 
with CH2Cl2 (3 x 20 mL) and the organic extracts were dried (MgSO4) and 
concentrated. The resulting crude oil 217 (1.00 g), without any further purification, 
was dissolved in CH2Cl2 (10 mL) and mixed with a saturated aqueous solution of 
Na2CO3 (10 mL). Ethyl malonyl chloride (12.0 mL, 9.36 mmol) was added in one 
portion to the vigorously stirred mixture. The aqueous layer was separated and 
extracted with CH2Cl2 (3 x 50 mL) and the combined organic layers were dried 
(MgSO4) and concentrated in vacuo. Purification of the residue by column 
chromatography (3:1 hexane/EtOAc) afforded the amide 206 (1.00 g, 19%, over 
three steps) as a white solid; m.p. 66-70 °C; IR (CHCl3) 3329 (NH), 2987, 2939, 
1745 (C=O), 1680 (C=O), 1522, 1271, 1211, 1028, 852 cm-1, 1H NMR (360 MHz, 
CDCl3) δ 8.37-8.35 (1H, m, CHNH), 5.52 (1H, d, J = 7.5 Hz, CHC≡N), 4.35 (2H, q, 
J = 7.1 Hz, CH2CH3), 4.23 (2H, q, J = 7.1 Hz, CH2CH3), 3.43 (2H, s, CH2), 1.35 
(3H, t, J = 7.1 Hz, CH2CH3), 1.29 (3H, t, J = 7.1 Hz, CH2CH3); 13C NMR (62.9 
MHz, CDCl3) δ 168.7 (C), 165.2 (2 x C), 163.0 (C), 113.7 (C), 64.1 (CH2), 62.0 
(CH2), 42.8 (CH), 40.2 (CH2), 13.9 (CH3), 13.8 (CH3), 13.8 (CH3); LRMS (ES) Mass 
calcd for C10H14NaN2O5 [M+Na]+: 265.1, found: 265.0.  
 
Dimethyl N-benzyl-N-(carbomethoxyacetyl)aminomalonate (208) 
 
To a solution of diethyl aminomalonate hydrochloride 218 (363 mg, 1.93 mmol) in 
dry MeOH at 0 oC, NaBH3CN (121 mg, 1.93 mmol) and benzaldehyde (213 μL, 2.11 
mmol) were added.119 Glacial acetic acid was added dropwise (until pH = 6) to the 
reaction mixture, which was then allowed to warm up to room temperature and 
stirred for 24h. The mixture was diluted with H2O (10 mL) and Na2CO3 was added 
portionwise (until pH = 9-10). The aqueous layer was then saturated with NaCl, 
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extracted with CHCl3 (3 x 10 mL), dried (Na2SO4) and concentrated in vacuo to 
leave a yellow residue (428 mg). The residue (200 mg), without any further 
purification, was dissolved in CH2Cl2 (1 mL) and mixed with a saturated aqueous 
solution of Na2CO3. To the vigorously stirred mixture, methyl-3-chloro-3-
oxopropionate 220 (110 μL, 1.01 mmol) was added in one portion. The aqueous 
layer was separated and extracted with CH2Cl2 (3 x 5 mL) and the combined organic 
layers were dried (MgSO4) and concentrated in vacuo. Purification of the residue by 
column chromatography (1:1, hexane/EtOAc) afforded the amide 208 as a white 
solid (190 mg, 29 %, over two steps); m.p. 69-72 °C; IR (CHCl3) 2364, 1745 (C=O), 
1664 (C=O), 1434, 1253, 1197, 1163, 1018, 992, 746 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 7.29-7.35 (5H, m, ArH), 5.57 (1H, s, CHN), 4.75 (2H, s, CH2C=O), 3.74 
(3H, s, OCH3), 3.66 (6H, s, OCH3), 3.48 (2H, s, ArCH2); 13C NMR (62.9 MHz, 
CDCl3) δ 167.7 (C), 167.1 (C), 166.1 (C), 135.4 (C), 128.8 (2 x CH), 127.8 (2 x CH), 
60.5 (CH), 52.8 (2 x CH3), 52.4 (CH3). 51.2 (CH2), 40.9 (CH3); HRMS (ES) Exact 
mass calcd for C16H20NO7 [M+H]+: 338.1234, found: 338.1237.  
 
Diethyl N-(2-carbethoxyacetyl)-N-(4-methoxyphenyl)aminomalonate (210) 
 
To a vigorously stirred mixture of the amine 224120 (1.00 g, 3.56 mmol) in CH2Cl2 (4 
mL) and saturated aqueous Na2CO3 solution (4 mL) at room temperature was added 
ethyl malonyl chloride (0.61 mL, 4.47 mmol) in one portion. The mixture was stirred 
for 1 h and then partitioned between saturated aqueous NaHCO3 solution (30 mL) 
and CH2Cl2 (30 mL). The aqueous layer was separated and extracted with CH2Cl2 
solution (3 x 50 mL) and the combined organic layers were dried (MgSO4) and 
concentrated in vacuo to leave the amide 210 (1.39 g, 98%) as a brown oil. IR (film) 
2983, 2938, 2840, 1742 (C=O), 1672 (C=O), 1510, 1250, 1034, 843 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 7.41 (2H, dm, J = 8.9 Hz, ArH), 6.88 (2H, d, J = 8.9 Hz, ArH), 
5.55 (1H, s, CHN), 4.23-4.09 (6H, m, 3 x CO2CH2CH3), 3.82 (3H, s, OCH3), 3.24 
(2H, s, CH2C=O), 1.29-1.14 (9H, m, 3 x CO2CH2CH3); 13C NMR (62.9 MHz, 
CDCl3) δ 166.9 (2 x C), 165.6 (2 x C),  159.9 (C), 131.9 (C), 130.7 (2 x CH), 114.5 
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(2 x CH), 64.3 (CH), 62.0 (2 x CH2), 61.2 (CH2), 55.4 (CH3), 41.4 (CH2), 14.0 
(CH3), 13.8 (2 x CH3); HRMS (ES) Exact mass calcd for C19H26NO8 [M+H]+: 
395.1653, found: 395.1654.  
 
Dimethyl N-(2-carbomethoxyacetyl)-N-(4-methoxyphenyl)aminomalonate (211) 
 
To a vigorously stirred mixture of the amine 223 (3.00 g, 11.8 mmol)117 in CH2Cl2 
(11 mL) and saturated aqueous Na2CO3 solution (11 mL) at room temperature was 
added methyl malonyl chloride (1.57 mL, 14.2 mmol) over 1 min. The mixture was 
stirred for 4 h, and a further portion of methyl malonyl chloride 220 (0.65 mmol, 
5.92 mmol) was added. After stirring for another 1 h, the reaction was partitioned 
between saturated aqueous NaHCO3 solution (20 mL) and CH2Cl2 (20 mL). The 
aqueous layer was separated and extracted with CH2Cl2 solution (3 x 50 mL) and the 
combined organic layers were dried (MgSO4) and concentrated in vacuo to leave the 
amide 211 (4.00 g, 96%) as a brown oil. IR (film) 3004, 2954, 2843, 1747 (C=O), 
1671 (C=O), 1509, 1436, 1249, 1218, 1167; 1H NMR (360 MHz, CDCl3) δ 7.38 (2H, 
dm, J = 8.3 Hz, ArH), 6.89 (2H, dm, J = 8.3 Hz, ArH), 5.54 (1H, s, CHN), 3.82 (3H, 
s, OCH3), 3.72 (6H, s, 2 x OCH3), 3.69 (3H, s, OCH3), 3.26 (2H, s, CH2C=O); 13C 
NMR (62.9 MHz, CDCl3) δ 167.3 (C), 166.8 (C), 165.9 (2 x C), 159.9 (C), 131.8 
(C), 130.4 (2 x CH), 114.6 (2 x CH), 64.1 (CH), 55.4 (CH3), 52.8 (2 x CH3), 52.3 
(CH3), 41.1 (CH2); HRMS (ES) Exact mass calcd for C16H20NO8 [M+H]+: 353.1183, 
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To a stirred solution of tethered diacid 203 (36 mg, 0.10 mmol), KOtBu (2 mg, 0.02 
mmol) in CH2Cl2 (1 mL) at room temperature was added a solution of alkynone 133a 
(16 mg, 0.1 mmol) in CH2Cl2 (1 mL) via cannula dropwise over 1 min. The reaction 
was stirred at room temperature for 16 h and concentrated in vacuo. Purification of 
the residue by column chromatography (3:1, hexane/EtOAc) afforded the cyclised 
product 204 as a white solid (27.8 mg, 99%); m.p. 102-106 °C; IR (CHCl3) 3342, 
3209, 2981, 1739 (C=O), 1652 (C=O), 1512, 1367, 1248, 1035, 836 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 7.22 (2H, dm, J = 9.0 Hz, ArH), 6.82 (2H, dm, J = 9.0 Hz, 
ArH), 4.64 (2H, bs, NH2), 4.23-4.12 (4H, m, 2 x OCH2CH3), 3.76 (3H, s, OCH3), 
1.72 (3H, s, CH3), 1.15 (6 H, t, J = 7.1 Hz, 2 x OCH2CH3); 13C NMR (62.9 MHz, 
CDCl3) δ 173.6 (C), 166.0 (2 x C), 158.2 (C), 150.7 (C), 129.8 (C), 129.0 (2 x CH), 
113.8 (2 x CH), 101.2 (C), 75.2 (C), 62.8 (2 x CH2), 55.3 (CH3), 13.8 (2 x CH3), 6.9 






To a stirred solution of tethered diacid 212 (41 mg, 0.10 mmol), KOtBu (2 mg, 0.02 
mmol) in CH2Cl2 (1 mL) at room temperature was added a solution of alkynone 133a 
(16 mg, 0.10 mmol) in CH2Cl2 (1 mL) via cannula dropwise over 1 min. The reaction 
was stirred at room temperature for 16 h and concentrated in vacuo. Purification of 
the residue by column chromatography (3:1, hexane/EtOAc) afforded the mono-
Michael adduct 226 (E) as colourless oil (42 mg, 97%). IR (film) 3066, 2985, 2941, 
1745 (C=O), 1670 (C=O), 1510, 1446, 1373, 1244, 1026 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 7.88-7.86 (2H, m, ArH), 7.58-7.54 (1H, m, ArH), 7.47-7.43 (4H, m, ArH), 
7.22 (1H, d, J = 15.8 Hz; CH=CHC=O), 7.07 (1H, d, J = 15.8 Hz; CH=CHC=O), 
6.91 (2H, d, J = 9.0 Hz, ArH), 4.36-3.99 (6H, m, 3 x OCH2CH3), 3.83 (3H, s, 
OCH3), 3.88 (1H, q, J = 7.0 Hz; CHCH3), 1.33-1.30 (6H, m, CHCH3, 2 x 
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OCH2CH3), 1.20 (3H, t, J = 7.1 Hz; OCH2CH3), 1.13 (3H, t, J = 7.1 Hz; OCH2CH3); 
13C NMR (62.9 MHz, CDCl3) δ 190.9 (C), 170.6 (C), 170.2 (C), 165.8 (C), 165.3 
(C), 160.0 (C), 140.4 (CH), 278.7 (C), 132.9 (CH), 132.3 (CH), 131.5 (C), 131.1 
(CH), 128.9 (2 x CH), 128.5 (2 x CH), 128.1 (CH), 114.5 (2 x CH), 75.1 (C), 62.9 
(CH2), 62.7 (CH2), 61.2 (CH2), 55.4 (CH3), 44.1 (CH), 14.0 (CH3),13.9 (CH3), 13.8 
(CH3), 13.7 (CH3); LRMS (ES) Exact mass calcd. for C23H29NO8 [M+H]+: 540.2, 
found: 540.2. 
 
5.2.3 Double Michael Reactions: General Procedure 
 
To a stirred solution of the appropriate tethered diacid (0.20 mmol), KOtBu (4.7 mg, 
0.04 mmol) and the appropriate metal salt (0.04 mmol) in CH2Cl2 (0.5 mL) at room 
temperature was added a solution of the appropriate alkynone (0.22 mmol) in CH2Cl2 
(0.5 mL) via cannula dropwise over 1 min. The reaction was stirred at room 
temperature for 16 h and concentrated in vacuo. Purification of the residue by 
column chromatography afforded the double Michael product. 
 
 (±)-(3R,4R)-3,5,5-Tricarbethoxy-1-(4-methoxyphenyl)-4-(2-
oxo-2-phenylethyl)pyrrolidin-2-one (227a). The title compound 
was prepared according to the General Procedure from tethered 
diacid 210 (79 mg, 0.20 mmol), alkynone 133a (29 mg, 0.22 mmol) and Ni(acac)2 
(10.8 mg, 0.04 mmol) and purified by column chromatography (20:1 CH2Cl2/Et2O) 
to give a yellow oil (80 mg, 76%) as an 18:1 inseparable mixture of diastereomers 
227a. Trituration with Et2O, followed by recrystallization from Et2O/hexane gave 
colorless crystals suitable for X-ray diffraction. m.p 101–102 °C; IR (film) 3047, 
2980, 1733 (C=O), 1713 (C=O), 1674 (C=O), 1509, 1249, 1053, 803, 778 cm-1; 1H 
NMR (360 MHz, CDCl3) δ 7.97-7.95 (2H, m, ArH), 7.63-7.57 (1H, m, ArH), 7.51-
7.47 (2H, m, ArH), 7.16 (2H, d, J = 8.9 Hz, ArH), 6.87 (2H, d, J = 8.9 Hz, ArH), 
4.37-4.24 (4H, m, 2 x OCH2CH3), 4.18-4.06 (3H, m, OCH2CH3 and CH2CH), 3.80 
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(3H, s, OCH3), 3.64 (1H, d, J = 11.3 Hz, CHC=O), 3.61 (1H, dd, J = 16.7, 4.7 Hz, 
CH2CH), 3.02 (1H, dd, J = 16.7, 9.1 Hz, CH2CH), 1.31-1.26 (6H, m, 2 x OCH2CH3), 
1.06 (3H, t, J = 7.0 Hz, OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 196.4 (C),  
170.1 (C),  168.4 (C),  167.9 (C),  166.1 (C),  159.2 (C),  136.1 (C),  133.5 (CH), 
129.3 (2 x CH), 129.1 (C), 128.7 (2 x CH), 128.1 (2 x CH), 114.0 (2 x CH), 75.4 (C), 
62.8 (CH2), 62.4 (CH2), 61.9 (CH2), 55.4 (CH3), 52.7 (CH), 40.3 (CH), 39.1 (CH2), 
14.0 (CH3), 14.0 (CH3), 13.6 (CH3); HRMS (ES) Exact mass calcd. for C28H32NO9 




The title compound was prepared according to the General 
Procedure from tethered diacid 210 (79 mg, 0.20 mmol), 
alkynone 133b (35 mg, 0.22 mmol) and Mg(OTf)2 (12.9 mg, 
0.04 mmol) and purified by column chromatography (25% EtOAc/petrol) to give a 
yellow oil (77 mg, 69%) as a 10:1 inseparable mixture of diastereomers. IR (film) 
2981, 2937, 2840, 1734 (C=O), 1717 (C=O), 1679 (C=O), 1600, 1511, 1249, 1171, 
1026 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.94 (2H, dm, J = 9.0 Hz, ArH), 7.15 (2H, 
dm, J = 9.1 Hz, ArH), 6.95 (2H, dm, J = 9.0 Hz, ArH), 6.87 (2H, dm, J = 9.1 Hz, 
ArH), 4.39-4.22 (4H, m, 2 x OCH2CH3), 4.18-4.03 (3H, m, OCH2CH3 and CH2CH), 
3.88 (3H, s, OCH3), 3.80 (3H, s, OCH3), 3.64 (1H, d, J = 11.3 Hz, CHC=O), 3.57 
(1H, dd, J = 16.3, 4.6 Hz, CH2CH), 2.91 (1H, dd, J =16.3, 9.3 Hz, CH2CH), 1.28 
(3H, t, J = 7.1 Hz, OCH2CH3), 1.27 (3H, t, J = 7.1 Hz, OCH2CH3), 1.05 (3H, t, J = 
7.1 Hz, OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 194.9 (C), 170.2 (C),  168.4 (C), 
167.9 (C), 166.1 (C), 163.7 (C), 159.2 (C), 130.4 (2 x CH), 129.3 (2 x CH), 129.2 (2 
x C), 114.0 (2 x CH), 113.8 (2 x CH), 75.4 (C), 62.8 (CH2), 62.4 (CH2), 61.8 (CH2), 
55.5 (CH3), 55.4 (CH3), 52.7 (CH), 40.5 (CH), 38.7(CH2), 14.1 (CH3), 14.0 (CH3), 




oxoethyl]-1-(4-methoxyphenyl)pyrrolidin-2-one (227c). The 
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title compound was prepared according to the General Procedure from tethered 
diacid 210 (39.5 mg, 0.1 mmol), alkynone 133c (25 mg, 0.12 mmol) and Mg(OTf)2 
(5 mg, 0.02 mmol) and purified by column chromatography (20:1 CH2Cl2/Et2O) to 
give a yellow oil (25 mg, 45%) as a > 19:1 inseparable mixture of diastereomers. IR 
(film) 2981, 2928, 1734(C=O), 1692(C=O), 1585, 1511, 1249, 1179, 1010, 829; 1H 
NMR (360 MHz, CDCl3) 7.84 (2H, dm, J = 8.7 Hz, ArH), 7.63  (2H, dm, J = 8.7 Hz, 
ArH), 7.15 (2H, dm, J = 9.1 Hz, ArH), 6.87 (2H, dm, J = 9.1 Hz,, ArH), 4.39-4.22 
(4H, m, 2 x OCH2CH3), 4.17-4.03 (3H, m, OCH2CH3 and CH2CH), 3.80 (3H, s, 
OCH3), 3.63 (1H, d, J = 11.4, CHC=O), 3.57 (1H, dd, J = 16.4, 4.7 Hz, CH2CH), 
2.92 (1H, dd, J =16.4, 9.2, CH2CH), 1.29 (3H, t, J = 7.1, OCH2CH3), 1.28 (3H, t, J = 
7.2, OCH2CH3), 1.05 (3H, t, J = 7.1, OCH2CH3); 13C NMR (62.9 MHz, CDCl3) 
195.6 (C),  169.9 (C), 168.4 (C), 167.9 (C), 166.1 (C), 159.3 (C), 134.8 (C), 132.1 (2 
x CH), 129.6 (2 x CH), 129.3 (2 x CH), 129.1 (C), 128.8 (C), 114.1 (2 x CH), 75.3 
(C), 63.3 (CH2), 62.9 (CH2), 62.4 (CH2), 55.8 (CH3), 52.9 (CH), 40.7 (CH), 39.5 
(CH2), 14.4 (CH3), 14.4 (CH3), 13.9 (CH3); HRMS (ES) Exact mass calcd. for 
C28H3179BrNO9 [M+H]+: 604.1177, found: 604.1177. 
 
 (±)-(3R,4R)-3,5,5-Tricarbethoxy-1-(4-methoxyphenyl)-4-[2-
(2-naphthyl)-2-oxoethyl]pyrrolidin-2-one (227d). The title 
compound was prepared according to the General Procedure 
from tethered diacid 210 (79 mg, 0.20 mmol), alkynone 133d 
(40 mg, 0.22 mmol) and Mg(OTf)2 (12.9 mg, 0.04 mmol) and 
purified by column chromatography (20:1 CH2Cl2/Et2O) to give a yellow oil (79 mg, 
69%) as an 8:1 inseparable mixture of diastereomers. IR (film) 2981, 2935, 2848, 
1735 (C=O), 1716 (C=O), 1687 (C=O), 1511, 1249, 1214, 1025 cm-1; 1H NMR (360 
MHz, CDCl3) δ 8.66-8.63 (1H, m, ArH), 8.04-8.02 (1H, m, ArH), 7.96-7.94 (1H, m, 
ArH), 7.90-7.88 (1H, m, ArH), 7.64-7.51 (3H, m, ArH), 7.18 (2H, dm, J = 9.0 Hz, 
ArH), 6.88 (2H, dm, J = 9.0 Hz, ArH), 4.40-4.09 (7H, m, 3 x OCH2CH3 and 
CH2CH), 3.80 (3H, s, OCH3), 3.68 (1H, dd, J = 17.0, 4.9 Hz, CH2CH), 3.67 (1H, d, 
J = 11.3 Hz, CHC=O), 3.16 (1H, dd, J = 17.0, 8.9 Hz, CH2CH), 1.29 (3H, t, J = 7.1 
Hz, OCH2CH3), 1.25 (3H, t, J = 7.2 Hz, OCH2CH3), 1.09 (3H, t, J = 7.1 Hz, 
OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 200.0 (C), 170.1 (C), 168.5 (C), 168.0 
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(C), 166.1 (C), 159.2 (C), 134.5 (C), 134.0 (C), 133.3 (CH), 130.1 (C), 129.2 (2 x 
CH and CH), 128.4 (CH), 128.1 (CH), 128.0 (CH), 126.6 (CH), 125.8 (CH), 124.2 
(CH), 114.0 (2 x CH), 73.4 (C), 62.8 (CH2), 62.4 (CH2), 61.9 (CH2), 55.3 (CH3), 52.9 
(CH), 42.3 (CH2), 40.7 (CH), 14.0 (2 x CH3), 13.6 (CH3); HRMS (ES) Exact mass 
calcd. for C32H34NO9 [M+H]+: 576.2228, found: 576.2231. 
 
 (±)-(3R,4R)-3,5,5-Tricarbethoxy-1-(4-methoxyphenyl)-4-
[2-(4-nitrophenyl)-2-oxoethyl]pyrrolidin-2-one (227e). The 
title compound was prepared according to the General 
Procedure from tethered diacid 210 (79 mg, 0.20 mmol), 
alkynone 133e (39 mg, 0.22 mmol) and Ni(acac)2 (10.8 mg, 
0.04 mmol) and purified by column chromatography (25% EtOAc/petrol) to give a 
yellow oil (88 mg, 77%). IR (film) 2936, 2849, 1734 (C=O), 1717 (C=O), 1604, 
1526, 1511, 1348, 1249, 1223, 1026 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.35 (2H, 
dm, J = 8.9 Hz, ArH), 8.15 (2H, dm, J = 8.9 Hz, ArH), 7.14 (2H, dm, J = 9.0 Hz, 
ArH), 6.88 (2H, dm, J = 9.0 Hz, ArH), 4.39-4.23 (4H, m, 2 x OCH2CH3), 4.18-4.05 
(3H, m, OCH2CH3 and CH2CH), 3.80 (3H, s, OCH3), 3.66 (1H, dd, J = 16.3, 4.6 Hz, 
CH2CH), 3.64 (1H, d, J = 11.4 Hz, CHC=O), 2.97 (1H, dd, J =16.3, 9.2 Hz, 
CH2CH), 1.31 (3H, t, J = 7.1 Hz, OCH2CH3), 1.30 (3H, t, J = 7.2 Hz, OCH2CH3), 
1.04 (3H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 195.4 (C), 169.6 
(C), 168.2 (C), 167.8 (C), 166.0 (C), 159.3 (C), 150.5 (C), 140.3 (C), 129.3 (2 x CH), 
129.2 (2 x CH), 128.9 (C), 123.9 (2 x CH), 114.1 (2 x CH), 75.2 (C), 63.0 (CH2), 
62.6 (CH2), 62.0 (CH2), 55.4 (CH3), 52.2 (CH), 40.2 (CH), 39.6 (CH2), 14.1 (CH3), 
14.0 (CH3), 13.5 (CH3); HRMS (ES) Exact mass calcd. for C28H31N2O11 [M+H]+: 
571.1922, found: 571.1923. 
 
 (±)-(3R,4R)-3,5,5-Tricarbethoxy-4-[2-(4-chlorophenyl)-2-
oxoethyl]-1-(4-methoxyphenyl)pyrrolidin-2-one (227f). The 
title compound was prepared according to the General 
Procedure from tethered diacid 210 (79 mg, 0.20 mmol), 
alkynone 133f (36 mg, 0.22 mmol) and Mg(OTf)2 (12.9 mg, 
0.04 mmol) and purified by column chromatography (20:1 CH2Cl2/Et2O) to give a 
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yellow oil (68 mg, 61%) as a 14:1 inseparable mixture of diastereomers. IR (film) 
2983, 2940, 2841, 1743 (C=O), 1673 (C=O), 1510, 1250, 1035, 844 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 7.91 (2H, dm, J = 8.5 Hz, ArH), 7.46 (2H, dm, J = 8.5 Hz, 
ArH), 7.15 (2H, dm, J = 9.0 Hz, ArH),  6.87 (2H, dm, J = 9.0 Hz, ArH), 4.42-4.25 
(4H, m, 2 x OCH2CH3), 4.21-4.07 (3H, m, OCH2CH3 and CH2CH), 3.79 (3H, s, 
OCH3), 3.63 (1H, d, J = 11.4 Hz, CHC=O), 3.58 (1H, dd, J = 16.3, 4.7 Hz, CH2CH), 
2.93 (1H, dd, J =16.4, 9.2, CH2CH), 1.29 (3H, t, J = 7.1 Hz, OCH2CH3), 1.28 (3H, t, 
J = 7.1 Hz, OCH2CH3), 1.05 (3H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (62.9 MHz, 
CDCl3) δ 195.4 (C), 170.0 (C), 168.4 (C), 167.9 (C), 166.1 (C), 159.2 (C), 140.0 (C), 
134.4 (C), 129.5 (2 x CH), 129.3 (2 x CH), 129.0 (2 x CH and C), 114.1 (2 x CH), 
75.3 (C), 62.9 (CH2), 62.5 (CH2), 61.9 (CH2), 55.4 (CH3), 52.5 (CH), 40.3 (CH), 39.1 
(CH2), 14.1 (CH3), 14.0 (CH3), 13.5 (CH3); HRMS (ES) Exact mass calcd. for 
C28H31ClNO9 [M+H]+: 560.01682, found: 560.1683. 
 
 (±)-(3R,4R)-3,5,5-Tricarbethoxy-4-[2-(4-fluorophenyl)-2-
oxoethyl]-1-(4-methoxyphenyl)pyrrolidin-2-one (227g). The 
title compound was prepared according to the General 
Procedure from tethered diacid 210 (79 mg, 0.20 mmol), 
alkynone 133g (30 mg, 0.22 mmol) and Mg(OTf)2 (12.9 mg, 
0.04 mmol) and purified by column chromatography (20:1 CH2Cl2/Et2O) to give a 
yellow oil (81 mg, 75%) as a 15:1 inseparable mixture of diastereomers. IR (film) 
2982, 2937, 2840, 1735 (C=O), 1718 (C=O), 1691 (C=O), 1597, 1511, 1249, 1230, 
1158 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.02-7.98 (2H, m, ArH), 7.17 (2H, dm, J = 
8.7 Hz, ArH), 7.15 (2H, dm, J = 9.0 Hz, ArH), 6.87 (2H, d, J = 9.0 Hz, ArH), 4.39-
4.21 (4H, m, 2 x OCH2CH3), 4.17-4.03 (3H, m, OCH2CH3 and CH2CH), 3.80 (3H, s, 
OCH3), 3.63 (2H, d, J = 11.4 Hz, CHC=O), 3.58 (1H, dd, J = 16.4, 4.6 Hz, CH2CH), 
2.93 (1H, dd, J = 16.4, 9.3 Hz, CH2CH), 1.29 (3H, t, J = 7.1 Hz, OCH2CH3), 1.28 
(3H, t, J = 7.2 Hz, OCH2CH3), 1.05 (3H, t, J = 7.2 Hz, OCH2CH3); 13C NMR (62.9 
MHz, CDCl3) δ 195.0 (C), 170.0 (C), 168.3 (C), 167.9 (C), 166.0 (C), 165.9 (C, d, JF 
= 255.0 Hz), 159.2(C), 132.5 (C, d, JF = 2.9 Hz), 130.8 (2 x CH, d, JF = 9.4 Hz), 
129.3 (2 x CH), 129.0 (C), 115.8 (2 x CH, d, JF = 21.9 Hz), 114.0 (2 x CH), 75.3 (C), 
62.4 (CH2), 62.8 (CH2),  61.9 (CH2), 55.3 (CH3), 52.5 (CH), 40.3 (CH), 39.0 (CH2), 
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14.0 (CH3), 13.9 (CH3), 13.5 (CH3); 19F NMR (235 MHz, CDCl3) δ –104.6; HRMS 
(ES) Exact mass calcd. for C28H31FNO9 [M+H]+: 544.1977, found: 544.1976. 
 
 (±)-(3R,4R)-3,5,5-Tricarbomethoxy-1-(4-methoxyphenyl)-4-
(2-oxo-2-phenylethyl)pyrrolidin-2-one (228a). The title 
compound was prepared according to the General Procedure from 
tethered diacid 211 (71 mg, 0.20 mmol), alkynone 133a (29 mg, 0.22 mmol) and 
Mg(OTf)2 (12.9 mg, 0.04 mmol) and purified by column chromatography (20:1 
CH2Cl2/Et2O) to give a yellow oil (58 mg, 60%) as a 10:1 inseparable mixture of 
diastereomers. IR (film) 2954, 1740 (C=O), 1716 (C=O), 1687 (C=O), 1511, 1435, 
1248, 830 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.96-7.93 (2H, m, ArH), 7.63-7.57 
(1H, m, ArH), 7.51-7.47 (2H, m, ArH), 7.15 (2H, dm, J =  8.9 Hz, ArH), 6.89 (2H, 
dm, J =  8.9 Hz, ArH), 4.10 (1H, ddd, J = 11.3, 8.4, 5.1 Hz, CH2CH), 3.67 (1H, d, J 
= 11.3 Hz, CH=O), 3.83 (3H, s, OCH3), 3.81 (3H, s, OCH3), 3.80 (3H, s, OCH3), 
3.69 (3H, s, OCH3), 3.55 (1H, dd, J = 17.2, 5.1 Hz, CH2CH), 3.07 (1H, dd, J = 17.2, 
8.4 Hz, CH2CH); 13C NMR (62.9 MHz, CDCl3) δ 196.4 (C), 169.9 (C), 168.8 (C), 
168. x CH), 128.0 (2 x CH), 125.0 (C), 114.1 (2 x CH), 75.6 (C), 55.3 (CH3), 53.2 
(CH3), 53.1 (CH3), 52.8 3 (C), 166.5 (C), 159.3 (C), 136.0 (C), 133.5 (CH),  129.2 (2 
x CH), 128.8 (C), 128.7 (2 (CH3), 52.5 (CH),  40.4 (CH), 38.9 (CH2); HRMS (ES) 
Exact mass calcd. for C25H26NO9 [M+H]+: 501.1868, found: 533.1875. 
 
(±)-(3R,4R)-3,5,5-Tricarbomethoxy-4-[2-(4-methoxyphenyl)-
2-oxoethyl]-1-(4-methoxyphenyl)pyrrolidin-2-one (228b). The 
title compound was prepared according to the General Procedure 
from tethered diacid 211 (71 mg, 0.2 mmol), alkynone 133b (50 
mg, 0.24 mmol) and Mg(OTf)2 (13 mg, 0.04 mmol) and purified 
by column chromatography (20:1 CH2Cl2/Et2O) to give a yellow oil (68 mg, 60%) as 
a 8:1 inseparable mixture of diastereomers. IR (film) 2955, 2847, 1741 (C=O), 1715 
(C=O), 1605, 1526, 1511, 1348, 1250, 855; 1H NMR (360 MHz, CDCl3) 7.93 (2H, 
dm, J = 9.0 Hz, ArH), 7.14 (2H, dm, J = 9.1 Hz, ArH),  6.95 (2H, dm, J = 9.0 Hz, 
ArH), 6.88 (2H, dm, J = 9.1 Hz, ArH), 4.08 (1H, ddd, J = 11.2, 8.7, 5.1 Hz, 
CH2CH), 3.89 (3H, s, OCH3), 3.82 (3H, s, OCH3), 3.81 (3H, s, OCH3), 3.80 (3H, s, 
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OCH3), 3.69 (3H, s, OCH3), 3.67 (1H, d, J = 11.2 Hz, CHC=O), 3.51 (1H, dd, J = 
16.8, 5.1 Hz, CH2CH), 2.98 (1H, dd, J = 16.8, 8.7 Hz, CH2CH); 13C NMR (62.9 
MHz, CDCl3) 194.9 (C), 170.0 (C), 168.9 (C), 168.3 (C), 163.8 (C), 159.3 (C), 130.4 
(2 x CH), 129.2 (2 x CH), 128.8 (C), 125.0 (C), 114.2 (2 x CH), 113.8 (2 x CH), 75.6 
(C), 55.5 (CH3), 55.3 (CH3), 53.2 (CH3), 53.1 (CH3),  52.8 (CH3), 52.5 (CH),  40.5 





The title compound was prepared according to the General 
Procedure from tethered diacid 211 (71 mg, 0.20 mmol), 
alkynone 133c (46 mg, 0.22 mmol) and Mg(OTf)2 (12.9 mg, 
0.04 mmol) and purified by column chromatography (20:1 CH2Cl2/Et2O) to give a 
yellow oil (68 mg, 60%) as a 10:1 inseparable mixture of diastereomers. IR (film) 
2953, 2924, 2844, 1740 (C=O), 1716 (C=O), 1690, 1585, 1511, 1249 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 7.82 (2H, d, J = 8.5 Hz, ArH), 7.64 (2H, d, J = 8.5 Hz, ArH), 
7.14 (2H, dm, J =  9.0 Hz, ArH), 6.88 (2H, dm, J =  9.0 Hz, ArH), 4.08 (1H, ddd, J = 
11.4, 8.6, 5.1 Hz, CH2CH), 3.83 (3H, s, OCH3), 3.81 (3H, s, OCH3), 3.80 (3H, s, 
OCH3), 3.68 (3H, s, OCH3), 3.67 (1H, d, J = 11.4 Hz, CH=O), 3.51(1H, dd, J = 17.0, 
5.1 Hz, CH2CH), 3.00 (1H, dd, J = 17.0, 8.6 Hz, CH2CH); 13C NMR (62.9 MHz, 
CDCl3) δ 195.6 (C), 169.8 (C), 168.8 (C), 168.3 (C), 166.6 (C), 159.4 (C), 134.7 (C), 
132.1 (2 x CH), 129.6 (2 x CH), 129.3 (2 x CH), 128.9 (C), 128.8 (C), 114.2 (2 x 
CH), 75.5 (C), 55.4 (CH3), 53.3 (CH3), 53.2 (CH3), 53.0 (CH3), 52.4 (CH), 40.4 
(CH), 38.9 (CH2); HRMS (ES) Exact mass calcd. for C25H2579BrNO9 [M+H]+: 
561.0707, found: 561.0706. 
 
 (±)-(3R,4R)-3,5,5-Tricarbomethoxy-1-(4-methoxyphenyl)-4-
[2-(1-naphthyl)-2-oxoethyl]pyrrolidin-2-one (228d). The title 
compound was prepared according to the General Procedure 
from tethered diacid 211 (71 mg, 0.20 mmol), alkynone 133d 
(40 mg, 0.22 mmol) and Ni(acac)2 (10.8 mg, 0.04 mmol) and 
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purified by column chromatography (20:1 CH2Cl2/Et2O) to give a yellow oil (72 mg, 
67%) as a 15:1 inseparable mixture of diastereomers. IR (film) 2935, 2849, 2360, 
1739 (C=O), 1715 (C=O), 1607, 1510, 1435, 1364, 1250 cm-1; 1H NMR (360 MHz, 
CDCl3) δ 8.61 (1H, d, J = 7.8 Hz, ArH), 8.04 (1H, d, J = 8.3 Hz, ArH), 7.93-7.88 
(2H, m, ArH), 7.65-7.51 (3H, m, ArH), 7.17 (2H, d, J =  9.1 Hz, ArH), 6.89 (2H, d, J 
=  9.1 Hz, ArH), 4.21 (1H, ddd, J = 11.3, 8.3, 5.6 Hz, CH2CH), 3.84 (3H, s, OCH3), 
3.81 (3H, s, OCH3), 3.77 (3H, s, OCH3), 3.72 (3H, s, OCH3), 3.69 (1H, d, J = 11.3 
Hz, CHC=O), 3.59 (1H, dd, J = 17.4, 5.6 Hz, CH2CH), 3.23 (1H, dd, J = 17.4, 8.3 
Hz, CH2CH); 13C NMR (62.9 MHz, CDCl3) δ 200.0 (C), 169.8 (C), 168.9 (C), 168.3 
(C), 166.6 (C), 159.2 (C), 134.4 (C), 133.9 (C), 133.4 (CH), 130.0 (C), 129.1 (2 x 
CH), 128.8 (C), 128.4 (CH), 128.2 (CH), 127.9 (CH), 126.6 (CH), 125.7 (CH),  
124.2 (CH), 114.2 (2 x CH), 75.6 (C), 55.3 (CH3), 53.2 (2 x CH3), 52.9 (CH3), 52.6 
(CH), 42.2 (CH2), 40.7 (CH); HRMS (ES) Exact mass calcd. for C29H28NO9 [M+H]+: 




The title compound was prepared according to the General 
Procedure from tethered diacid 211 (71 mg, 0.2 mmol), 
alkynone 133e (42 mg, 0.24 mmol) and Ni(acac)2 (10 mg, 
0.04 mmol) and purified by column chromatography (20:1 CH2Cl2/Et2O) to give a 
yellow oil (41 mg, 39%) as a single diastereomer. IR (film) 2955, 2841, 1740 (C=O), 
1715 (C=O), 1600, 1511, 1250, 1171, 1028, 834; 1H NMR (360 MHz, CDCl3) 8.35 
(2H, dm, J = 9.0 Hz, ArH), 8.13 (2H, dm, J = 9.0 Hz, ArH), 7.13 (2H, dm, J = 9.1 
Hz,, ArH), 6.89 (2H, dm, J = 9.1 Hz, ArH), 4.10 (1H, ddd, J = 11.4, 8.6, 5.2 Hz, 
CHCH2), 3.84 (3H, s, OCH3), 3.83 (3H, s, OCH3), 3.81 (3H, s, OCH3), 3.68 (1H, d, 
J = 11.4 Hz, CHC=O), 3.69 (3H, s, OCH3), 3.59 (1H, dd, J = 17.0, 5.2 Hz, CHCH2), 
3.07 (1H, dd, J = 17.0, 8.6 Hz, CHCH2); 13C NMR (62.9 MHz, CDCl3) 195.3 (C), 
169.5 (C), 168.7 (C), 168.2 (C), 166.6 (C), 159.4 (C), 150.6 (C), 140.3 (C), 129.3 (2 
x CH), 129.2 (2 x CH), 128.6 (C), 124.0 (2 x CH), 114.3 (2 x CH), 75.4 (C), 55.4 
(CH3), 53.3 (CH3), 53.2 (CH3), 53.0 (CH3), 52.2 (CH),  40.3 (CH), 39.5 (CH2); 
HRMS (ES) Exact mass calcd. for C25H25N2O11 [M+H]+: 530.14, found: 530.00. 






The title compound was prepared according to the General 
Procedure from tethered diacid 211 (71 mg, 0.20 mmol), 
alkynone 133f (39 mg, 0.24 mmol) and Ni(acac)2 (10 mg, 0.04 
mmol) and purified by column chromatography (20:1 CH2Cl2/Et2O) to give a yellow 
oil (47 mg, 45%) as a >20:1 inseparable mixture of diastereomers. IR (film) 2954, 
2922, 1740 (C=O), 1716 (C=O), 1690, 1589, 1511, 1436, 1249, 829; 1H NMR (360 
MHz, CDCl3) 7.89 (1H, dm, J = 8.6 Hz, ArH), 7.47 (1H, dm J = 8.6 Hz, ArH), 7.14 
(2H, dm, J =  9.0 Hz, ArH), 6.88 (2H, d, J =  9.0 Hz, ArH), 4.08 (1H, ddd, J = 13.6, 
8.5, 5.1 Hz, CHCH2), 3.83 (3H, s, OCH3), 3.82 (3H, s, OCH3), 3.81 (3H, s, OCH3), 
3.68-3.65 (4H, m, OCH3 and CHC=O), 3.52(1H, dd, J = 17.0, 5.1 Hz, CHCH2), 3.23 
(1H, dd, J = 17.0, 8.5 Hz, CHCH2); 13C NMR (62.9 MHz, CDCl3) 195.4 (C), 169.8 
(C), 168.8 (C), 168.3 (C), 166.6 (C), 159.4 (C), 140.1 (C), 134.3 (C), 129.5 (2 x CH), 
129.3 (2 x CH), 129.1 (2 x CH), 128.8 (C), 114.2 (2 x CH), 75.5 (C), 55.4 ( OCH3), 
53.3 (CH3), 53.2 (CH3), 52.9 (CH3), 52.4 (CH),  40.4 (CH), 38.9 (CH2); HRMS (ES) 




The title compound was prepared according to the General 
Procedure from tethered diacid 211 (71 mg, 0.20 mmol), 
alkynone 133g (30 mg, 0.22 mmol) and Ni(acac)2 (10.8 mg, 
0.04 mmol) and purified by column chromatography (20:1 CH2Cl2/Et2O) to give a 
yellow solid (59 mg, 59%) as a 10:1 inseparable mixture of diastereomers. m.p. 146–
147 °C; IR (CHCl3) 2955, 2924, 2847, 1741 (C=O), 1716 (C=O), 1689 (C=O), 1597, 
1510, 1249, 1231, 1158 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.00-7.96 (2H, m, 
ArH), 7.18-7.13 (4H, m, ArH), 6.88 (2H, d, J = 9.0 Hz, ArH), 4.08 (1H, ddd, J = 
11.3, 8.6, 5.1 Hz, CH2CH), 3.82 (3H, s, OCH3), 3.81 (3H, s, OCH3), 3.80 (3H, s, 
OCH3), 3.67 (1H, d, J = 11.3 Hz, CHC=O), 3.52 (1H, dd, J = 16.9, 5.1 Hz, CH2CH), 
3.01 (1H, dd, J = 16.9, 8.6 Hz, CH2CH); 13C NMR (62.9 MHz, CDCl3) δ 194.9 (C), 
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169.8 (C), 168.7 (C), 168.2 (C), 166.6 (C), 165.9 (C, d, JF = 255.5 Hz), 159.3 (C), 
132.5 (C, d, JF = 2.8 Hz), 130.8 (2 x CH, d, JF = 9.4 Hz), 129.2 (2 x CH), 128.8 (C), 
115.8 (2 x CH, d, JF = 22.0 Hz), 114.2 (2 x CH), 75.5 (C), 55.3 (CH3), 53.2 (CH3), 
53.1 (CH3), 52.9 (CH3), 52.4 (CH),  40.4 (CH), 38.8 (CH2); 19F NMR (235 MHz, 




(233) and diethyl 2-[N-(2-carbethoxyacetyl)-N-(4-methoxyphenyl)amino]-2-(3-
oxobutyl)malonate (234) 
 
Using Mg(OTf)2: To a stirred solution of the tethered diacid 210 (79 mg, 0.20 mmol), 
KOtBu (4.7 mg, 0.04 mmol) and Mg(OTf)2 (12.9 mg, 0.04 mmol) in CH2Cl2 (1 mL) 
at room temperature was added methyl vinyl ketone (232) (20 μL, 0.22 mmol). The 
reaction was stirred at room temperature for 16 h and concentrated in vacuo. 
Purification of the residue by column chromatography (25% EtOAc/hexane→50% 
EtOAc/hexane) gave the Michael adduct 233 (48 mg, 52%) as a pale yellow oil. 
Using Ni(acac)2: To a stirred solution of the tethered diacid 210 (79 mg, 0.20 mmol), 
KOtBu (4.7 mg, 0.04 mmol) and Ni(acac)2 (10.8 mg, 0.04 mmol) in CH2Cl2 (1 mL) 
at room temperature was added methyl vinyl ketone (20 μL, 0.22 mmol). The 
reaction was stirred at room temperature for 16 h and concentrated in vacuo. 
Purification of the residue by column chromatography (25% EtOAc/hexane→50% 
EtOAc/hexane) gave the Michael adduct 233 (10 mg, 11%) as a pale yellow oil 
followed by the Michael adduct 234 (28 mg, 30%) as a pale yellow oil. 
Data for 233: 
IR (film) 2983, 2938, 2908, 1741 (C=O), 1716 (C=O), 1668 (C=O), 1509, 1250, 
1180, 1031 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.36 (2H, br s, ArH), 6.87 (2H, d, J 
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= 8.3 Hz, ArH), 5.44 (1H, s, NCH), 4.28-4.00 (4H, m, 3 x OCH2CH3), 3.81 (3H, s, 
OCH3), 3.46 (1H, dd, J = 8.1, 6.3 Hz, CHCH2), 2.60-2.43 (2H, m, CHCH2CH2), 2.12 
(3H, s, CH3C=O), 2.10-2.05 (2H, m, CHCH2), 1.26 (3H, t, J = 7.1 Hz, OCH2CH3), 
1.25 (3H, t, J = 7.1 Hz, OCH2CH3), 1.16 (3H, t, J = 7.1 Hz, OCH2CH3); 13C NMR 
(62.9 MHz, CDCl3) δ 207.7 (C), 169.6 (C), 169.1 (C), 165.9 (C), 165.4 (C), 159.9 
(C), 131.9 (C), 131.2 (CH), 130.3 (CH), 114.5 (2 x CH), 64.9 (CH), 62.0 (2 x CH2), 
61.3 (CH2), 55.4 (CH3), 47.6 (CH), 40.1 (CH2), 29.8 (CH3), 23.1 (CH2), 14.0 (CH3), 
13.9 (CH3), 13.8 (CH3); HRMS (ES) Exact mass calcd. for C23H32NO9 [M+H]+: 
466.2072, found: 466.2070. 
Data for 234: IR (film) 2982, 2939, 2841, 1741 (C=O), 1671 (C=O), 1509, 1366, 
1248, 1031, 843 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.36 (2H, dm, J = 9.0 Hz, 
ArH), 6.91 (2H, dm, J = 9.0 Hz, ArH), 4.19 (2H, q, J = 7.2 Hz, OCH2CH3), 4.19 
(2H, q, J = 7.1 Hz, OCH2CH3), 4.12 (2H, q, J = 7.1 Hz, OCH2CH3), 3.83 (3H, s, 
OCH3), 3.11 (2H, s, EtO2CCH2), 2.63-2.59 (2H, m, CH2CH2C=O), 2.17-2.13 (2H, 
m, CH2CH2C=O), 2.06 (3H, s, CH3C=O), 1.28 (6H, t, J = 7.1 Hz, 2 x OCH2CH3), 
1.21 (3H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 206.6 (C), 167.6 
(2 x C), 167.4 (C), 167.0 (C), 160.0 (C), 131.5 (2 x CH), 131.4 (C), 114.6 (2 x CH), 
71.2 (C), 62.0 (2 x CH2), 61.1 (CH2), 55.5 (CH3), 42.4 (CH2), 38.5 (CH2), 29.9 
(CH3), 28.9 (CH2), 14.0 (2 x CH3), 13.9 (CH3); HRMS (ES) Exact mass calcd. for 





To a solution of the double Michael product 227a (53 mg, 0.10 mmol) in THF (1 
mL) at room temperature was added NaH (60% dispersion in mineral oil, 40 mg, 
0.10 mmol) in one portion, followed by BnBr (18 μL, 0.15 mmol). The mixture was 
stirred at room temperature for 5 h, quenched with H2O (10 mL), and extracted with 
EtOAc (3 x 10 mL), and the combined organic layers were dried (MgSO4) and 
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concentrated in vacuo. Purification of the residue by column chromatography (20% 
EtOAc/hexane→33% EtOAc/hexane) gave the benzylated pyrrolidinone 238 (41 mg, 
67%) as a yellow oil. IR (film) 2982, 2936, 2904, 1741 (C=O), 1706 (C=O), 1510, 
1249, 1070, 1030, 913 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.94-7.91 (2H, m, ArH), 
7.59 (1H, t, J = 7.4 Hz, ArH), 7.48 (2H, app t, J = 7.6 Hz, ArH), 7.32 (5H, br s, 
ArH), 7.19 (2H, dm, J = 8.9 Hz, ArH), 6.83 (2H, dm, J = 8.8 Hz, ArH), 4.31-4.25 
(2H, m, OCH2CH3), 4.15-3.91 (5H, m, 2 x OCH2CH3 and CH2CH), 3.79 (3H, s, 
OCH3), 3.64 (1H, dd, J = 18.2, 10.8 Hz, CH2CH), 3.64 (1H, d, J = 14.1 Hz, CH2Ph), 
3.24 (1H, d, J = 14.1 Hz, CH2Ph), 3.10 (1H, dd, J = 18.2, 4.0 Hz, CH2CH), 1.35 (3H, 
t, J = 7.2 Hz, OCH2CH3), 1.00-0.95 (6H, m, 2 x OCH2CH3); 13C NMR (62.9 MHz, 
CDCl3) δ 196.4 (C), 172.0 (C), 169.9 (C), 167.4 (C), 167.1 (C), 159.1 (C), 136.4 (C), 
135.4 (C), 133.2 (CH), 131.0 (2 x CH), 130.4 (2 x CH), 129.3 (C), 128.6 (2 x CH), 
128.4 (2 x CH), 127.9 (2 x CH), 127.3 (CH), 113.7 (2 x CH), 75.7 (C), 62.3 (CH2), 
61.9 (CH2), 61.7 (CH2), 58.6 (C), 55.3 (CH3), 40.4 (CH), 37.4 (CH2), 36.7 (CH2), 
14.1 (CH3), 13.6 (2 x CH3); HRMS (ES) Exact mass calcd. for C35H38NO9 [M+H]+: 





A solution of double Michael product 227a (53 mg, 0.10 mmol) in DMF (1 mL) was 
heated to 110 °C for 72 h. After cooling to room temperature, the mixture was 
partitioned between H2O (15 mL) and EtOAc (15 mL). The aqueous layer was 
separated and extracted with EtOAc (2 x 15 mL), and the combined organic layers 
were dried (MgSO4) and concentrated in vacuo. Purification of the residue by 
column chromatography (25% EtOAc/hexane→33% EtOAc/hexane) gave the 
decarboxylated pyrrolidinone 238 (27 mg, 60%) as a yellow oil. IR (film) 2981, 
2936, 2838, 1730 (C=O), 1687 (C=O), 1511, 1294, 1248, 1031, 690 cm-1; 1H NMR 
(360 MHz, CDCl3) δ 7.96 (2H, d, J = 7.3 Hz, ArH), 7.63-7.59 (1H, m, ArH), 7.52-
7.47 (2H, m, ArH), 7.17 (2H, dm, J = 8.9 Hz, ArH), 6.88 (2H, dm, J = 8.9 Hz, ArH), 
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4.40-4.26 (2H, m, OCH2CH3), 4.19-4.03 (2H, m, OCH2CH3), 3.80 (3H, s, OCH3), 
3.80-3.70 (1H, m, CH2CH), 3.54 (1H, dd, J = 17.2, 3.9 Hz, PhCOCH2), 3.02-2.94 
(2H, m, CH2CON and PhCOCH2), 2.40 (1H, dd, J = 16.7, 11.1 Hz, CH2CON), 1.30 
(3H, t, J = 7174.8 (C), 168.1 (C), 166.8 (C), 159.1 (C), 136.3 (C), 133.5 (CH), 129.5 
(C and 2 x CH), 128.8 (2 x CH), 128.1 Hz, OCH2CH3), 1.06 (3H, t, J = 7.1 Hz, 
OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 196.7 (C), 174.8 (C), 168.1 (C), 166.8 
(C), 159.2 (C), 136.3 (C),133.5 (CH), 129.5 (2 x CH), 128.8 (2 x CH), 128.0 (2 x 
CH), 114.1 (2 x CH), 62.5 (CH2), 62.3 (CH2), 60.4 (C), 55.4 (CH3), 39.8 (CH2), 36.7 
(CH), 35.6 (CH2), 14.2 (CH3), 13.6 (CH3); HRMS (ES) Exact mass calcd. for 
C25H28NO7 [M+H]+: 454.1860, found: 454.1863. 
 
Stereochemical Determinations 
The relative configuration of 227a was determined by X-ray crystallography. Crystal 
structure deposited at the Cambridge Crystallographic Data Center; Deposition 
Number: CCDC 638217 Note – there is a small degree of disorder associated with 








The relative stereochemistries of the remaining double Michael products 9–17 were 
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5.3 Michael addition combined with Friedel-Crafts alkylation 
 
3-Dimethylaminophenyl ethyl malonate (333).  
 
DMF (1 mL) was added dropwise over 15 min to a solution of the acid 225 (2.00 g, 
15.1 mmol) and (COCl)2 (1.28 mL, 15.1 mmol) in CH2Cl2 (5 mL) at room 
temperature. The solution thus obtained was transferred by cannula to a stirred 
solution of the alcohol 334 (1.48 g, 10.8 mmol) and EtNiPr2 (2.9 mL, 17.3 mmol) in 
CH2Cl2 (5 mL) at room temperature. The reaction mixture was stirred at room 
temperature for 16h, after that was partitioned between saturated aqueous NaHCO3 
solution (20 mL) and CH2Cl2 (20 mL). The aqueous layer was separated and 
extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers were dried 
(MgSO4) and concentrated in vacuo. Purification of the residue by column 
chromatography (15% EtOAc/hexane) afforded the desired ester 333 (1.17 g, 43%) 
as a colourless oil. 1H NMR (250 MHz, CDCl3) δ 7.19-7.12 (1H, m, ArH), 6.54-6.50 
(1H, m, ArH), 6.42-6.35 (2H, m, ArH), 4.2 (2H, q, J = 7.1 Hz OCH2CH3), 3.53 (2H, 
s, CH2), 2.87 (6H, s, N(CH3)2), 1.26 (3H, t, J = 7.1 Hz OCH2CH3); 13C NMR (62.9 
MHz, CDCl3) δ 166.1 (C), 165.0 (C), 151.5 (C), 151.4 (C), 129.5 (CH), 110.0 (CH), 
108.7 (CH), 104.9 (CH), 61.5 (CH2), 41.5 (CH2), 40.2 (2 x CH3), 13.9 (CH3); HRMS 
(ES) Exact mass calcd. for C13H18NO4 [M+H]+: 252.1230, found: 252.1227. 
 
Diethyl 2-(3-dimethylaminophenoxy) malonate (341) and 2,3-bis-(3-
dimethylaminophenoxy)-2,3-bis-diethylethoxycarbonylsuccinic acid diethyl 
ester (342). 
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A mixture of alcohol 334 (1.00 g, 7.3 mmol) and K2CO3 (2.00 g, 14.6 mmol) in 
acetone (20 mL) was heated to reflux. Diethylchloromalonate 345 (2.35 mL, 14.6 
mmol) was then added dropwise to the mixture and the resulting suspension was 
stirred for 6 h. After that time the mixture was allowed to cool down to room 
temperature and quenched with a saturated aqueous NaHCO3 solution (20 mL). ). 
The aqueous layer was separated and extracted with CH2Cl2 (3 x 20 mL) and the 
combined organic layers were dried (MgSO4) and concentrated in vacuo. Purification 
of the residue by column chromatography (10% EtOAc/hexane) afforded the the 
byproduct 342 (96 mg, 2%) as a colourless oil, followed by the desired ester 341 
(1.05 g, 49%) as a yellow oil. 
Data for 342: 
IR (film) 2983, 2812, 1763 (C=O), 1610 (C=O), 1504, 1267, 1228, 1153, 1051, 928 
cm-1; 1H NMR (360 MHz, CDCl3) δ 7.16-7.09 (2H, m, ArH), 6.56-6.47 (6H, m, 
ArH), 4.33 (8H, q, J = 7.1, OCH2CH3), 2.93 (12H, s, 2 x N(CH3)2), 1.26 (12H, t, J = 
7.1, 4 x OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 163.5 (4 x C), 154.5 (2 x C), 
151.6 (2 x C), 129.5 (2 x CH), 108.6 (2 x CH), 104.8 (2 x CH), 102.5 (2 x CH), 88.7 
(2 x C), 63.8 (4 x CH2), 40.3 (4 x CH3),  13.6 (4 x CH3); LRMS (EI) Mass calcd. for 
C15H22NO5 [M+H]+: 588.3, found: 588.2. 
Data for 341: 
IR (film) 2979, 2924, 1749 (C=O), 1608 (C=O), 1502, 1225, 1159, 1022, 827, 754 
cm-1; 1H NMR (360 MHz, CDCl3) δ 7.16-7.11 (1H, m, ArH), 6.55-6.49 (3H, m, 
ArH), 5.31 (1H, s, CH(CO2Et)2), 4.31 (4H, q, J = 7.1 Hz OCH2CH3), 2.94 (6H, s, 
N(CH3)2), 1.27 (3H, t, J = 7.1 Hz OCH2CH3), 1.26 (3H, t, J = 7.1 Hz OCH2CH3); 
13C NMR (62.9 MHz, CDCl3) δ 165.8 (2 x C), 157.9 (C), 151.9 (C), 129.7 (CH), 
107.2 (CH), 101.8 (CH), 100.6 (CH), 76.3 (CH), 62.3 (2 x CH2), 40.8 (2 x CH3), 14.4 
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5.3.1 Michael Additions: General Procedure 
 
To a stirred solution of the ester (1 equiv.) and KOtBu (1 equiv. or 0.2 equiv.) in 
CH2Cl2 (1 mL) at room temperature was added a solution of the appropriate 
alkynone (1.2 equiv.) in CH2Cl2 (1 mL) via cannula dropwise over 1 min. The 
reaction was stirred at room temperature for 15 min., quenched with NH4Cl saturated 
solution (2 mL), extracted with CH2Cl2 (5 x 3 mL) and concentrated in vacuo. 
Purification of the residue by column chromatography afforded the two geometrical 
stereoisomers. 
 
(E)-Diethyl-2-(3-dimethylaminophenoxy)-2-(3-oxobutenyl)malonate (346a) and 
(Z)-diethyl-2-(3-dimethylaminophenoxy)-2-(3-oxobutenyl)malonate (347a). 
 
The title compounds were prepared according to the General Procedure from the 
ester 341 (59 mg, 0.20 mmol), alkynone 133h (15 μL, 0.24 mmol) and KOtBu (4 mg, 
0.04 mmol) and purified by column chromatography (15% Et2O/CH2Cl2) to give first 
diastereomer 346a (E) as a yellow solid (40 mg, 56%), followed by diastereomer 
347a (Z) as a yellow oil (22 mg, 31%).  
Data for 346a: 
M.p 76–78 °C; IR (film) 2981, 2925, 1747 (C=O), 1687 (C=O), 1610, 1234, 1167, 
1055, 845, 758 cm-1; 1H NMR (360 MHz, CDCl3) 7.41 (1H, d, J = 16.2 Hz, 
CH=CHC=O), 7.07-7.20 (1H, m, ArH), 6.55 (1H, d, J = 16.2 Hz, CH=CHC=O), 
6.42-6.39 (2H, m, ArH), 6.11-6.08 (1H, m, ArH), 4.37-4.23 (4H, m, 2 x OCH2CH3), 
2.95 (6H, s, N(CH3)2), 2.32 (3H, s, CH3C=O), 1.25 (6H, t, J = 7.1 Hz, 2 x 
OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 197.1 (C), 169.9 (2xC), 155.4 (C), 
151.8 (C), 138.4 (CH), 132.8 (CH), 129.3 (CH), 107.0 (CH), 104.0 (CH), 101.8 
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(CH), 83.5 (C), 63.0 (2 x CH2), 40.4 (2 x CH3), 28.1 (CH3), 13.8 (2 x CH3); HRMS 
(ES) Exact mass calcd. for C19H26NO6 [M+H]+: 364.1755, found: 364.1756. 
Data for 347a: 
IR (film) 2981, 2808, 1739(C=O), 1676 (C=O), 1610 (C=O), 1502, 1238, 1171, 
1041, 850 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.00 (1H, t, J = 8.2 Hz, ArH), 6.70 
(1H, d, J = 12.4 Hz, CH=CHC=O), 6.35 (1H, dd, J = 8.3, 2.4 Hz, ArH), 6.29 (1H, t, 
J = 2.4 Hz, ArH), 6.25 (1H, d, J = 12.4 Hz, CH=CHC=O), 6.10-6.07 (1H, m, ArH), 
4.26 (4H, q, J = 7.1 Hz, 2 x OCH2CH3), 2.89 (6H, s, N(CH3)2), 2.14 (3H, s, 
CH3C=O), 1.21 (6H, t, J = 7.1 Hz, 2 x OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 
199.7 (C), 166.4 (2 x C), 155.5 (C), 151.7 (C), 132.4 (CH), 132.1 (CH), 129.1 (CH), 
106.9 (CH), 104.5 (CH), 102.3 (CH), 82.3 (C), 62.7 (2 x CH2), 40.4 (2 x CH3), 30.4 
(CH3), 13.7 (2 x CH3); HRMS (ES) Exact mass calcd. for C19H26NO6 [M+H]+: 






The title compounds were prepared according to the General Procedure from ester 
341 (100 mg, 0.33 mmol), ester 133i (0.04 mL, 0.39 mmol) and KOtBu (37 mg, 0.33 
mmol) and purified by column chromatography (15% Et2O/CH2Cl2) to give first 
diastereomer 346b (E) yellow oil (78 mg, 60%), followed by diastereomer 347b (Z) 
yellow oil (20 mg, 15%). 
Data for 346b: 
IR (film) 2979, 2808, 1772 (C=O), 1745 (C=O), 1726 (C=O), 1614 (C=O), 1504, 
1234, 1163, 858 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.54 ( 1 H, d, J = 15.9 Hz, 
CH=CHC=O), 7.04-6.99 (1H, m, ArH), 6.38-6.35 (2H, m, ArH), 6.29 (1H, d, J = 
15.9 Hz, CH=CHC=O), 6.09-6.06 (1H, m, ArH), 4.32-4.16 (6H, m, 3 x OCH2CH3), 
2.91 (6H, s, N(CH3)2), 1.28 (3H, t, J = 7.1 Hz, OCH2CH3), 1.20 (6H, t, J = 7.1 Hz, 2 
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x OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 165.8 (2 x C), 165.3 (C), 155.4 (C), 
151.8 (C), 139.8 (CH), 129.2 (CH), 125.2 (CH), 106.9 (CH), 104.2 (CH), 101.8 
(CH), 83.6 (C), 62.9 (2 x CH2), 60.8 (CH2), 40.4 (2 x CH3), 14.1 (CH3), 13.8 (2 x 
CH3); HRMS (ES) Exact mass calcd. for C20H28NO7 [M+H]+: 394.1860, found: 
394.1860. 
Data for 347b: 
IR (film) 2979, 2789, 1739 (C=O), 1745 (C=O), 1610 (C=O), 1560, 1238, 1171, 
1041, 850 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.00 (1H, t, d, J = 8.2 Hz, ArH), 6.98 
(1H, d, J = 12.2 Hz, CH=CHC=O), 6.35 (1 H, dd, J = 8.3, 2.4 Hz, ArH), 6.29 ( 1 H, 
t, J = 2.4 Hz, ArH), 6.08-6.06 (1H, m, ArH), 6.06 (1H, d, J = 12.2 Hz, 
CH=CHC=O), 4.26 (4H, q, J = 7.1 Hz, OCH2CH3), 4.16 (2 H, q, J = 7.2 Hz, 
OCH2CH3), 2.89 (6H, s, N(CH3)2), 1.25 (3H, t, J = 7.1 Hz, OCH2CH3), 1.21 (6H, t, J 
= 7.1 Hz, 2 x OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 166.5 (2 x C), 165.0 (C), 
155.6 (C), 151.7 (C), 136.6 (CH), 129.1 (CH), 124.8 (CH), 107.0 (CH), 104.7 (CH), 
102.5 (CH), 81.9 (C), 62.7 (2 x CH2), 60.7 (CH2), 40.4 (2 x CH3), 14.0  (CH3), 13.8 







The title compounds were prepared according to the General Procedure from the 
ester 341 (59 mg, 0.20 mmol), alkynone 133a (31 mg, 0.24 mmol) and KOtBu (4 mg, 
0.04 mmol) and purified by column chromatography (15% Et2O/CH2Cl2) to give first 
diastereomer 346c (E) as a yellow oil (53 mg, 62%), followed by diastereomer 347c 
(Z) yellow oil (25 mg, 30%). 
Data for 346c: 
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IR (film) 2981, 2794, 1738 (C=O), 1685 (C=O), 1614 (C=O), 1508, 1448, 1234, 
1095, 858 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.86-7.84 (2H, m, ArH), 7.60 (1H, d, 
J = 15.7 Hz, CH=CHC=O), 7.55-7.53 (1H, m, ArH), 7.45-7.41 (2H, m, ArH), 7.34 
(1H, d, J = 15.7 Hz, CH=CHC=O), 7.03 (1H, t, J = 8.2 Hz, ArH), 6.42-6.41 (1H, m, 
ArH), 6.38 (1H, dd, J = 8.2, 2.1 Hz, ArH), 6.17-6.14 (1H, m, ArH), 4.35-4.20 (4H, 
m, 2 x OCH2CH3), 2.92 (6H, s, N(CH3)2), 1.22 (6H, t, J = 7.1 Hz, 2 x OCH2CH3); 
13C NMR (62.9 MHz, CDCl3) δ 189.4 (C), 165.9 (2 x C), 155.5 (C), 151.8 (C), 139.3 
(CH), 137.1 (C), 133.2 (CH), 129.4 (CH), 128.7 (3 x CH), 128.5 (2 x CH), 106.9 
(CH), 104.4 (CH), 101.9 (CH), 84.0 (C), 62.9 (2 x CH2), 40.4 (2 x CH3), 13.8 (2 x 
CH3); HRMS (ES) Exact mass calcd. for C24H28NO6 [M+H]+: 426.1911, found: 
426.1917. 
Data for 347c: 
IR (film) 2981, 2802, 1741(C=O), 1682 (C=O), 1622 (C=O), 1508, 1450, 1234, 
1030, 858  cm-1; 1H NMR (360 MHz, CDCl3) δ 7.69-7.65 (2H, m, ArH), 7.48-7.41 
(1H, m, ArH), 7.31-7.25 (2H, m, ArH), 6.96 (1H, d, J = 12.4 Hz, CH=CHC=O), 6.91 
(1H, t, J = 8.2 Hz, ArH), 6.75 (1H, d, J = 12.4 Hz, CH=CHC=O), 6.25-6.21 (1H, m, 
ArH), 5.99-5.95 (2H, m, ArH), 4.28 (4H, q, J = 7.1 Hz, 2 x OCH2CH3), 2.70 (6H, s, 
N(CH3)2), 1.21 (6H, t, J = 7.1 Hz, 2 x OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 
192.3 (C), 166.7 (2 x C), 155.4 (C), 151.5 (C), 136.4 (C), 133.8 (CH), 132.8 (CH), 
130.7 (CH), 128.7 (3 x CH), 128.1 (2 x CH), 106.8 (CH), 104.4 (CH), 102.9 (CH), 
82.3 (C), 62.7 (2 x CH2), 40.3 (2 x CH3), 13.8 (2 x CH3); HRMS (ES) Exact mass 
calcd. for C24H28NO6 [M+H]+: 426.1911, found: 426.1911. 
 
(E)-Diethyl-2-(3-Dimethylaminophenoxy)-2-[3-(4-methoxyphenyl)3-
oxopropenyl)]malonate (346e) and (Z)-diethyl-2-(3-dimethylaminophenoxy)-2-
[3-(4-methoxyphenyl)-3-oxopropenyl]malonate (347e). 
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The title compounds were prepared according to the General Procedure from ester 
341 (100 mg, 0.33 mmol), alkynone 133b (62 mg, 0.39 mmol) and KOtBu (37 mg, 
0.33 mmol) and purified by column chromatography (15% Et2O/CH2Cl2) to give first 
diastereomer 346e (E) as a yellow oil (70 mg, 46%), followed by diastereomer 347e 
(Z) yellow oil (35 mg, 23%). 
Data for 346e: 
IR (film) 2979, 1743 (C=O), 1668 (C=O), 1606 (C=O), 1508, 1452, 1254, 1174, 
1039, 843 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.85 (2H, d, J = 8.9 Hz, ArH), 7.57 
(1H, d, J = 15.7 Hz, CH=CHC=O), 7.34 (1H, d, J = 15.7 Hz, CH=CHC=O), 7.02 
(1H, t, J = 8.2 Hz, ArH), 6.89 (2H, d, J = 8.9 Hz, ArH), 6.42-6.41 (1H, m, ArH), 
6.37 (1H, dd, J = 8.3, 2.2 Hz, ArH), 6.16  (1H, dd, J = 8.1, 2.3 Hz, ArH), 4.34-4.20 
(4H, m, 2 x OCH2CH3), 3.85 (3H, s OCH3), 2.91 (6H, s, N(CH3)2), 1.22 (6H, t, J = 
7.1 Hz, 2 x OCH2CH3); 13C NMR (125.8 MHz, CDCl3) δ 187.6 (C), 165.9 (2 x C), 
163.7 (C), 155.6 (C), 151.8 (C), 138.4 (CH), 131.1 (2 x CH), 130.1 (C), 129.3 (CH), 
128.6 (CH), 113.8 (2 x CH), 106.9 (CH), 104.4 (CH), 101.9 (CH), 84.1 (C), 62.9 (2 x 
CH2), 55.4 (CH3), 40.4 (2 x CH3), 13.8 (2 x CH3); C25H30NO7 [M+H]+: 456.2017, 
found: 456.2022. 
Data for 347e: 
IR (film) 2927, 1745 (C=O), 1662 (C=O), 1604 (C=O), 1504, 1454, 1244, 1169, 
1028, 831 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.65 (2H, d, J = 8.9 Hz, ArH), 6.91 
(1H, d, J = 12.4 Hz, CH=CHC=O), 6.94-6.91 (1H, m, ArH), 6.75 (2H, d, J = 8.9 Hz, 
ArH), 6.73 (1H, d, J = 12.4 Hz, CH=CHC=O), 6.25-6.22 (1H, m, ArH), 5.99-5.96 
(2H, m, ArH), 4.27 (4H, q, J = 7.1 Hz, 2 x OCH2CH3), 3.81 (3H, s, CH3), 2.72 (6H, 
s, N(CH3)2), 1.22 (6H, t, J = 7.1 Hz, 2 x OCH2CH3); 13C NMR (125.8 MHz, CDCl3) 
δ 191.1 (C),  166.7 (2 x C), 163.3 (C), 155.5 (C), 151.5 (C), 132.9 (CH), 131.0 (CH), 
130.9 (2 x CH), 1129.7 (C), 128.6 (CH), 113.3 (2 x CH), 106.7 (CH), 104.4 (CH), 
102.9 (CH), 82.2 (C), 62.7 (2 x CH2 ), 55.3 (CH3), 40.2 (2 x CH3), 13.8 (2 x CH3); 








oxopropenyl]malonate (346f) and (Z)-diethyl-2-(3-dimethylaminophenoxy)-2-[3-
(4-chlorophenyl)-3-oxopropenyl]malonate (347f) 
 
The title compounds were prepared according to the General Procedure from the 
ester 341 (100 mg, 0.33 mmol), alkynone 133f (63 mg, 0.39 mmol) and KOtBu (37 
mg, 0.33 mmol) and purified by column chromatography (15% Et2O/CH2Cl2) to give 
first diastereomer 346f (E) yellow oil (64 mg, 42%), followed by diastereomer 347f 
(Z) yellow oil (50 mg, 33%). 
Data for 346f: 
IR (film) 2981, 1745 (C=O), 1672 (C=O), 1612 (C=O), 1502, 1450, 1248, 1167, 
1057, 827 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.80 (2H, d, J = 8.5 Hz, ArH), 7.63 
(1H, d, J = 15.7 Hz, CH=CHC=O), 7.42 (2H, d, J = 8.5 Hz, ArH), 7.32 (1H, d, J = 
15.7 Hz, CH=CHC=O), 7.06 (1H, t, J = 8.2 Hz, ArH), 6.45-6.44 (1H, m, ArH), 6.40 
(1H, dd,  J = 8.3, 2.2 Hz, ArH), 6.16 (1H, dd, J = 8.1, 2.3 Hz, ArH), 4.38-4.24 (4H, 
m, ArH), 2.95 (6H, s, N(CH3)2), 1.25 (6H, t, J = 7.1 Hz, 2 x OCH2CH3); 13C NMR 
(125.8 MHz, CDCl3) δ 118.1 (C), 166.8 (2 x C), 155.5 (C), 151.8 (C), 139.8 (CH), 
135.4 (C), 130.1 (2 x CH), 129.3 (CH), 128.9 (2 x CH), 128.3 (CH), 107.0 (CH), 
104.3 (CH), 101.8 (CH), 84.0 (C), 63.0 (2 x CH2), 40.3 (2 x CH3), 13.8 (2 x CH3); 
C24H27ClNO6 [M+H]+: 460.1521, found: 460.1520. 
Data for 347f: 
IR (film) 2981, 1745 (C=O), 1670 (C=O), 1608 (C=O), 1506, 1452, 1232, 1149, 
1061, 825 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.55 (2H, d, J = 8.5 Hz, ArH), 7.19 
(2H, d, J = 8.5 Hz, ArH), 6.97 (1H, d, J = 12.4 Hz, CH=CHC=O), 6.89 (1H, t, J = 
8.2 Hz, ArH), 6.66 (1H, d, J = 12.4 Hz, CH=CHC=O), 6.21 (1H, dd, J = 8.3, 2.3 Hz, 
ArH), 5.91 (1H, dd, J = 8.1, 2.2 Hz, ArH), 5.85 (1H, t, J = 2.3 Hz, ArH), 4.28 (4H, 
q, J = 7.1, 2 x OCH2CH3), 2.71 (6H, s, N(CH3)2), 1.22 (6H, t, J = 7.1, 2 x 
OCH2CH3); 13C NMR (125.8 MHz, CDCl3) δ 191.7 (C), 166.5 (2 x C), 155.2 (C), 
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151.5 (C), 139.1 (C), 134.6 (C), 133.4 (CH), 130.6 (CH), 129.9 (2 x CH), 128.7 
(CH), 128.3 (2 x CH), 106.6 (CH), 103.8 (CH), 102.4 (CH), 82.0 (C), 62.8 (2 x CH2), 
40.1 (2 x CH3), 13.8 (2 x CH3); C24H27ClNO6 [M+H]+: 460.1521, found: 460.1525. 
 
(E)-Diethyl-2-(3-dimethylaminophenoxy)-2-[3-(4-nitrophenyl)-3-
oxopropenyl]malonate (346d) and (Z)-diethyl-2-(3-dimethylaminophenoxy)-2-
[3-(4-nitrophenyl)-3-oxopropenyl]malonate (347d) 
 
The title compounds were prepared according to the General Procedure from ester 
341 (100 mg, 0.33 mmol), alkynone 133e (63 mg, 0.39 mmol) and KOtBu (7.4 mg, 
0.06 mmol) and purified by column chromatography (15% Et2O/CH2Cl2) to give first 
diastereomer 345d (E) as a yellow oil (64 mg, 42%), followed by diastereomer 346d 
(Z) as a yellow oil (50 mg, 33%). 
Data for 346d: 
IR (film) 2892, 1771(C=O), 1746 (C=O), 1677 (C=O), 1614, 1526, 1348, 1256, 
1170, 855 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.27 (2H, d, J = 9.0 Hz, ArH), 7.95 
(2H, J = 9.0 Hz, ArH), 7.65 (1H, d, J = 15.7 Hz, CH=CHC=O), 7.28 (1H, d, J = 15.7 
Hz, CH=CHC=O), 7.07-7.00 (1H, m, ArH), 6.42-6.37 (2H, m, ArH), 6.13-6.08 (1H, 
m, ArH), 4.38-4.19 (4H, m, 2 x OCH2CH3), 2.93 (6H, s, N(CH3)2), 1.23 (6H, t, J = 
7.1, 2 x OCH2CH3); 13C NMR (125.8 MHz, CDCl3) δ 187.9 (C), 165.6 (2 x C), 155.4 
(C), 151.8 (C), 150.2 (C), 141.6 (C), 141.3 (CH), 129.7 (2 x CH), 129.4 (CH), 128.0 
(CH), 123.8 (2 x CH), 107.0 (CH), 104.0 (CH), 101.8 (CH), 83.9 (C), 63.1 (2 x CH2), 
40.4 (2 x CH3), 13.8 (2 x CH3); HRMS (ES) Exact mass calcd. for C24H27N2O8 
[M+H]+: 471.1762, found: 471.1756. 
Data for 347d: 
IR (film) 2978, 2924, 1741(C=O), 1684 (C=O), 1608 (C=O), 1527, 1344, 1228, 
1059, 849 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.02 (2H, d, J = 8.8 Hz, ArH), 7.71 
(2H, d, J = 8.8 Hz, ArH), 7.06 (1H , d, J = 12.5 Hz, CH=CHC=O), 6.88 (1H, t, J = 
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8.3, Hz, ArH), 6.67 (1H , d, J = 12.5 Hz, CH=CHC=O), 6.18 (1H, dd, J = 8.3, 2.4 
Hz, ArH), 5.86 (1H, dd, J = 8.1, 2.4 Hz, ArH), 5.71 (1H, t, J = 2.40, Hz, ArH), 4.28 
(4H, q, J = 7.1 Hz, 2 x OCH2CH3), 2.65 (6H, s, N(CH3)2), 1.22 (6H, t, J = 7.1, 2 x 
OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 191.7 (C), 166.1 (2 x C), 154.9 (C), 
151.3 (C), 149.7 (C), 140.4 (C), 133.6 (CH), 130.3 (CH), 129.4 (2 x CH), 128.7 
(CH), 122.9 (2 x CH), 106.4 (CH), 103.3 (CH), 101.6 (CH),  81.8 (C), 62.9 (2 x 
CH2), 39.7 (2 x CH3), 13.7 (2 x CH3); HRMS (ES) Exact mass calcd. for C24H27N2O8 
[M+H]+: 471.1762, found: 471.1756. 
 
(E)-Diethyl-2-(3-dimethylaminophenoxy)-2-(3-naphthalenyl-3-
oxopropenyl)malonate (346g) and (Z)-diethyl-2-(3-dimethylaminophenoxy)-2-(3-
naphthalenyl-3-oxopropenyl)malonate (347g). 
 
The title compounds were prepared according to the General Procedure from the 
ester 341 (100 mg, 0.33 mmol), alkynone 133d (70 mg, 0.33 mmol) and KOtBu (37 
mg, 0.33 mmol) and purified by column chromatography (15% Et2O/CH2Cl2) to give 
first diastereomer 346g (E) yellow oil (102 mg, 65%), followed by diastereomer 
347g (Z) as a yellow oil (13 mg, 8%); 
Data for 346g: 
IR (film) 2981, 1749 (C=O), 1666 (C=O), 1614, 1506, 1450, 1238, 1167, 1055, 781 
cm-1; 1H NMR (500 MHz, CDCl3) δ 8.36-8.34 (1H, m, ArH), 7.97 (1H, d, J = 7.0 
Hz, ArH), 7.88-7.86 (1H, m, ArH), 7.65 (1H, d, J = 8.1 Hz, ArH), 7.54-7.51 (3H, m, 
ArH, CH=CHC=O), 7.44 (1H, t, J = 7.6 Hz, ArH),  7.17 (1H, d, J = 15.9 Hz, 
CH=CHC=O), 7.08 (1H, t, J = 8.1, Hz, ArH), 6.42-6.40 (2H, m, ArH), 6.18-6.16 
(1H, m, ArH), 4.34-4.24 (4H, m, 2 x OCH2CH3), 2.92 (6H, s, N(CH3)2), 1.23 (6H, t, 
J = 7.1 Hz, 2 x OCH2CH3); 13C NMR (125.8 MHz, CDCl3) δ 193.3 (C),  165.9 (2 x 
C), 155.4 (C), 151.8 (C), 139.7 (CH), 135.5 (C), 133.7 (C), 132.8 (CH), 132.6 (CH), 
130.3 (C), 129.3 (CH), 128.5 (CH), 127.6 (CH), 126.4 (CH), 125.5 (CH), 124.3 
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(CH), 106.9 (CH), 104.2 (CH), 101.9 (CH), 83.7 (C), 62.9 (2 x CH2),  40.4 (2 x 
CH3), 13.8; HRMS (ES) Exact mass calcd. for C28H30NO6 [M+H]+: 476.2068, found: 
476.2062. 
Data for 347g: 
IR (film) 2922, 1741 (C=O), 1628, 1581, 1450, 1361, 1228, 1055, 810 cm-1; 1H 
NMR (360 MHz, CDCl3) δ 6.93 (1H, d, J = 8.4 Hz, ArH), 6.36 (1H, d, J = 1.8 Hz, 
ArH), 6.25 (1H, dd, J = 8.4, 1.8 Hz, ArH), 4.65 (1H, dd, J = 9.2, 5.0 Hz, CH2CH), 
4.37-4.22 (4H, m, 2 x OCH2CH3), 2.91 (6H, s, N(CH3)2), 2.82 (1H, dd, J = 17.2, 5.0 
Hz, CH2CH), 2.68 (1H, dd, J = 17.2, 9.2 Hz, CH2CH), 2.16 (3H, s, CH3C=O), 1.31 
(3H, m, OCH2CH3), 1.29 (3H, m, OCH2CH3); 13C NMR (125.8 MHz, CDCl3) δ 
205.6 (C), 167.5 (C), 166.8 (C), 158.6 (C), 151.9 (C), 124.7 (CH), 115.4 (C), 106.3 
(CH), 94.6 (CH), 91.6 (C), 62.5 (CH2), 62.3 (CH2), 45.7 (CH2), 42.5 (CH), 40.7 (2 x 
CH3), 30.4 (CH3), 14.0 (CH3), 13.9 (CH3); HRMS (ES) Exact mass calcd. for 
C19H26NO6[M+H]+: 364.1755, found: 364.1759. 
 
2,2-Dicarbethoxy-6-dimethylamino-3-(2-oxopropyl)-3H-benzofuran (348a) and 
2,2-dicarbethoxy-4-dimethylamino-3-(2-oxopropyl)-3H-benzofuran (349). 
 
To a stirred solution of the mono-Michael product 347a (50 mg, 0.13 mmol) in 
CH2Cl2 (1 mL) at room temperature, BF3·OEt2 (64 μL, 0.52 mmol) was added 
dropwise over 1 min. The reaction was stirred for 15 min. and then was quenched 
with aqueous NaHCO3 solution (5 mL), extracted with CH2Cl2 (3 x 5mL), dried 
(MgSO4) and concentrated in vacuo. Purification of the residue by column 
chromatography (15% EtOAc/hexane) afforded the regioisomeric product 349 as a 
brown oil (8 mg, 16%), followed by product 348a as a yellow oil (36 mg, 72%). 
Data for 349: 
IR (film) 2925, 1739 (C=O), 1610, 1506, 1450, 1363, 1227, 1153, 1039, 854 cm-1; 
1H NMR (360 MHz, CDCl3) δ 7.10 (1H, t, J = 8.1 Hz, ArH), 6.57 (1H, d, J = 8.0 Hz, 
ArH), 6.49 (1H, d, J = 8.1 Hz, ArH), 4.99 (1H, dd, J = 9.2, 3.5 Hz, CH2CH), 4.37-
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4.12 (4H, m, 2 x OCH2CH3), 2.88 (1H, dd, J = 17.5, 3.5 Hz, CH2CH), 2.79 (6H, s, 
N(CH3)2), 2.68 (1H, dd, J = 17.5, 9.2 Hz, CH2CH), 2.13 (3H, s, CH3C=O), 1.31 (3H, 
t, J = 7.2 Hz, OCH2CH3), 1.29 (3H, t, J = 7.2 Hz, OCH2CH3); 13C NMR (125.8 
MHz, CDCl3) δ 205.6 (C), 167.7 (C), 166.6 (C), 157.9 (C), 150.0 (C), 129.7 (CH), 
117.1 (C), 110.3 (CH), 103.4 (CH), 90.8 (C), 62.6 (CH2), 62.4 (CH2), 43.6 (CH2), 
42.7 (2 x CH3), 42.3 (CH), 30.0 (CH3), 13.9 (CH3), 13.8 (CH3); HRMS (ES) Exact 
mass calcd. for C19H26NO6 [M+H]+: 364.1755, found: 364.1750. 
Data for 348a: 
IR (film) 2922, 1741 (C=O), 1628, 1581, 1450, 1361, 1228, 1055, 810 cm-1; 1H 
NMR (360 MHz, CDCl3) δ 6.93 (1H, d, J = 8.4 Hz, ArH), 6.36 (1H, d, J = 1.8 Hz, 
ArH), 6.25 (1H, dd, J = 8.4, 1.8 Hz, ArH), 4.65 (1H, dd, J = 9.2, 5.0 Hz, CH2CH), 
4.37-4.22 (4H, m, 2 x OCH2CH3), 2.91 (6H, s, N(CH3)2), 2.82 (1H, dd, J = 17.2, 5.0 
Hz, CH2CH), 2.68 (1H, dd, J = 17.2, 9.2 Hz, CH2CH), 2.16 (3H, s, CH3C=O), 1.31 
(3H, m, OCH2CH3), 1.29 (3H, m, OCH2CH3); 13C NMR (125.8 MHz, CDCl3) δ 
205.6 (C), 167.5 (C), 166.8 (C), 158.6 (C), 151.9 (C), 124.7 (CH), 115.4 (C), 106.3 
(CH), 94.6 (CH), 91.6 (C), 62.5 (CH2), 62.3 (CH2), 45.7 (CH2), 42.5 (CH), 40.7 (2 x 
CH3), 30.4 (CH3), 14.0 (CH3), 13.9 (CH3); HRMS (ES) Exact mass calcd. for 
C19H26NO6[M+H]+: 364.1755, found: 364.1759. 
 
5.3.2 General two-step Procedure without purification. 
 
To a stirred solution of the ester (100 mg, 0.33 mmol) and KOtBu (37 mg, 0.33 
mmol)) in CH2Cl2 (1 mL) at room temperature was added a solution of the 
appropriate alkynone (1.2 equiv.) in CH2Cl2 (1 mL) via cannula and dropwise over 1 
min. The reaction was stirred at room temperature for 15 min., quenched with 
saturated aqueous NaHCO3 solution (5 mL), extracted with CH2Cl2 (3 x 5 mL), dried 
(MgSO4) and concentrated in vacuo. The crude product was dissolved in CH2Cl2 (2 
mL) and to the resulting mixture BF3·OEt2 (48 μL, 0.39 mmol) was added dropwise 
over 1 min. The reaction was stirred for 15 min and then was quenched with aqueous 
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NaHCO3 solution (5 mL), extracted with CH2Cl2 (3 x 5mL) and the combined 
organic layers were concentrated in vacuo. Purification of the residue by column 
chromatography afforded the cyclised product. 
 
2,2-Dicarbethoxy-6-dimethylamino-3-(2-
oxophenylethyl)-3H-benzofuran (348c). The title 
compound was prepared according to the General two-step 
Procedure from alkynone 133a (50 mg, 0.39 mmol) and 
purified by column chromatography (15% EtOAc/hexane) to give a yellow oil (40 
mg, 37% over two steps). IR (film) 2924, 1741 (C=O), 1685 (C=O), 1628 (C=O), 
1512, 1450, 1363, 1234, 1045, 808 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.95-7.92 
(2H, m, ArH), 7.59-7.54 (1H, m, ArH), 7.48-7.43 (2H, m, ArH), 6.97 (1H, dd, d, J = 
8.4, 0.7 Hz, ArH), 6.38 (1H, d, J = 2.3 Hz, ArH), 6.23 (1H, dd, J = 8.4, 2.3 Hz, 
ArH), 4.90 (1H, dd,  J = 8.9, 5.0 Hz, CH2CH), 4.40-4.14 (4H, m, 2 x OCH2CH3), 
3.40 (1H, dd, J = 17.1, 5.0 Hz, CH2CH), 3.23 (1H, dd, J = 17.1, 8.9 Hz, CH2CH), 
2.91 (6H, s, N(CH3)2), 1.31 (3H, t, J = 7.1 Hz, OCH2CH3), 1.27 (3H, t, J = 7.1 Hz, 
OCH2CH3); 13C NMR (62.9 MHz, CDCl3) δ 197.1 (C), 167.6 (C), 166.9 (C), 158.7 
(C), 151.9 (C), 136.7 (C), 133.2 (CH), 128.6 (2 x CH), 128.1 (2 x CH), 125.0 (CH), 
115.6 (C), 106.4 (CH), 94.7 (CH), 91.9 (C), 62.6 (CH2), 62.3 (CH2), 42.8 (CH), 41.1 
(CH2), 40.7 (2 x CH3), 14.0 (2 x CH3); HRMS (ES) Exact mass calcd. for C24H28NO6 
[M+H]+: 426.1911, found: 426.1907. 
 
2,2-Dicarbethoxy-6-dimethylamino-3-[2-(4-
chlorophenyl)-2-oxethyl]-3H-benzofuran (348f). The 
title compound was prepared according to the General 
two-step Procedure from alkynone 133f (63.0 mg, 0.39 
mmol) and KtBuO (37 mg, 0.33 mmol) and purified by column chromatography 
(15% EtOAc/hexane) to give a red solid (66 mg, 44% over two steps); m.p. 115-119 
°C; IR (film) 2924, 1741 (C=O), 1687 (C=O), 1628 (C=O), 1512, 1450, 1275, 1232, 
1049, 822 cm-1; 1H NMR (360 MHz, CDCl3) δ 1H NMR (360 MHz, CDCl3) δ 7.86 
(2H, d, J = 8.3 Hz, ArH), 7.42 (2H, d, J = 8.3 Hz, ArH), 6.9 (1H, d, J = 8.3 Hz, 
ArH), 6.37 (1H, s, ArH), 6.22 (1H, d, J = 8.3 Hz, ArH), 4.87-4.84 (1H, m, CH2CH), 
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4.37-4.15 (4H, m, 2 x OCH2CH3), 3.36 (1H, dd, J = 17.1, 5.0 Hz, CH2CH), 3.19 
(1H, dd, J = 17.1, 8.8 Hz, CH2CH), 2.89 (6H, s, N(CH3)2), 1.30 (3H, t, J = 7.1 Hz, 
OCH2CH3), 1.28-1.25 (3H, m, OCH2CH3);13C NMR (125.8 MHz, CDCl3) δ 195.9 
(C), 167.5 (C), 166.8 (C), 58.7 (C), 151.9 (C), 139.7 (C), 134.9 (C), 129.4 (2 x CH), 
128.9 (2 x CH), 124.9 (CH), 115.3 (C), 106.3 (CH), 94.6 (CH), 91.8 (C), 62.5 (CH2), 
62.3(CH2), 42.8 (CH2), 40.9 (CH), 40.6 (CH3), 29.6 (CH3), 14.0 (CH3), 13.9 (CH3); 




The title compound was prepared according to the 
General two-step Procedure from alkynone 133b 
(53.0 mg, 0.33 mmol) and purified by column chromatography (15% EtOAc/hexane) 
to give a yellow solid (52 mg, 35% over two steps); m.p. 100-102 °C; IR (film) 2924, 
1745 (C=O), 1676 (C=O), 1601, 1510, 1452, 1361, 1236, 1036, 827 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 7.91 (2H, d, J = 8.8 Hz, ArH), 6.95 (1H d, J = 8.4 Hz, ArH), 
6.92 (2H, d, J = 8.8 Hz, ArH), 6.37 (1H, d, J = 1.90 Hz, ArH), 6.22 (dd, J = 8.4, 2.0 
Hz, ArH), 4.88 (1H, dd, J = 9.0, 5.0 Hz, CH2CH), 4.37-4.14 (4H, m, 2 x OCH2CH3), 
3.86 (3H, s, OCH3), 3.32 (1H, dd, J = 16.8, 5.0 Hz, CH2CH), 3.17 (1H, dd, J = 16.8, 
9.0 Hz, CH2CH), 2.89 (6H, s, N(CH3)2), 1.30 (3H, t, J = 7.1 Hz, OCH2CH3), 1.27 
(3H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (125.8 MHz, CDCl3) δ 195.6 (C), 167.6 
(C), 166.9 (C), 163.5 (C), 158.7 (C), 151.9 (C), 130.3 (2 x CH2), 129.8 (C), 125.0 
CH), 115.7 (C), 113.7 (2 x CH2), 106.3 (CH), 94.6 (CH), 91.9 (C), 62.5 (CH2), 62.3 
(CH2), 55.4 (CH3), 42.9 (CH), 40.7 (CH3), 40.6 (CH2), 29.6 (CH3), 14.0 (CH3), 13.9 





The title compound was prepared according to the 
General two-step Procedure from alkynone 133d (72.0 
mg, 0.39 mmol) and purified by column chromatography (15% EtOAc/hexane) to 
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give a yellow oil (102 mg, 65% over two steps); IR (film) 2922, 1743 (C=O), 1684 
(C=O), 1628, 1510, 1452, 1360, 1230, 1053, 793 cm-1; 1H NMR (360 MHz, CDCl3) 
δ 8.71 (1H, d, J = 8.6 Hz, ArH), 7.99 (1H, d, J = 8.2 Hz, ArH), 7.88 (1H, d, J = 8.0 
Hz, ArH), 7.79 (1H, d, J = 8.0 Hz, ArH), 7.65-7.60 (1H, m, ArH), 7.57-7.53 (1H, m, 
ArH), 7.48-7.44 (1H, m, ArH), 7.05 (1H, d, J = 8.4 Hz, ArH), 6.41 (1H, d, J = 2.2 
Hz, ArH), 6.25 (1H, dd, J = 8.4, 2.2 Hz, ArH), 4.98 (1H, dd, J = 9.0, 5.0 Hz, 
CH2CH), 4.42-4.14 (4H, m, 2 x OCH2CH3), 3.47 (1H, dd, J = 17.1, 5.0 Hz, CH2CH), 
3.36 (1H, dd, J = 17.1, 9.0 Hz, CH2CH), 2.91 (6H, s, N(CH3)2), 1.33 (3H, t, J = 7.1 
Hz, OCH2CH3), 1.26 (3H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (125.8 MHz, CDCl3) 
δ 200.9 (C), 167.6 (C), 166.9 (C), 158.7 (C), 151.9 (C), 135.3 (C), 133.9 (C), 132.9 
(CH), 130.1 (C), 128.4 (CH), 128.0 (2 x CH), 125.8.5 (CH), 125.7 (CH),  124.9 
(CH), 124.3 (CH), 115.5 9 (C), 106.4 (CH), 94.7 (CH), 91.9 (C), 62.6 (CH2), 62.3 
(CH2), 44.2 (CH2), 43.2 (CH), 40.7 (2 x CH3), 14.0 (CH3), 13.9 (CH3); HRMS (ES) 
Exact mass calcd. for C28H30NO6 [M+H]+: 476.2068, found: 476.2068. 
 
2,2-Dicarbethoxy-6-dimethylamino-3-(2-oxopropyl)-3H-
benzofuran (348a). The title compound was prepared 
according to the General two-step Procedure from ester 341 
(59 mg, 0.20 mmol), KOtBu (4 mg, 0.04 mmol), and alkynone 
133h (14 μL, 0.20 mmol) purified by column chromatography (15% EtOAc/hexane) 






To a stirred solution of ester 341 (100 mg, 0.33 mmol) and KOtBu (7.4 mg, 0.06 
mmol) in CH2Cl2 (1 mL) at room temperature was added a solution of alkynone 133e 
(70 mg, 0.40 mmol) in CH2Cl2 (1 mL) via cannula and dropwise over 1 min. The 
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reaction was stirred at room temperature for 15 min., quenched with saturated 
aqueous NaHCO3 solution (5 mL), extracted with CH2Cl2 (3 x 5mL) and 
concentrated in vacuo. The crude product was diluted with CH2Cl2 (2 mL) and 
Yb(OTf)3·xH2O (12 mg, 0.02 mmol) was added to the resulting mixture which was 
then microwaved at 100oC for 15 min. Purification of the resulting mixture by 
column chromatography afforded the cyclised product as an orange solid (59 mg, 
38%); m.p. 150-153 °C; IR (CHCl3) 2924, 2852, 1741 (C=O), 1695 (C=O), 1630, 
1523, 1448, 1346, 1228, 854; 1H NMR (500 MHz, CDCl3) δ 8.29 (2H , d,  J = 8.8 
Hz, ArH), 8.07 (2H , d,  J = 8.8 Hz, ArH), 6.93 (1H, d,  J = 8.4 Hz, ArH), 6.37 (1H, 
d,  J = 2.2 Hz, ArH), 6.22 (1H, dd, J = 8.4, 2.2Hz, ArH), 4.85 (1H, dd, J = 8.5, 5.4 
Hz, CH2CH), 4.38-4.17 (4H, m, 2 x OCH2CH3), 3.45 (1H, dd, J = 17.3, 5.3 Hz, 
CH2CH), 3.26 (1H, dd, J = 17.3, 8.5 Hz, CH2CH), 2.90 (6H, s, N(CH3)2), 1.33-1.27 
(6H, m, 2 x OCH2CH3); 13C NMR (125.8 MHz, CDCl3) δ 195.9 (C), 167.5 (C), 166.8 
(C), 158.7 (C), 152.1 (C), 150.3 (C), 141.0 (C), 129.1 (2 x CH), 124.7 (CH), 123.9 (2 
x CH), 114.8 (C), 106.3 (CH), 94.6 (CH), 91.6 (C), 62.7 (CH2), 62.4 (CH2), 42.8 
(CH2), 41.5 (CH), 40.6 (CH3), 14.0 (CH3), 13.9 (CH3); HRMS (ES) Exact mass 
calcd. for C24H27N2O8 [M+H]+: 471.1762, found: 471.1764. 
 
5.3.3 Combined Michael addition/Friedel-Crafts-cyclisation: General one-pot 
Procedure. 
 
A solution of the ester 341 (30 mg, 0.10 mmol), the alkynone (0.12 mmol) and 
Yb(OTf)3·xH2O (12 mg, 0.02 mmol) in CH2Cl2 (1 mL) at room temperature was 
microwaved at 100 oC for 15 min. Purification of the resulting mixture by column 
chromatography afforded the cyclised product. 
 
2,2-Dicarberthoxy-6-dimethylamino-3-(2-
oxophenylethyl)-3H-benzofuran (348c). The title 
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compound was prepared according to the General one-pot Procedure from alkynone 
133a (16 mg, 0.12 mmol) and purified by column chromatography (15% 





The title compound was prepared according to the 
General one-pot Procedure from alkynone 133c (31.0 
mg, 0.15 mmol) and purified by column chromatography (15% EtOAc/hexane) to 
give a yellow oil (40 mg, 80%); IR (film) 2924, 1743 (C=O), 1694 (C=O), 1627, 
1512, 1450, 1275, 1360, 1043, 811 cm-1; 1H NMR (360 MHz, CDCl3) δ 1H NMR 
(360 MHz, CDCl3) δ 7.79 (2H, d, J = 8.6 Hz, ArH), 7.59 (2H, d, J = 8.6 Hz, ArH), 
6.93 (1H, d, J = 8.4 Hz, ArH), 6.37 (1H, d, J = 2.2 Hz, ArH), 6.22 (1H, dd, J = 8.4, 
2.2 Hz, ArH), 4.86 (1H, dd, J = 8.7, 5.2 Hz, CH2CH), 4.39-4.14 (4H, m, 2 x 
OCH2CH3), 3.35 (1H, dd, J = 17.1, 5.2 Hz, CH2CH), 3.18 (1H, dd, J = 17.1, 8.7 Hz, 
CH2CH), 2.90 (6H, s, N(CH3)2), 1.33-1.25 (6H, m, 2 x OCH2CH3); 13C NMR (62.9 
MHz, CDCl3) δ 196.1 (C), 167.5 (C), 166.9 (C), 158.7 (C), 151.9 (C), 135.4 (C), 
131.9 (2 x CH), 129.6 (2 x CH), 128.4 (C), 124.8 (CH), 115.3 (C), 106.3 (CH), 94.6 
(CH), 91.8 (C), 62.6 (CH2), 62.3 (CH2), 42.8 (CH), 41.00 (CH2), 40.6 (2 x CH3), 14.0 
(CH3), 13.9 (CH3); HRMS (ES) Exact mass calcd. for C24H2779BrNO6 [M+H]+: 




The title compound was prepared according to the 
General one-pot Procedure from alkynone 133b (24.0 
mg, 0.15 mmol) and purified by column chromatography (15% EtOAc/hexane) to 
give a yellow solid (24 mg, 53% over two steps). (See pp. 142 for further 
information). 
 




naphthalenyl-2-oxethyl)-3H-benzofuran (348g). The 
title compound was prepared according to the General 
one-pot Procedure from alkynone 133d (27.0 mg, 0.15 
mmol) and purified by column chromatography (15% EtOAc/hexane) to give a 
yellow oil (22 mg, 44%). (See pp. 143 for further information) 
 
2,2-Dicarbethoxy-6-dimethylamino-3-(2-oxopropyl)-3H-
benzofuran (348a). The title compound was prepared 
according to the General one-pot Procedure from alkynone 
133a (9 μL, 0.12 mmol) and purified by column 
chromatography (15% EtOAc/hexane) to give yellow oil (19 mg, 54%). (See pp. 139 
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ABSTRACT
In the presence of substoichiometric quantities of potassium tert -butoxide and an additional metal salt, amide-tethered diacids undergo double
Michael reactions with alkynones to provide highly functionalized pyroglutamic acid derivatives. The metal salt was found to play an important
role in improving the diastereoselectivities of the reactions.
Pyroglutamic acid (1) and its derivatives are structural units
of widespread chemical significance, having been heavily
utilized as building blocks for the synthesis of numerous
biologically active compounds.1
Considering the multitude of synthetic applications for
pyroglutamic acids, much research effort has been devoted
to the development of new methods for the synthesis of
functionalized derivatives.1,2 In this Letter, we present a novel
route to highly functionalized pyroglutamic acids using
double Michael reactions3 of amide-tethered diacids with
alkynones.
Over the past few years, Grossman and co-workers have
described a range of reactions where compounds containing
two acidic carbon atoms undergo double Michael reactions
with electron-deficient alkynes (mostly 3-butyn-2-one) to
provide highly functionalized cyclic products.4,5 Generating
two new carbon-carbon bonds and up to three new stereo-
genic centers with often high levels of diastereoselectivity,
this reaction has been effectively utilized in the preparation
of a range of five- and six-membered carbocycles.4 In
† University of Edinburgh.
‡ AstraZeneca.
(1) For a recent review, see: Na´jera, C.; Yus, M. Tetrahedron:
Asymmetry1999, 10, 2245-2303.
(2) For recent, representative examples, see: (a) Soloshonok, V. A.; Cai,
C.; Yamada, T.; Ueki, H.; Ohfune, Y.; Hruby, V. J. Am. Chem. Soc.
2005, 127, 15296-15303. (b) Chang, M.-Y.; Sun, P.-P.; Chen, S.-T.; Chang,
N.-C.Tetrahedron Lett.2003, 44, 5271-5273. (c) Alvarez-Ibarra, C.; Csa´kÿ,
A. G.; Gómez de la Olivia, C.Eur. J. Org. Chem.2002, 4190-4194. (d)
Merino, P.; Revuelta, J.; Tejero, T.; Chiacchio, U.; Rescifina, A.; Piperno,
A.; Romeo, G.Tetrahedron: Asymmetry2002, 13, 167-172.
(3) Little, R. D.; Masjedizadeh, M. R.; Wallquist, O.; McLoughlin, J. I.
Org. React.1995, 47, 315-512.
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1999, 64, 340-341. (b) Grossman, R. B.; Rasne, R. M.; Patrick, B. O.J.
Org. Chem.1999, 64, 7173-7177. (c) Grossman, R. B.; Pendharker, D.
S.; Patrick, B. O.J. Org. Chem.1999, 64, 7178-7183. (d) Grossman, R.
B.; Skaggs, A. J.; Kray, A. E.; Patrick, B. O.Org. Lett.1999, 1, 1583-
1586. (e) Grossman, R. B.; Pendharker, D. S.; Rasne, R. M.; Varner, M.
A. J. Org. Chem.2000, 65, 3255-3258. (f) Grossman, R. B.; Rasne, R.
M. Org. Lett. 2001, 3, 4027-4030. (g) Holeman, D. S.; Rasne, R. M.;
Grossman, R. B.J. Org. Chem.2002, 67, 3149-3151. (h) Hattori, K.;
Grossman, R. B.J. Org. Chem.2003, 68, 1409-1417. For a review, see:
(i) Grossman, R. B.Synlett2001, 13-21.
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comparison, application of this methodology to heterocycle
construction has been limited, with just one report of a [5+
1] annulation route to piperidines having been described.5
In view of the convergent and modular nature of these
transformations, we were drawn to the prospect of utilizing
double Michael reactions of alkynones in a concise synthesis
of highly functionalized pyroglutamic derivatives, according
to the strategy outlined in Scheme 1. It was hoped that under
suitable conditions, an amide-tethered diacid2 would react
with an alkynone3 to first give mono-Michael adduct4 and/
or 5, which would then cyclize to the pyroglutamic acid
derivative6.
Our preliminary investigations began with the double
Michael reaction of amide-tethered diacid7a with aromatic
alkynone3a (Table 1). In all previous examples of double
Michael reactions reported by Grossman and co-workers,4,5
a mandatory requirement for success is the presence of at
least one nitrile substituent in the tethered diacid, which ends
up in a pseudoaxial position in the product.4i It is proposed
that the small size of the nitrile group reduces the magnitude
of unfavorable 1,3-diaxial interactions between acidifying
groups in the transition state for cyclization, which would
otherwise inhibit ring closure.4i At the outset of this work, it
was therefore uncertain whether diacid7a, which does not
possess a nitrile substituent, would undergo successful double
Michael reaction. Although treatment of a mixture of7aand
3a with PPh3 in acetonitrile4c gave no reaction (entry 1), we
found that KOtBu in CH2Cl24a led to the formation of the
desired pyroglutamic acid derivative8, albeit as a 1:1 mixture
of diastereomers (entry 2).
We next investigated the effect of Lewis acidic additives
on the reaction.6 Substoichiometric quantities of Fe(acac)37
and Zn(OTf)28 were found to inhibit the reaction (entries 3
and 4), though Zn(OTf)2 had a beneficial effect on di-
astereoselectivity (entry 4). Finally, we identified Mg(OTf)29
(entry 5) and Ni(acac)210 (entry 6) as promising additives,
allowing double Michael product8 to be isolated in 68-
76% yield and with up to 18:1 diastereomeric ratio.
Recrystallization of8 from a mixture of diethyl ether and
hexane afforded crystals that were suitable for X-ray crystal-
lography, which allowed us to confirm that the major
diastereomer obtained in these reactions possessestran
stereochemistry (Figure 1).
With optimized conditions in hand, the scope of the
reaction was explored (Figure 2). Using7a as the tethered
(6) For a review of transition-metal-catalyzed Michael reactions of 1,3-
dicarbonyl compounds, see: Christoffers, J.Eur. J. Org. Chem.1998, 1259-
1266.
(7) For examples of iron-catalyzed Michael reactions of 1,3-dicarbonyl
compounds, see: (a) Fei, C. P.; Chan, T. H.Synthesis1982, 467-468. (b)
Kočovksý, P.; Dvořák, D. Tetrahedron. Lett.1986, 27, 5015-5108. (c)
Christoffers, J.Chem. Commun.1997, 943-944. (d) Christoffers, J.J. Chem.
Soc., Perkin Trans. 1997, 3141-3149. (e) Christoffers, J.Synlett2001,
723-732.
(8) For examples of zinc-catalyzed Michael reactions of 1,3-dicarbonyl
compounds, see: Brunner, H.; Krumey, C.J. Mol. Catal. A1999, 142,
7-15.
(9) For examples of magnesium-catalyzed Michael reactions of 1,3-
dicarbonyl compounds, see: (a) Ji, J.; Barnes, D. M.; Zhang, J.; King, S.
A.; Wittenberger, S. J.; Morton, H. E.J Am. Chem. Soc.1999, 121, 10215-
10216. (b) Barnes, D. M.; Ji, J.; Fickes, M. G.; Fitzgerald, M. A.; King, S.
A.; Morton, H. E.; Plagge, F. A.; Preskill, M.; Wagaw, S. H.; Wittenberger,
S. J.; Zhang, J.J. Am. Chem. Soc.2002, 124, 13097-13105. (c)
MacCulloch, A. C.; Yolka, S.; Jackson, R. F. W.Synlett2002, 1700-1702.
Scheme 1. Proposed Double Michael Addition Route to
Pyroglutamic Acid Derivatives




1c PPh3 (20 mol %) n/a 0
2 KOtBu (20 mol %) 1:1 68
3 KOtBu (20 mol %), Fe(acac)3 (20 mol %) 1:1 31
4 KOtBu (20 mol %), Zn(OTf)2 (20 mol %) >19:1 27
5 KOtBu (20 mol %), Mg(OTf)2 (20 mol %) 11:1 68
6 KOtBu (20 mol %), Ni(acac)2 (20 mol %) 18:1 76
a As determined by1H NMR analysis of the isolated product. Due to
overlapping signals from other compounds, diastereomeric ratios could not
be determined from1H NMR analysis of the unpurified reaction mixtures.
b Isolated yields of mixtures of diastereoisomers that were inseparable by
column chromatography.c MeCN used as solvent in place of CH2Cl2.
Figure 1. X-ray crystal structure of double Michael product8.
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diacid, a range of different aromatic alkynones3 possessing
substituents of varying electronic character underwent double
Michael reactions to provide pyroglutamic acid derivatives
9-13 in 61-77% yield. Tethered diacid7b, containing
methyl esters in place of the ethyl esters in7a, also
underwent reaction uneventfully, affording double Michael
products14-17.
Additional experiments provided some insight into the
reaction pathway and the role played by the metal salts
(Scheme 2). Equation 1 highlights differences in the effect
of Mg(OTf)2 and Ni(acac)2. Reaction of methyl vinyl ketone
(18) with diacid7a using Mg(OTf)2 as additive led to19 as
the only observable Michael product in 52% yield, with the
remainder of material being unreacted7a. This experiment
indicates that under these conditions, the methylene carbon
adjacent to the amide carbonyl of7a is the more reactive of
the two acidic positions. However, the analogous experiment
using Ni(acac)2 provided a mixture of19and the alternative
Michael product20, among other side-products.
Exposure of a 1:1 diastereomeric mixture of double
Michael product8 obtained using KOtBu alone (Table 1,
entry 2) to standard reaction conditionsi cludingadditional
Mg(OTf)2 or Ni(acac)2 led to recovery of8 in high yield
with no discernible change in diastereomeric composition
(eq 2). These experiments suggest that under these conditions,
post-cyclization epimerization (which could occur via a
deprotonation-reprotonation sequence or a retro-Michael-
Michael sequence) does not occur, and therefore diastereo-
selection observed in the presence of additional metal salt
is the result of a kinetically controlled process. However,
the manner in which the metal salt imparts diastereoselec-
tivity is not clear at this time.
Conversion of double Michael product8 into other
potentially useful compounds is shown in Scheme 3. Treat-
ment of8 with NaH and BnBr provided alkylated product
(10) For examples of nickel-catalyzed Michael reactions of 1,3-dicarbonyl
compounds, see: (a) Nelson, J. H.; Howells, P. N.; DeLullo, G. C.; Landen,
G. L.; Henry, R. A.J. Org. Chem.1980, 45, 1246-1249. (b) Clariana, J.;
Gálvez, N.; Marchi, C.; Moreno-Man˜as, M.; Vallribera, A.; Molins, E.Tetra-
hedron1999, 55, 7331-7344. (c) Christoffers, J.; Ro¨âler, U.; Werner, T.
Eur. J. Org. Chem.2000, 701-705. (d) Evans, D. A.; Seidel, D.J. Am.
Chem. Soc.2005, 127, 9958-9959. (e) Evans, D. A.; Thomson, R. J.;
Franco, F.J. Am. Chem. Soc.2005, 127, 10816-10817. (f) Itoh, K.;
Hasegawa, M.; Tanaka, J.; Kanemasa, S.Org. Lett.2005, 7, 979-981. (g)
Yanagita, H.; Kodama, K.; Kanemasa, S.Tetrahedron Lett.2006, 47, 9353-
9357.
Figure 2. Double Michael reactions of amide-tethered diacids7a
and7b with assorted aromatic alkynones. Cited yields are of isolated
inseparable mixtures of diastereoisomers. Diastereomeric ratios were
determined by1H NMR analysis of the isolated products. Due to
overlapping signals from other compounds, diastereomeric ratios
could not be determined by1H NMR analysis of unpurified reaction
mixtures.
Scheme 2. Experiments Probing the Role of Mg(OTf)2 and
Ni(acac)2
Scheme 3. Elaboration of Double Michael Product9
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21,11 and monodecarboxylation to22 was accomplished by
heating a DMF solution of8 to 110°C.
In summary, we have developed a double Michael addition
route to highly functionalized pyroglutamic acid deriva-
tives that utilizes amide-tethered carbon diacids and aro-
matic alkynones as substrates. The reactions proceed with
good levels of trans-diastereoselectivity, provided that
substoichiometric quantities of Mg(OTf)2 or Ni(acac)2 are
employed as additives. Further work will address the
development of enantioselective variants of these reactions.
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